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Abstract 
 Nausea and vomiting are common but serious side effects associated 
with many therapeutic drugs.  Whilst the physiological mechanisms behind the 
generation of the vomiting response are well characterised, the range of emetic 
stimuli that can generate the response are poorly understood.  The potential of 
using Dictyostelium discoideum, a eukaryotic amoeba, as a model for predicting 
emetic liability was examined in this thesis.  The effects of a range of known 
emetic and aversive compounds on Dictyostelium cell behaviour was 
investigated, resulting in the identification of a small number that strongly 
inhibited cell migration in a concentration-dependent and reversible manner.  
These active compounds included a range of bitter compounds and the pungent 
tastant, capsaicin.  A Dictyostelium mutagenesis screen was then used to 
identify genes controlling sensitivity to bitter tastants.  This screen identified a 
mutant containing a disrupted grlJ gene as showing partial resistance to 
phenylthiourea in growth and behavioural changes in movement.  GrlJ is a G-
protein coupled receptor that regulates a phenylthiourea-dependent effect by 
inhibition of a phosphatidylinositol (PIP3) signalling pathway. A search for 
proteins sharing homology to GrlJ identified an uncharacterised GABAB-like 
receptor, Q8NHA5, involved in the detection of phenylthiourea in Dictyostelium.  
This thesis has therefore identified Dictyostelium as a potentially useful model 
for the identification of bitter and pungent tastants.  In addition, this thesis has 
identified the Dictyostelium protein, GrlJ, as well as an uncharacterised human 
protein, Q8NHA5, involved in the detection of the bitter tastant, phenylthiourea.   
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 Aspects of the physiology and pharmacology of nausea and vomiting will 
be reviewed in this introduction to provide background for the potential use of 
Dictyostelium as a model for the replacement of sentient species in the 
identification of emetic liability of novel chemical entities.  In addition, some of 
the key compounds involved in the induction of these responses will be 
discussed.  Current sentient models used in emetic research will then be 
outlined, before exploring alternative non-sentient approaches that have the 
potential to reduce or possibly replace the number of animals involved in emetic 
research.  Finally, the use of a single celled social amoeba, Dictyostelium 
discoideum, has as a potential biomedical model in emetic research will be 
introduced. 
1.1. Nausea and Vomiting 
Many therapeutic drugs that are marketed today have gastrointestinal 
side effects, of which nausea (over 50% of drugs) and vomiting (emesis) (over 
33% of drugs) are the most common (Holmes et al., 2009).  Nausea is an 
“unpleasant sensation of sickness, which is often followed by the urge to vomit” 
(Parkinson et al., 2011).  This sensation predominantly but not exclusively 
precedes the physical action of vomiting, which can be described as the forceful 
expulsion of gastric contents from the stomach through the mouth (Parkinson et 
al., 2011). Nausea and vomiting can be caused by gastrointestinal upset, an 
unpleasant smell, concussion, anticipation of fear, imbalance of the vestibular 
system and various drug treatments (Sanger and Andrews, 2006).   
During drug treatment, nausea and vomiting are severe side effects that 
can adversely affect clinical response when administered orally, due to 
prevention of efficient absorption of drugs from the gastrointestinal tract into the 
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systemic circulation (Parkinson et al., 2011).  Anticipatory nausea and vomiting, 
which is commonly seen in patients receiving cancer chemotherapy, can also 
hinder patient compliance during drug treatments (Parkinson et al., 2011).  In 
addition, the highly unpleasant nature of the experience can also discourage 
patients from taking their treatments, which may also result in poor treatment 
efficacy.  
1.2. Physiology of Nausea and Vomiting 
In considering the biological process of vomiting (emesis), the 
physiological process of vomiting will firstly be examined.  The emetic response 
occurs in 3 phases consisting of a pre-ejection, ejection and a post-ejection 
phase (Lindley and Andrews, 2005).   
1.2.1. Pre-ejection phase 
Upon detection of nauseating or emetic stimuli, numerous physiological 
changes occur, known as the pre-ejection phase.  This phase has been 
associated with increased plasma levels of the hormones vasopressin 
(associated with the induction of nausea) and adrenaline (associated with 
stress) (Andrews and Rudd, 2004; Lindley and Andrews, 2005).  The pre-
ejection phase is also characterised by relaxation of the proximal stomach to 
delay gastric emptying and facilitating space for intestinal contents (Andrews 
and Rudd, 2004).  This is followed by a giant retrograde contraction originating 
in the small intestine, forcing intestinal contents into the relaxed stomach 
(Andrews and Rudd, 2004).  In addition, other physical symptoms characterised 
by the pre-ejection phase include retching, the onset of tachycardia 
(accelerated heart rate), cutaneous vasoconstriction, pallor (pale skin), 
20 
 
salivation and cold sweating (Andrews and Rudd, 2004; Lindley and Andrews, 
2005).   
1.2.2. Ejection phase 
Vomiting is characterised by rhythmic contractions of the diaphragm, 
external intercostal and abdominal muscles, which compress the stomach 
(Andrews and Rudd, 2004; Lindley and Andrews, 2005).  Simultaneously, the 
crural fibres of the diaphragm surrounding the oesophagus (usually in a 
contracted state) relax facilitating the expulsion of gastric contents (Holmes et 
al., 2009).  This combination of abdominal contractions generate an extremely 
high pressure in the stomach, resulting in vomiting (Andrews and Rudd, 2004). 
1.2.3. Post-ejection phase 
Once vomiting has occurred, the subject often suffers numerous 
exhaustive physical symptoms, characterised by a subject feeling exhausted, 
dehydrated and weak, due to the respective violent contractions and fluid loss 
that have just occurred (Richards and Andrews, 2007).   
1.3. Pharmacology of Nausea and Vomiting 
In order to survive exposures to ingested harmful substances, humans 
and many animals developed an emetic response (Andrews and Sanger, 1993).  
The mucosal lining of the gastrointestinal tract is sensitive to a range of stimuli, 
resulting in neurotransmitter release by enterochromaffin cells and causing 
activation of afferent fibres in the vagus nerve (Sanger and Andrews, 2006).  
One of the primary mediators involved in generating the emetic response is 5-
hydroxytryptamine (serotonin), which is stored and released by 
enterochromaffin cells, activating 5-hydroxytryptamine3 (5-HT3) receptors on 
afferent vagal termini   (Andrews et al., 1988) (Figure 1.1).  It is proposed that 
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emetic compounds, such as chemotherapeutic agents, activate 
enterochromaffin cells by generating reactive oxygen species (such as the 
superoxide anion (O2
-)), causing increased intracellular calcium and thus 
facilitating extracellular serotonin release (Andrews and Rudd, 2004).  Orally 
administered emetic compounds such as copper sulphate and ipecac (a mixture 
of plant alkaloids) are proposed to initiate serotonin release from 
enterochromaffin cells, which subsequently initiates the acute onset of vomiting 
(Sanger and Andrews, 2006).  In cancer chemotherapy, radiation therapy and 
injected chemotherapeutic agents can also result in the enterochromaffin cell-
mediated acute onset of vomiting (Andrews and Davis, 1993; Andrews et al., 
1988) (Figure 1.1).  The 5-HT3 receptor is now the target of antiemetic drugs, 
designed to block receptor activation (such as granisetron, ondansetron, 
palonosetron) (Ryan, 2012; Bhandari et al., 1992), resulting in vagal 
transmission involved in the acute onset of vomiting.     
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Figure 1.1.  The emetic response generated by ingested toxins, radiotherapy and 
intravenous agents.  Orally-ingested emetic compounds or radiation can induce vomiting by 
initiating serotonin (NT) release from enterochromaffin cells located throughout the 
gastrointestinal tract.  Serotonin acts on abdominal vagal afferent nerve endings, which 
terminate in the nucleus tractus solitarius (NTS).  This forms part of the dorsal vagal complex 
(DVC), which also consists of the area postrema and the dorsal motor vagal nucleus (DMN).  In 
addition, compounds absorbed into hepatic portal veins that subsequently enter the systemic 
circulation can generate the emetic reflex by acting on receptors located in the area postrema 
(which is located outside of the blood-brain barrier) or initiating serotonin release from 
enterochromaffin cells (from the blood side).  Receptor activation in the dorsal vagal complex 
results in signalling through vagal efferent fibres, involved in relaxation of the proximal stomach, 
inhibiting the transit of gastric contents and initiating a giant retrograde contraction of the small 
intestine.  Activation in the dorsal vagal complex also mediates expulsion of gastric contents 
through nerves other than the vagus. 
 
Abdominal vagal afferent fibres terminate in the dorsal vagal complex, 
located in the hindbrain (Andrews and Rudd, 2004), which comprises the 
nucleus tractus solitarius (part of a group of nuclei known as the emetic central 
pattern generator) the dorsal motor vagal nucleus (the site of origin of vagal 
efferent neurones) as well as the area postrema (Miller and Leslie, 1994; 
Hornby, 2001) (Figure 1.1).  The nucleus tractus solitarius is regarded as a key 
integrator, receiving inputs from multiple organs and inducing the activation of 
emetic motor outputs (Andrews and Rudd, 2004).  The dorsal vagal complex as 
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a whole contains a variety of receptors, which include primary emetic mediatory 
receptors 5-HT3 and neurokinin (NK1) (Costall and Naylor, 1992; Saito et al., 
2003).   
In addition to 5-HT3 receptor activation through enterochromaffin cell-
mediated serotonin release, injected or orally ingested emetic compounds that 
enter the systemic circulation can diffuse into the area postrema, which is 
located outside the blood-brain barrier (Figure 1.1) (Andrews et al., 1988).  The 
area postrema (also known as the chemoreceptor trigger zone) acts as a 
chemoreceptor for multiple compounds, since it contains numerous receptors 
(Andrews and Rudd, 2004).  Upon detection of emetic compounds (such as the 
opioid receptor agonist loperamide) in the area postrema, neurones terminating 
in the nucleus tractus solitarius are activated, resulting in the induction of emetic 
motor outputs (Andrews and Rudd, 2004; Miller and Leslie, 1994; Bhandari et 
al., 1992).  Lesion of the area postrema eliminates the vomiting response 
caused by cytotoxic agents such as cisplatin (delayed phase vomiting) (Percie 
du Sert et al., 2009), apomorphine (a dopamine D2 receptor agonist) and 
morphine (an opioid receptor agonist) (Andrews and Rudd, 2004; Miller and 
Leslie, 1994).   
1.4. Emetic Compounds 
Although the physiological and pharmacological mechanisms involved in 
the emetic response have been partially characterised, the individual molecular 
and receptor targets remain poorly understood.  Various receptors and 
channels are responsible for the generation of the emetic response, which 
include ligand-gated ion channels, ion channels and G-protein coupled 
receptors (Costall and Naylor, 1992; Storr and Sharkey, 2007) (Figure 1.2).  A 
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range of receptors and channels associated with the induction of vomiting as 
well as the targets of drugs involved in interacting with these receptors will now 
be discussed. 
 
Figure 1.2.  Principal receptors and channels involved in the emetic response.  Emetic 
compounds that activate cell surface receptors predominantly fall into three distinct groups: (A) 
Ligand gated ion channels such as the 5-HT3 receptor, which is activated by the 
neurotransmitter (NT), serotonin. (B) Ion channels that include the TRPV1 receptor, a calcium 
permeable cation channel activated by vanilloid binding (V) or heat detection on the C-terminal.  
Cells expressing the TRPV1 receptor are located in throughout the body.  (C) G-protein coupled 
receptors, activated by agonists (A) binding to the N-terminal region causing dissociation of 
heterotrimeric α, β and γ subunits, which mediate a cascade of intracellular pathways.  Specific 
receptors such as the neurokinin1 receptor, activated by Substance P, and predominantly 
located in the dorsal vagal complex, are shown to induce emesis.  
1.4.1.  Ligand gated ion channels 
Activation of ligand gated ion channels results in neurotransmission 
(Alexander et al., 2011) These channels contain a pore that allows ions to travel 
across the cell membrane upon receptor activation by neurotransmitters 
(Figure 1.2) (Alexander et al., 2011).   
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1.4.1.1. 5-HT3 receptor 
Located in the dorsal vagal complex as well as afferent vagal fibres 
originating near the gastrointestinal tract, the 5-HT3 receptor has been identified 
as one of the principal receptors involved in the emetic response to chemo- and 
radiotherapy (Fujiwara-Sawada et al., 2003; Javid and Naylor, 2002; Torii et al., 
1991).  To block emetic side effects as a result of these therapies, clinically 
available anti-emetic drugs, such as granisetron, ondansetron and 
paolonosetron, are 5-HT3 receptor antagonists (Ryan, 2012).  Activation of this 
receptor by serotonin or by metformin-induced release of serotonin (as used in 
the treatment of diabetes), induces emesis in the Suncus murinus (Fujiwara-
Sawada et al., 2003; Cubeddu et al., 2000).  
Enterochromaffin cell-mediated serotonin release can be caused by 
metallic elements such as copper, which is shown to act through the 5-HT3 
(Fukui et al., 1993b) and possibly 5-HT4 receptor (Fukui et al., 1994).  At high 
concentrations, copper has been shown to induce emesis in the ferret and dog 
(Makale and King, 1992; Kayashima et al., 1978b; Kayashima et al., 1978b).  
Whilst it is shown that the gastro-duodenal luminal concentration of copper is a 
vital inducing factor in emesis in dogs, little is understood about the molecular 
mechanism involved in copper-induced emesis (Cushny, 1918; Kayashima et 
al., 1978b).   Copper is also an essential element required in the human diet.  
However, due to its emetic properties, guidelines for the permitted concentration 
of copper in drinking water have been generated (Araya et al., 2001; Olivares et 
al., 2001).   
Reactive oxygen species generated in enterochromaffin cells are also 
shown to cause serotonin release, resulting in abdominal vagus nerve activation 
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(Andrews et al., 2000a; Torii et al., 1994).  The oral ingestion of pyrogallol, a 
generator of the destructive superoxide anion, O2
-, induces vomiting in the 
Suncus murinus, which is subsequently abolished upon abdominal vagotomy (a 
process where the abdominal vagus nerve is severed) (Torii et al., 1994).   
Selective serotonin reuptake inhibitors (SSRIs) are effective treatments 
for depression and anxiety, which also have reduced side effects in comparison 
to other anti-depressants.  Fluoxetine, an SSRI has however been shown to 
have potent emetic properties in the Suncus murinus (Fujiwara-Sawada et al., 
2003).  Whilst SSRIs cause emesis, episodes can be reduced with the gradual 
development of tolerance (Fujiwara-Sawada et al., 2003).  Increased brain 
serotonin levels due to reduced reuptake into cells may lead to generation of 
the emetic response via activation of 5-HT3 receptors (Fujiwara-Sawada et al., 
2003). 
1.4.1.2. Nicotinic acetylcholine receptor 
 Nicotine, a natural plant alkaloid and the addictive component in tobacco, 
is a highly toxic substance with potent emetic properties in dogs and cats 
(Yamamoto et al., 2004; Torii et al., 1991; Laffan and Borison, 1957).  Evidence 
has also shown the nicotinic receptor, which is activated by acetylcholine, is 
also located both peripherally and centrally, as ablation of the area postrema 
still leads to the onset of emesis in cats (Laffan and Borison, 1957). 
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1.4.2.  Ion Channels 
Activation of ion channels can be initiated by voltage (voltage-gated ion 
channels) or by second messengers (Alexander et al., 2011), resulting in the 
release of ions.  These channels contain a pore, for ion transport (Alexander et 
al., 2011).  
1.4.2.1. Voltage-gated sodium channel  
 Voltage gated sodium channels are located predominantly in excitable 
cells.  Veratridine, a voltage-gated sodium channel activator induces emesis in 
the cat by vagal activation, which may originate centrally in the nodose ganglion 
of the vagus nerve, located in the cervical region of the spine (Borison and 
Fairbanks, 1952). 
1.4.2.2. TRPV1 Receptor 
Transient receptor potential vanilloid 1 (TRPV1) channels belong to a 
superfamily of calcium permeable cation channels located on the cell 
membrane (Dong et al., 2010).  Members of this family can be by subdivided 
into 6 sub-families: canonical, vanilloid, melastatin, mucolipin, polycystin and 
ankyrin channels (Alexander et al., 2011).  TRPV1 channels are six 
transmembrane domain containing proteins, containing intracellular N and C 
termini that interact to form homo- or heterotetramers (Alexander et al., 2011).  
Activation of this receptor is initiated by extracellular binding of vanilloid 
compounds, naturally found in plants, or detection of heat in the C-terminus 
(Brauchi et al., 2007) (Figure 1.2).   
The TRPV1 receptor is primarily expressed in neurones distributed 
throughout the body and is responsible for sensations of heat, pain and burning 
(Pingle et al., 2007).  The receptor is highly conserved across mammalian 
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species and causes emesis in the Suncus murinus by initiating release of 
substance P from neurones (Smith et al., 2002; Rudd and Wai, 2001; Andrews 
et al., 2000a; Andrews et al., 2000b).  Upon activation, TRPV1 channels allow 
calcium influx, which drives substance P release through activation of 
intracellular phosphatidylinositol 4,5-bisphosphate (PIP2) (Brauchi et al., 2007). 
Two principal agonists involved in inducing TRPV1 receptor mediated 
emesis are capsaicin (the “hot” component of chillies) and its ultra-potent 
analogue, resiniferatoxin, which are believed to act directly on the nucleus 
tractus solitarius (Andrews et al., 2000b).  In addition to the burning sensation 
experienced by TRPV1 activation, the receptor has also been associated with 
metallic taste in artificial sweeteners and salts (Riera et al., 2007; Riera et al., 
2009). 
1.4.3. G Protein-Coupled Receptors 
 Receptors belonging to the family of G protein-coupled receptors consist 
of an extracellular N-terminal “binding” domain, followed by a central looping 
seven-transmembrane α-helical domain as well as an intracellular C-terminal 
domain (Schioth et al., 2007) (Figure 1.2).   G-protein coupled receptors 
arrange themselves in a tertiary structure where the α-helical regions are 
organised into an anticlockwise “barrel” shape (Schioth et al., 2007).  Upon 
receptor activation, heterotrimeric α, β and γ subunits dissociate from the 
membrane, resulting in an intracellular signalling cascade, ultimately inducing 
neurotransmission and subsequent vomiting.   
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1.4.3.1. Neurokinin receptor  
 The neurokinin (NK1) receptor, is a G-protein coupled receptor, activated 
by substance P and induces emesis in dogs (Andrews and Rudd, 2004).  NK1 
receptors are located throughout the dorsal vagal complex (Costall and Naylor, 
1992; Saito et al., 2003), where receptor activation triggers efferent fibres to 
initiate the emetic response (Saito et al., 2003; Andrews and Rudd, 2004).  This 
receptor is pivotal in the induction of emesis since a range of stimuli, which 
include nicotine, opioids, ipecac, radiation, chemotherapy, motion and 
anaesthesia (Andrews and Rudd, 2004).   
1.4.3.2. Dopamine receptor 
Non-selective dopamine receptor agonists can activate any of four 
specific dopamine G-protein coupled receptors isoforms, D1-D4.  Stimulation of 
these receptors with compounds such as apomorphine, a D2 receptor agonist, 
has been used as symptomatic treatments for neurodegenerative disorders 
such as Parkinson’s disease and psychosis (Depoortere et al., 2008). 
Dopamine receptor agonists activate receptors located in the area postrema, 
where D2 receptor agonism specifically is responsible for generation of the 
emetic response in ferrets (Storr and Sharkey, 2007; Osinski et al., 2005).   
1.4.3.3. Opioid receptor 
  Four different subtypes of opioid receptor exist, delta, kappa, mu and 
noiciceptin, of which mu activation by compounds such as morphine (Andrews 
et al., 1996) and loperamide (used in treatment for diarrhoea) (Bhandari et al., 
1992) in the area postrema (Bhandari et al., 1992) induces emesis.  
Loperamide has a long half-life and takes time to be metabolised and cleared 
from the body.  Upon treatment with loperamide in ferrets, emetic episodes 
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occur, which decrease as a tolerance is shown to develop upon repeat dosing 
(Bhandari et al., 1992).   
1.4.3.4. Prostanoid receptor 
 Numerous prostaglandins such as prostaglandins E2 and F2α cause 
vomiting with varying potencies in ferrets by activating the prostanoid receptor 
(Kan et al., 2002; Kan et al., 2003).  It is unclear how the prostanoid receptor is 
involved in the induction of emesis as precise mechanisms of action are 
currently unknown. 
1.4.3.5. T2R Receptor 
A final group of GPCRs located throughout epithelia, including taste 
buds, the stomach as well as the lungs, are taste (type II) receptors (T2R), 
responsible for the perception of bitter taste (Kinnamon, 2011).  At higher 
concentrations, T2R receptor ligands can cause emesis upon ingestion (Sibert 
and Frude, 1991).  In addition, some emetic chemotherapeutic agents have 
been associated with inducing the sensation of bitter taste, which may in part be 
responsible for nausea and/or vomiting (Peyrot des et al., 2011; Fetting et al., 
1985).   
Genes encoding proteins responsible for bitter taste detection have been 
identified in humans since a pre-Neanderthal age, providing a conserved 
mechanism for identifying potentially toxic substances (Lalueza-Fox et al., 
2009a).  These receptors are found along the gastric mucosa and in taste buds 
located on the tongue and in the lungs (Kinnamon, 2011; Wu et al., 2002).  
Upon activation of T2R receptors, heterotrimeric G-proteins (Gα-gustducin and 
Gβγ subunits) dissociate from the membrane, where Gβγ activates 
phospholipase Cβ2 (PLCβ2).  Increased PLCβ2 activity catalyses the cleavage of 
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PIP2 to release inositol triphosphate (IP3) and sn-diacylglycerol (DAG) 
(Kinnamon, 2011).  The second messenger DAG activates protein kinases C 
and D (PKC, PKD respectively), both of which trigger the release of 
gastrointestinal peptides (Rozengurt and Sternini, 2007).  IP3 acts on the IP3 
receptor (IP3R3) to facilitate the release of Ca
2+ from intracellular stores, 
activating a mucolipin channel, TRPM5 (Figure 1.3) (Clapp et al., 2008; 
Sternini, 2007; Chen et al., 2006; Sawano et al., 2005; Caicedo and Roper, 
2001).  This channel activation facilitates membrane depolarisation and ATP 
release through the Pannexin-1 (P1X) receptor, resulting in the generation of 
action potentials though neurotransmitters serotonin and noradrenaline 
(Kinnamon, 2011; Huang et al., 2008).  A third receptor, vesicular ATP 
transporter (VNUT) may also be involved in the facilitation of ATP release 
(Kinnamon, 2011). 
The GPCR subunit, Gα-gustducin, maintains a basal active state in taste 
receptor cells, enabling fast signal transduction upon stimulation (Clapp et al., 
2008) (Figure 1.3).  The G-protein increases phosphodiesterase (PDE) activity, 
which in turn reduces intracellular cAMP (Kinnamon, 2011).  Decreased cAMP 
levels subsequently down-regulate protein kinase A (PKA) activity, an enzyme 
that reduces PLCβ2 activity, leading to hydrolysis of PIP2 and decreasing 
downstream Ca2+ release (Clapp et al., 2008; Kinnamon, 2011).  In addition to 
stimulation of T2R receptors, denatonium benzoate has been shown to induce 
neural signal transduction in a pathway independent of G-protein activation by 
inducing calcium release from intracellular stores (Sawano et al., 2005).  
Intracellular calcium release by bitter compounds denatonium benzoate and 
phenylthiourea also results in discharge of the hormone, cholecystokinin (CCK) 
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from enteroendocrine cells, which is a known regulator of gastric motility (Chen 
et al., 2006).  
 
Figure 1.3. Bitter tastants function through activation of T2R receptors located in taste 
cells throughout the digestive tract.  Upon activation, the Gβγ subunit dissociates from the cell 
membrane activating phospholipase Cβ2 (PLCβ2), which increases PIP2 phosphorylation into 
inositol triphosphate (IP3) and sn-diacylglycerol (DAG).  IP3 subsequently binds to its respective 
receptor, IP3R3, mediating calcium release from intracellular stores, which is subsequently 
released from the cell by TRMP5 receptors, driving membrane depolarisation.  In addition to 
calcium release from the cell, ATP is also released through P1X and VNUT receptors, driving 
cholecystokinin (CCK) (from enteroendocrine cells) and neurotransmitter (NT) (from taste buds) 
release.  DAG is believed to drive the activation of protein kinases C and D (PKC and PKD), 
which mediates the release of gastrointestinal peptides from the cell. The Gα subunit is plays a 
role in regulation of calcium within the cell whereby it activates phosphodiesterases (PDE) to 
reduce cAMP within the cell.  This in turn reduces protein kinase A activity, which leads to 
reduced activity of PLCβ2 and the binding of IP3 to IP3R3.   
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The T2R family of receptors is encoded by 25 different genes, which 
share a 30-70% homology (Adler et al., 2000; Chandrashekar et al., 2000).  
These different receptors show ligand specificity where 6-nitrosaccharin and 
denatonium both activate human TAS2R44 receptors, whereas for example 
TAS2R61 receptors are 6-nitrosaccharin specific (Pronin et al., 2004).  This 
specificity has also been shown to be dependent upon bitter ligand binding, as 
measured by varying calcium release from cells (Caicedo and Roper, 2001).   
Phenylthiourea and 6-n-propylthiouracil are both compounds that are 
perceived as extremely bitter or not at all in 70% and 30% of humans 
respectively.  This phenomenon is due to the activity of a principal bitter 
receptor gene, the hTAS2R38, which contains single nucleotide polymorphisms 
(Bufe et al., 2005).  Amino acid substitutions can occur on this gene, giving rise 
to five different haplotypes resulting in three distinct taster statuses, known as 
supertaster, taster and non-taster (Tepper et al., 2009; Bufe et al., 2005).  Two 
more alleles for the human T2R genes, TAS2R43 and TAS2R44, are also 
shown to cause hypersensitivity to bitter tastants found in plants as well as 
finding saccharin, an artificial sweetener, bitter (Pronin et al., 2007).  Recent 
evidence has also shown genetic bitter taster status plays a role in sensitivity to 
motion sickness and nausea (Benson et al., 2012) as well as possible links with 
epilepsy (Pal et al., 2004). 
Bitter tastants are perceived as being toxic, where animals commonly 
display “hard-wired” food aversive behaviour upon detection (Kinnamon, 2011; 
Yarmolinsky et al., 2009).  This aversive behaviour has even been exploited to 
aid the survival of the northern quoll, an endangered species (O'Donnel et al., 
2010).  Aside from the behavioural response of aversion to bitter taste, bitter 
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tastants also cause physiological responses such as delayed gastric emptying 
(Glendinning et al., 2008). 
1.4.4.  Transporters and Enzymes 
In addition to receptors, the emetic response can be generated by 
various transporters and enzymes.  Membrane transporters require ATP to 
actively transport compounds across the hydrophobic cell membrane against a 
diffusion gradient (Alexander et al., 2011).  In addition to transporters, 
numerous drugs often target enzyme inhibition in order to prevent a specific 
cellular function (Alexander et al., 2011). 
1.4.4.1. Emetic compound transport into cells  
 Whilst G protein-coupled receptors are the largest family of membrane 
proteins in the human genome, solute carrier transporters are the second 
largest (Alexander et al., 2011).  Many therapeutic drugs are transported across 
the plasma membrane via solute carrier transporters; emetic compounds 
include cytotoxic agents such as 5-fluorouracil, cisplatin, and methotrexate 
(Alexander et al., 2011).  Chemotherapeutic agents administered orally or 
intravenously include a wide variety of chemical structures that are cytotoxic to 
dividing cells and used to treat cancer.  Cytotoxic compounds prescribed during 
chemotherapy such as 5-fluorouracil and cisplatin have strong emetic effects in 
multiple animal models including the ferret (Bannink et al., 2008; Percie du Sert 
et al., 2010; Fetting et al., 1985).   
1.4.4.2. Enzyme inhibitors  
Digoxin is a cardiac glycoside used in the treatment of numerous heart 
conditions and is also taken into cells by solute carrier transporters (Alexander 
et al., 2011). Treatment of patients with high doses often results in digoxin 
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poisoning, a common symptom of which is vomiting in cats (Parsons and 
Summers, 1971).   Little is known about the mechanism for the induction of 
emesis by cardiac glycosides, however it has been shown that they act upon 
the area postrema to induce emesis (Parsons and Summers, 1971). 
Cyclic nucleotides are a part of second messenger systems, which are 
created by cyclases (Alexander et al., 2011).  Phosphodiesterases are involved 
in the hydrolysis of cyclic adenosine monophosphate (cAMP) or cyclic 
guanosine mononphosphate (cGMP).  Compounds such as the 
phosphodiesterase IV inhibitors, rolipram (an anti-inflammatory treatment) are 
associated with emetic side effects in ferrets (Aoki et al., 2001).  These agents 
inhibit phosphodiesterase activity, which is responsible for the degradation of 
3,5-adenosine cyclic monophosphate (cAMP) (Aoki et al., 2001).  
1.5. Animal Models in Emetic Research 
Whilst the physiological mechanisms of the emetic response is clearly 
understood, many specific molecular targets of emetic compounds remain 
diverse and uncharacterised, which has resulted in extensive animal research 
(Andrews and Horn, 2006).  This has subsequently led to the development of 
several sentient models for studying the vomiting response.  Animals used in 
emetic research can be divided into those that do not have a vomiting reflex 
(mice, rats) and those that do (ferret, pig, dog, cat and primates).  Non-vomiting 
species such as the rat cannot vomit as they may lack the neural pathways or 
anatomical features to do so (a narrow oesophagus for example) (Andrews and 
Horn, 2006; Sanger et al., 2011; Horn et al., 2013).  Conversely, animals that 
can vomit display sensitivity to emetic stimuli, which varies between species.  It 
therefore makes it difficult to establish a single animal model that is most 
36 
 
indicative of emesis in humans for newly developed therapeutic drugs (Holmes 
et al., 2009).  
Animals lacking the emetic reflex demonstrate an alternative behaviour 
known as pica where they ingest kaolin (a form of clay) in response to 
potentially toxic substances (Andrews and Horn, 2006; Holmes et al., 2009).  
Kaolin slows gastric emptying and absorbs harmful toxic substances (Liu et al., 
2005).  Pica can however be induced by non-emetic stimuli and may therefore 
not always be predictive of emetic liability, giving rise to false positive or 
negative results (Andrews and Horn, 2006).  Non-emetic species are also used 
in conditioned taste aversion/food avoidance experiments, where animals avoid 
substances associated with toxicity (Andrews and Horn, 2006).  A recent study 
has however underlined the importance of genetics, species difference and the 
physiology behind the vomiting response, where it was suggested rodents such 
as the rat could be vital in understanding molecular targets in emetic research 
(Sanger et al., 2011). 
Animal research requires the implementation of the 3 R’s:  Refinement, 
Reduction, Replacement (Holmes et al., 2009).  In investigating the specific 
physiology involved in the induction of vomiting, no single sentient model exists, 
as different animals’ exhibit varying sensitivities to the same compound (Percie 
du Sert et al., 2012), apomorphine being a prime example (Andrews and Rudd, 
2004). In addition, repeated animal experimentation with emetic stimuli is 
presumed to induce a large amount of suffering (Holmes et al., 2009; Parkinson 
et al., 2011).  This presumption can be based upon the unpleasant feelings 
humans experience during episodes of nausea and vomiting.  In addition, whilst 
newly developed compounds may not actually cause emesis themselves, 
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animals cannot be monitored for unpleasant symptoms such as nausea, which 
precede vomiting (Parkinson et al., 2011; Holmes et al., 2009). 
To refine, reduce and replace the use of animals in emetic research, a 
tiered approach to these tests has been suggested.  This incorporates 
preliminary literature searches and in vitro mammalian tests followed by the use 
of a reduced number of in vivo experiments using sentient models as proposed 
by Holmes and colleagues (Figure 1.4).   
Less complex models such as implementing non-sentient organisms in 
emetic research could be extremely beneficial in assisting this research.  The 
ease of manipulating non-sentient organisms through genetic mutations and 
using readily available molecular markers could also provide valuable 
information about currently unknown molecular mechanisms in emetic research.  
In addition, early identification of emetic liability in non-sentient models during 
drug development would be of substantial benefit, because this would reduce 
the number of animals involved as well as the cost of research.  Use of non-
sentient models in emetic research could also provide fast and potentially high 
throughput results.  The second part of this introduction discusses the 
properties that a potential non-sentient model, Dictyostelium discoideum, may 
have for use in emetic research.  
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Figure 1.4.  A Proposed Novel Tiered Model for Reducing Animals used in Testing for 
Emetic Liability.  This diagram suggests a novel approach to developing therapeutic drugs for 
emetic liability.  This method employs database searching and  tests to reduce in vitro animal 
models.  The number of in vivo models used to predict emetic liability would then be 
substantially reduced.  This figure is from a review by Holmes et al. (2009). 
1.6. Dictyostelium discoideum 
First discovered in 1935 by K.B. Raper, Dictyostelium discoideum is a 
single celled organism (Raper, 1935), which naturally survives on forest floors in 
damp conditions, chemotaxing towards folate (secreted by bacteria) and 
feeding on bacteria through phagocytosis (Boeckeler and Williams, 2007; 
Cosson and Soldati, 2008).  After exhaustion of its food source, Dictyostelium 
cells starve and undergo a complex multicellular phenomenon, known as 
development, where cells migrate towards one another, ultimately forming a 
multicellular fruiting body (Figure 1.5).  This process has one crucial role, 
sporulation, which is essential for survival of the organism (Williams et al., 
2006a).  
Upon starvation, Dictyostelium cells secrete the chemoattractant, cAMP, 
in pulses over a period of 5-6 hours, which mediates the coordination of 
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individual cells towards a central location by G-protein coupled receptor 
activation resulting in directed migration (McMains et al., 2008).  Over this 
period, cells interact with one another to form streams until approximately 105 
cells have migrated to a central aggregation centre called a mound (Williams et 
al., 2006a).  At this point, differential gene expression determines alternate cell 
fate, where cells either express as pre-spore or pre-stalk cells in a respective 
4:1 ratio (Williams et al., 2006a).  After 10-16 hours, this cellular partitioning 
enables the formation of multicellular slugs, consisting of anterior pre-stalk and 
posterior pre-spore cells (MacWilliams and Bonner, 1979; Jang and Gomer, 
2011).  
Upon culmination, Dictyostelium stalk cells form a stalk, on top of which 
spore cells then form a spore head (Jang and Gomer, 2011).  The final fruiting 
body structure measures approximately 1mm in height consisting of a basal 
disc, a stalk consisting of dead vacuolated stalk cells and a spore head 
containing approximately 80, 000 spore cells (Williams et al., 2006a).  
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Figure 1.5.  Life Cycle of Dictyostelium discoideum.  Upon starvation, Dictyostelium cells 
secrete the chemoattractant, cAMP, initiating cellular migration towards a central aggregation 
point, where they form a mound.  During this phase, cells differentiate to form anterior pre-stalk 
or posterior pre-spore cells, causing the mound to develop either into a migrating slug or a 
“Mexican hat”-shaped complex.  Upon culmination, developed, vacuolated stalk cells ultimately 
form a stalk for spore cells to develop into a mature fruiting body, which then germinates to 
disperse spores and restart the life cycle. 
1.7. Dictyostelium as a Biomedical Model 
Since its discovery, Dictyostelium has been developed into a highly 
regarded biomedical model, where the cells have been transformed under 
laboratory conditions so they can easily be maintained at 22oC and survive in 
liquid media, feeding on nutrients by macropinocytosis.  Manipulation of the 
Dictyostelium genome has also resulted in cells showing resistance to 
antibiotics such as penicillin and streptomycin, which can contribute to the 
prevention of infection of axenic medium by airborne laboratory pathogens.  
Under laboratory conditions, Dictyostelium cells have a steady doubling time of 
approximately 8 hours and cells can be monitored at a number of stages during 
their developmental process, the most common stages being chemotaxis (in 
developmentally starved cells) and development.   
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Over time, the molecular mechanisms responsible for the life cycle of 
Dictyostelium have been revealed.  The earliest substantial development of the 
organism as a biomedical model was the use of DNA-transformation techniques 
in Dictyostelium (Nellen et al., 1984).  The full 34 Mb Dictyostelium genome 
spanning over 6 chromosomes has now been completed (Eichinger et al., 
2005), allowing for the study of individual Dictyostelium genes as well as their 
comparison to the human genome.  Sequencing of the Dictyostelium genome 
has identified 22% of Dictyostelium genes sharing homology with human genes, 
which has made the organism a useful model for human drug targets and 
intracellular pathways involved in human disease (Eichinger et al., 2005).  Many 
genes and targets expressed in Dictyostelium are lacking in other biomedical 
models such as Saccharomyces cerevisiae and Schizosaccharomyces pombe, 
suggesting Dictyostelium may be a more advantageous non-sentient model 
(Eichinger et al., 2005).   
Dictyostelium is now being increasingly used in biomedical research 
(Boeckeler and Williams, 2007; Williams et al., 2006b), where multiple 
methodologies exist.  The effects of various compounds on cells can be 
monitored by using mutagenesis screens, gene manipulation, development 
assays and chemotaxis (Boeckeler and Williams, 2007).  The organism has 
now been used as a model for various diseases which include the analysis of 
Schwachman-Diamond syndrome (Wong et al., 2011), mitochondrial disease 
(Francione et al., 2010), Alzheimer’s disease signaling (McMains et al., 2010), 
as well as developing current understandings of microbial infection (Francione 
et al., 2009).  Dictyostelium has also been used in the investigation of valproic 
acid and lithium effects in epilepsy and bi-polar research (King et al., 2009; 
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Terbach et al., 2011; Xu et al., 2007; Chang et al., 2012), and chemotherapy 
research (Boeckeler and Williams, 2007).  
1.7.1. Channels and Receptors in Dictyostelium  
 The Dictyostelium genome contains a wide variety of channels and 
receptors, many of which share homology with those found in chordates.  
Examples include the P2X receptors (Burnstock and Verkhratsky, 2009), which 
are ATP-gated ion channels involved in osmoregulation (Baines et al., 2013) 
and calcium regulation (Ludlow et al., 2009), as well as polycystin-2 and 
mucolipin receptors, which are transient receptor potential (TRP) channels 
(Wilczynska et al., 2005).  In addition, Dictyostelium contains a diverse range of 
seven-transmembrane receptors, which are the largest and most versatile 
family of receptors in eukaryotes (Eichinger et al., 2005; Pierce et al., 2002).  
These receptors are the target of many therapeutic drugs in humans, although 
receptor activation can result in emetic episodes (Sections 1.4.1- 1.4.3).   
 In Dictyostelium, 55 G-protein coupled receptors exist, which can be 
subdivided into one family two (secretin), seventeen family three (GABAB-like), 
twenty five family five (frizzled/smoothened) and twelve family six (cAMP) 
receptors (Prabhu and Eichinger, 2006). To date, a role for the secretin and the 
frizzled/smoothened receptors in Dictyostelium, have yet to be discovered.   
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1.7.2. GABAB-like Receptors 
 The seventeen GABAB-like receptors in Dictyostelium, GrlA-GrlR, 
resemble GABAB or metabotropic glutamate receptors, where the 
transmembrane domains in particular share weak homology with higher 
eukaryotic GABAB receptors (Prabhu and Eichinger, 2006).  To date, few Grl-
family receptors have been successfully characterised; of those that have, only 
GrlE (Anjard and Loomis, 2006) and GrlB (Wu and Janetopoulos, 2013) are 
responsive to GABA.  Other partially characterised Grl-family receptors, GrlJ 
(Prabhu et al., 2007b) and GrlA (Prabhu et al., 2007a) do not appear to respond 
to GABA.  Grl-family receptors may play differing roles throughout development, 
where GrlA (Prabhu et al., 2007a) and GrlJ (Prabhu et al., 2007b) are shown to 
be involved in post-aggregation development, GrlE is shown to induce 
sporulation (Anjard and Loomis, 2006), and GrlB is involved in pre-aggregation 
development (Wu and Janetopoulos, 2013).  The remaining Grl-family receptors 
are yet to be characterised.      
1.7.3. cAMP Receptors 
Upon starvation, cAMP mediated chemotaxis towards a central 
aggregation point is driven by activation of cAR (cAMP) receptors, which belong 
to a family of 7-transmembrane serpentine GPCRs (Chung and Firtel, 2002).  
Located uniformly around the cell, 4 different types of cAR (cAR1-4) exist with 
varying affinities for cAMP (cAR1>cAR3>cAR2=cAR4) (McMains et al., 2008) 
and are shown to be involved in Dictyostelium development and differentiation 
(Verkerke-Van, I et al., 1998).  In addition to the four cAR receptors, 7 Crl 
(cAMP like) receptors, CrlA-CrlG, exist, although these are unlikely to bind 
cAMP (Prabhu and Eichinger, 2006).   
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1.8. Dictyostelium movement 
 Cell movement occurs during both vegetative and starved states in 
Dictyostelium.  Upon disappearance of available food sources, Dictyostelium 
undergoes a number of gene transcriptional changes, resulting in changes in 
cell motility (forming fast and slow cells) and a differentiation into pre-spore and 
pre-stalk cells as little as 30 minutes following starvation (Goury-Sistla et al., 
2012).  Upon starvation, cells begin to secrete and search for other sources of 
cAMP, undergoing random movement and migrating a zigzag manner (Li et al., 
2008).  Dictyostelium cells achieve this directionality by the forming pseudopods 
(a directional cellular protrusion), which split every fifteen seconds at an angle 
of approximately 60o from the direction of the previous pseudopod (Bosgraaf 
and van Haastert, 2009).  To initiate a change in direction, cells also produce de 
novo pseudopods, often far away from the existing pseudopod (Bosgraaf and 
van Haastert, 2009).  This combination of cellular protrusions enhances the 
probability of detecting cAMP. 
1.8.1. Detection of cAMP 
In its starved state (also known as chemotactically competent), detection 
of cAMP by cAR receptors in Dictyostelium results in directional chemotaxis 
(King and Insall, 2009).  Leading edge cell polarisation is a result of 
amplification of the external cue in Dictyostelium, allowing for an increased 
sensitivity to cAMP compared with the rest of the cell.  This amplification 
process subsequently enables Dictyostelium cell migration to occur down a 
cAMP gradient between the front and back of the cell as low as 2% (Chung and 
Firtel, 2002; Jin et al., 2008).   
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Upon binding of cAMP to cAR, conformational changes are generated 
predominantly within intracellular loops 2 and 3 of the receptor, causing the 
dissociation and subsequent activation of bound heterotrimeric G-proteins 
(Prabhu and Eichinger, 2006).  The Dictyostelium genome encodes 14 Gα-
subunits whilst only encoding a single Gβ- and one Gγ-subunit (although the Gγ-
subunit is yet to be discovered) (Eichinger et al., 2005).  Specifically, cAR 
activation results in dissociation by Gα2 and Gβγ sub-units (Chung and Firtel, 
2002), where both subunits play pivotal roles in cell polarisation (Chung and 
Firtel, 2002; Stephens et al., 2008).  Dissociation of Gβγ leads to activation of 
monomeric Ras-guanosine triphosphatases (GTPases), RasC and RasG, 
through binding to guanosine triphosphate (GTP) (Jin et al., 2008; Kae et al., 
2007).  GTPase binding to GTP is mediated by the Ras-guanine exchange 
factors (GEFs).  Conversely, GTPases are deactivated by GTPase binding to 
guanosine diphosphate (GDP), which is mediated by Ras-guanine activating 
proteins (GAPs) catalysing hydrolysis of GTP to GDP.  RasGEFs and RasGAPs 
therefore play key regulatory roles in Ras-GTPase signalling, particularly RasC 
and RasG, which in turn initiate downstream signalling events (Kae et al., 2007) 
(Figure 1.6).  
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Figure 1.6. Ras activation in Dictyostelium.  RasGTPases exists in their bound and unbound 
states, where it is bound to guanoside diphosphate (GDP) during in its inactive state.  Ras 
guanine exchange factors (RasGEFs) mediate dissociation of GDP from RasGTPase facilitating 
a pocket for guanosine triphosphate (GTP) to bind.  Binding of Ras-GTPase results in Ras 
activation and triggers downstream signalling events.  Ras guanine activating proteins 
(RasGAP) hydrolyse GTP into GDP and thus cause Ras inactivation. 
1.8.2. F-actin polymerisation  
In order to generate motion, Dictyostelium cells contain an F-actin 
cytoskeleton, consisting of a branched network of F-actin filaments that extend 
pseudopods at the leading edge of the cell and retract uropods (trailing end of 
the cell) (Bagorda et al., 2006).  During random cell movement, F-actin 
polymerisation occurs randomly and is not driven by an external cue.  During 
chemotaxis, activation of Ras at the leading edge results in F-actin 
polymerisation, which can occur individually or in combination with various 
signal amplification processes (Kortholt et al., 2011) (Figure 1.7).  
F-actin polymerisation at the leading edge is also initiated by activation of Rho-
GTPases, known as Rac.  These Rho-GTPases are also regulated, in a similar 
way to Ras, by RacGAPs and RacGEFs.  Recent research has identified a 
group of proteins, Elmo, that are involved in cAMP induced actin polymerisation, 
47 
 
which not only associate with G-protein subunits but also dock to RhoGTPases 
(Yan et al., 2012; Li et al., 2013; Xu and Jin, 2012).  
 
Figure 1.7. Pseudopod formation in Dictyostelium.  (A) During random cell movement, F-
actin polymerisation results in the formation of two different forms of pseudopod, split 
pseudopods and de novo pseudopods.  Split pseudopods are those that extend from an existing 
pseudopod, whereas de novo pseudopods occur at a random location within the cell. Activation 
of Rac signalling results in WASP and/or SCAR mediated Arp2/3 activity, which binds to F-actin 
filaments and induces polymerisation.  Rapid F-actin polymerisation results in forcing the cell 
membrane forward and creating a pseudopod.  (B) Upon detection of cAMP by cAR, Ras 
activates Rac independently or by various signalling mechanisms. Rac activation then results in 
the polymerisation of F-actin, creating pseudopods directed towards the chemoattractant, 
cAMP. 
Stimulation of Rac activates a complex known as suppressor of cAR 
(SCAR) (Veltman et al., 2012).  SCAR then catalyses F-actin polymerisation 
through the Arp2/3 complex, which binds to the edges of existing F-actin 
filaments (Pollard and Borisy, 2003).  Rapid formation of new F-actin filaments 
then drives the cell membrane forward, resulting in the formation of a 
pseudopod (Figure 1.7).  F-actin formation is controlled by ADF/cofilin proteins, 
which sever filaments and stabilise pseudopod production (Pollard and Borisy, 
2003).   
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In addition to SCAR, Rac catalyses Wiskott-Aldrich syndrome protein 
(WASP), which also mediates F-actin polymerisation, although predominantly at 
clathrin-coated pits during movement of vesicles (Veltman et al., 2012). Despite 
playing a pivotal role in the generation of F-actin filaments, ablation of the 
WASP/SCAR genes do not inhibit chemotaxis, with only slight reductions in cell 
velocity observed (Bear et al., 1998; Ibarra et al., 2005), indicating WASP and 
SCAR are not essential to F-actin polymerisation and other signalling 
mechanisms are involved. 
1.8.3. The Phosphatydylinositol-3-kinase Pathway 
 Activation of RasC and RasG, play crucial roles in the amplification of 
various chemotactic signals, including the phosphatydylinositol-3-kinase (PI3K) 
pathway (Bolourani et al., 2006).  There are 6 types of PI3K in Dictyostelium:  
PI31-5K all contain a Ras binding domain; PI36K does not (Hoeller and Kay, 
2007).  Upon cAMP detection and subsequent activation by Ras, PI3Ks convert 
the phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2) into 
phosphatidylinositol 3,4,5-triphosphate (PIP3) at the leading edge (Huang et al., 
2003).  Waves of production of PIP3 are followed by waves of F-actin 
polymerisation in a repeated fashion (Asano et al., 2008; Ueda and Shibata, 
2007). 
PIP3 binds to myosin I at the leading cell edge, which is involved in 
recruitment of actin filaments (Chen and Iijima, 2012; Chen et al., 2012).  In 
addition, PIP3 also binds to plekstrin homology domain containing proteins 
PhdA (Funamoto et al., 2001), cytosolic regulator of adenylyl cyclase (CRAC) 
(Lilly and Devreotes, 1994) and protein kinase B (PkB/Akt)  (Meili et al., 1999) 
(Figure 1.8).  Each protein plays a distinct role in the control of chemotactic 
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signalling.  PhdA is a regulator of cell polarity, where it assists in the control of 
F-actin polymerisation at the leading edge of chemotaxing cells (Funamoto et 
al., 2001).  PIP3 mediated activation of CRAC and PKB/Akt are both involved in 
the activation of adenylyl cyclase A (a 12 transmembrane protein) at the rear 
edge of the cell membrane (Insall et al., 1994; Lilly and Devreotes, 1994).  
Adenylyl cyclase A is located throughout the cell membrane and activation 
facilitates extracellular cAMP release (Garcia and Parent, 2008a; Kae et al., 
2007; McMains et al., 2008).  Adenylyl cyclase A activity is predominantly 
regulated by activation of RasC rather than RasG (Kae et al., 2007). 
PKB/Akt is also involved in the maintenance of cell polarity (Meili et al., 
1999) and also activates p21 activated kinase A (PAKa) (Chung and Firtel, 
2002).  Once activated, PAKa relocates to the rear of the cell activating myosin 
heavy chain kinases, which regulate the formation of myosin II (Bagorda et al., 
2006; Chung and Firtel, 2002).  Myosin II assists chemotaxis by augmenting cell 
rigidity at the cell sides and rear, preventing pseudopod extension laterally, as 
well as enabling membrane retraction at the rear of the cell (Jin et al., 2008).  
Myosin II is removed from the leading edge of the cell by receptor activating 
protein 1 (Rap1), which is activated by a RhoGEF domain containing protein 
GbpD, in a similar way to other GTPases (Kortholt et al., 2010).  Once 
activated, Rap1 then binds to a protein serine/threonine kinase (Phg2), which in 
turn regulates the breakdown of myosin II at the leading edge of the cell 
(Kortholt et al., 2010).  Rap1 is also a regulator of PI3K activity by binding to the 
kinase, resulting in PIP3 turnover (Kortholt et al., 2010).    
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Figure 1.8. Summary of chemotactic movement in Dictyostelium.  Detection of cAMP by 
cAR results in G-protein dissociation and activation of Ras.  Activation of Ras mediates the 
activity of 4 distinct pathways.  1.  Ras activates PI3K, which subsequently converts PIP2 to 
PIP3.  PI3K activity results in PIP3 binding to myosin I, involved in F-actin recruitment; PhdA, 
involved in maintenance of cell polarity and F-actin recruitment; PKB/Akt, involved in adenylyl 
cylcase A (ACA) activation, cell polarity, F-actin recruitment and also PakA mediated myosin 
chain kinase (MCK) activation; and CRAC, involved in adenylyl cyclase activation.  PI3K activity 
is also regulated by GbpD mediated activation of Rap1, which also regulates myosin II 
breakdown through Phg2 activity.  PIP3 is converted back to PIP2 by PTEN activity, where PIP2 
is broken down into diacylglycerol (DAG) and inositol triphosphate (IP3), which subsequently 
induces calcium release through the inositol triphosphate receptor (IP3R3).   2.  Ras activation is 
also regulated by the scaffold protein complex consisting of Sca1, aimless, RasGEFH and 
protein phosphatase 2A (Sca1 complex), which is formed upon F-actin recruitment.  Ras 
activation then activates the TORC2 complex, which subsequently activates PKB/Akt and 
PKBR1 activity.  3.  Ras initiates soluble guanylyl cyclase (sGC) activity, which is involved in F-
actin recruitment at the leading edge.  In addition, soluble guanylyl cyclase produces a second 
messenger, cyclic guanosine monophosphate, which mediates myosin chain kinase and 
subsequent myosin II activity through the protein GbpC.  4.  Ras is presumed (indicated by the 
dotted line as this is yet to be proven) to activate phospholipase A2, which converts 
phospholipids (PL) into arachadonic acid (AA) and lysophospholipids (LPL) resulting in F-actin 
and pseudopod regulation, although the molecular mechanisms are currently unclear.  
Phospholipase A2 activity is regulated by intracellular calcium, which can be increased by three 
distinct mechanisms.  Firstly, inositol triphosphate mediated release from calcium stores can 
increase intracellular calcium.  Second, increased extracellular uptake of calcium will also 
increase intracellular calcium.  Finally free fatty acids such as arachadonic acid can also 
influence calcium release, which subsequently results in increased phospholipase A2 activity. 
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In addition to PI3K activation by Ras, PIP3 production is also regulated by 
phosphatase and tension homologue (PTEN), which converts PIP3 back to PIP2 
at the uropod (Iijima and Devreotes, 2002).  Activation of PTEN assists in the 
temporal and spatial control of cell polarity, allowing surges of PIP3 formation to 
occur at the leading edge only, which assists in the maintenance of chemotactic 
amplification and directionality (Iijima et al., 2002).  PTEN is regulated by 
phospholipase C, another enzyme activated by G-protein dissociation, which 
breaks down PIP2 diacylglycerol (DAG) and inositol triphosphate (IP3) at the 
leading edge (Kortholt et al., 2007).  As a result, phospholipase C activity 
results in translocation of PTEN to the rear of the cell (Kortholt et al., 2007). 
During random cell movement, activation of Ras, PI3K and PTEN occurs 
independently of G-protein coupled receptor activation (Sasaki et al., 2007) 
where PI3K and Ras are shown to act in a positive feedback loop.  This loop 
may act to control stochastic chances in the F-actin cytoskeleton and thus 
negatively regulate the formation of pseudopods (Sasaki et al., 2007).  In the 
absence of PIP3 gradients by ablation of all type I PI3K1-5 and PTEN genes, 
Dictyostelium motility during random cell movement is substantially impaired, 
indicating a distinct role for the PI3K pathway, which may be directional sensing 
(Bosgraaf and van Haastert, 2009; Hoeller and Kay, 2007). 
Chemotaxis in the absence of PIP3 gradients, can still occur effectively in 
steep but not shallow cAMP gradients in Dictyostelium (Hoeller and Kay, 2007; 
van Haastert et al., 2007a).   In addition, the PI3K pathway is shown to play a 
fundamental role in the mechanism of cell movement, however not its 
directionality (Andrew and Insall, 2007). In steep chemotactic gradients, PIP3 
production at the leading edge of the cell is abundant, indicating a significant 
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role for PI3K signalling in cell movement (King and Insall, 2009).  In shallow 
chemotactic gradients however, PIP3 localisation is comparatively weaker, 
where absence of PIP3 gradients results in chemotactic defects (van Haastert et 
al., 2007a), indicating the phosphoinositide plays a comprehensive role in the 
general control of basic cell motility (King and Insall, 2009).   
1.8.4. Target of Rapamycin complex 2 
Dictyostelium chemotaxis is also regulated by the target of rapamycin 
complex 2 (TORC2), which consists of 3 proteins LST8, pianissimo and Rip3.  
TORC2 activation is regulated by RasC and mediates numerous downstream 
targets, including an overlapping role with PIP3 in PKB/Akt regulation (King and 
Insall, 2008; Kamimura et al., 2008).  Upon detection of cAMP gradients, F-actin 
initiates the recruitment of a scaffold protein complex, consisting of Sca1, 
aimless, RasGEFH and protein phosphate 2A, at the leading cell edge (Charest 
et al., 2010).  This scaffold protein complex then activates RasC, which triggers 
TORC2 activity (Charest et al., 2010).  Finally, TORC2 regulates PKB/Akt and 
its structurally-related homologue, PKBR1, to mediate F-actin formation, 
increased cAMP production through adenylyl cyclase and negative regulation of 
the Sca1 scaffold complex through phosphorylation (Charest et al., 2010) 
(Figure 1.8).  PKBR1 contains no plekstrin homology domains (Garcia and 
Parent, 2008b; Meili et al., 2000) and also targets two Ras-GEFs, a RacGAP 
and Talin B, which is a vital component for cellular adhesion in downstream 
signalling (King and Insall, 2008). 
In addition to PKB/Akt providing a distinct role in both PI3K and TORC2 
signalling, glycogen synthase kinase-A, a highly conserved homologue to 
human glycogen synthase kinase-3, is also involved in regulation of these 
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pathways (Teo et al., 2010).  Ablation of the glycogen synthase kinase-A gene 
results disruption of both chemotaxis and cAMP signalling in Dictyostelium cells 
(Teo et al., 2010), mediated by both PIP3 and TORC2 signalling, which 
resultantly blocks PKB/Akt and PKBR1phosphorylation. 
1.8.5. The Phospholipase A2 Pathway 
Dictyostelium has a range independent and complex signalling pathways 
all involved in chemotactic signalling, one of which is the phospholipase A2 
pathway (Chen et al., 2007).  The mechanism for activation of this pathway is 
currently unclear, however detection of cAMP (presumably via cAR) results in 
phospholipase A2 activity, which converts phospholipids located on the cell 
membrane to lysophospholipids and arachadonic acid (King and Insall, 2009; 
Sasaki et al., 2007; van Haastert et al., 2007a).   This process mediates rises in 
intracellular calcium levels, driving motility towards a chemoattractant (van 
Haastert et al., 2007b; King and Insall, 2009) (Figure 1.8).  Phospholipase A2 
activity is regulated by intracellular calcium, where increased levels result in 
activation of the pathway  (van Haastert et al., 2007b).  Intracellular calcium 
increases can be mediated by three distinct mechanisms, which include 
increased extracellular calcium uptake, IP3R3-mediated intracellular calcium 
release and increased fatty acid turnover (van Haastert et al., 2007b).  
Together, this indicates, Dictyostelium phospholipase A2 activity can be 
influenced partially by either phospholipase A2 itself (as this increases fatty acid 
turnover) or phospholipase C, which is responsible for conversion of PIP2 into 
inositol triphosphate and subsequent activation of IP3R3 (van Haastert et al., 
2007b). 
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The exact mechanisms by which phospholipase A2 regulates 
Dictyostelium movement are currently unclear, however since the protein is 
cytosolic, it may induce pseudopods as well as regulate cell movement at the 
rear of the cell (Chen et al., 2007; Veltman et al., 2008).  During random cell 
movement, phospholipase A2 activity is involved in the splitting of existing 
pseudopods, forming the previously discussed zigzag walk (Bosgraaf and van 
Haastert, 2009).  During shallow chemotactic gradients, ablation of the gene 
encoding phospholipase A2 results in chemotactic defects, in a similar manner 
to removing PIP3 gradients in Dictyostelium signalling, indicating both PI3K and 
phospholipase A2 have parallel roles, which are crucial in the formation of 
pseudopods (van Haastert et al., 2007b).  During steep gradients, as with PI3K, 
a role for phospholipase A2 activity becomes less distinct, where cells can 
chemotax effectively in the absence of phospholipase A2 (van Haastert et al., 
2007a).   
1.8.6. Alternative Amplification Pathways 
The enzyme, soluble guanylyl cyclase is another mechanism for cell 
chemotaxis in response to cAMP, which can initiate chemotaxis in the absence 
of PI3K or phospholipase A2 (Veltman and van Haastert, 2008). Soluble 
guanylyl cyclase is activated at the leading edge of cells and interacts with F-
actin to drive the formation of pseudopods in chemotaxis (Veltman et al., 2008).   
The second messenger product of soluble guanylyl cyclase, cyclic 
guanosine monophosphate is crucial at the rear of the cell during chemotaxis, 
where it suppresses pseudopod formation (Veltman et al., 2005).  In addition, 
cyclic guanosine monophosphate also inhibits the formation of lateral 
pseudopods by regulating myosin at the sides and rear of the cell (Veltman et 
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al., 2008) (Figure 1.8).  Cyclic guanosine monophosphate activates an enzyme, 
GpbC, which interacts with myosin light- and heavy- chain kinases and also 
assists in the retraction of pseudopods through myosin II (Bosgraaf et al., 2002; 
Veltman and van Haastert, 2008; Wang et al., 2011).  During random cell 
movement, cyclic guanosine monophosphate is involved in the formation of de-
novo pseudopods in random cell movement (Bosgraaf and van Haastert, 2009).   
Another explanation for a potential method for Dictyostelium cell 
migration is membrane blebbing at the leading edge of cells during cell 
migration (Yoshida and Soldati, 2006).  This is a result of cell membrane and F-
actin interaction disruptions (Fackler and Grosse, 2008).  A change in 
hydrostatic pressure within the cell, in conjunction with myosin II contraction, 
causes a section of the cell membrane to project forming a bleb (Fackler and 
Grosse, 2008; King and Insall, 2009).  When this occurs, F-actin polymerises at 
the centre of the bleb in order to counter and retract it.  Membrane blebs occur 
in Dictyostelium and can assist cell migration (King and Insall, 2009). 
A final possible kinase has been discovered known as Tsunami.  This 
kinase is associated with microtubules and poor chemotaxis has been displayed 
in Tsunami null cells (Tang et al., 2008; Wang et al., 2011).  Very little is known 
about the protein or the roles it plays in chemotaxis, however it has been shown 
to have possible implications in the regulation of PIP3. 
 Dictyostelium therefore contains a variety of signalling mechanisms 
controlling chemotaxis and random cell movement, where disruption of 
individual pathways does not inhibit chemotaxis.  However, disruption of 
multiple pathways can severely impact upon chemotactic behaviour (Veltman et 
al., 2008).  These multiple signalling pathways are comparable to those that 
56 
 
occur in leukocytes, making Dictyostelium an ideal model in the study of cell 
movement.  
1.9. Aims of this work 
 This PhD thesis set out to investigate the potential for Dictyostelium to be 
used as an early screen in the prediction of emetic liability, which if successful 
may reduce the number of animals used in emetic research (Holmes et al., 
2009).  In order to do so, the effects of a number of emetic compounds were 
investigated for their acute effects on Dictyostelium chemotaxis towards cAMP.   
Compounds that affected Dictyostelium behaviour during motility were explored 
in further detail. 
Emetic screening identified a number of bitter tastants, which blocked 
Dictyostelium motility.  A mutagenesis screen was then performed using bitter 
tastants as a selection medium to identify a number of potential molecular 
targets.    Some of these targets were selected and explored in further detail, 
where GrlJ was identified to show sensitivity to the bitter tastant phenylthiourea.   
grlJ was ablated in wild type Ax2 cells and the molecular mechanisms involved 
for phenylthiourea detection explored.  Finally, in a search for proteins related to 
GrlJ, an uncharacterised human protein, sharing weak homology with GrlJ, was 
identified.  This protein was cloned into Dictyostelium and its involvement in 
phenylthiourea detection explored. 
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Chapter 2 
Materials and Methods 
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2.1. Materials 
2.1.1. General reagents 
2.1.1.1. Reagents purchased from Sigma-Aldrich Co. Ltd 
(Dorset, England) 
2-Propanol, 5-fluorouracil, acrylamide (30% solution), actinomycin D, 
ammonium persulphate (APS), bacteriological agar, beta-mercaptoethanol, 
caffeine, calcium chloride, capsaicin, cisplatin, copper chloride, copper 
sulphate, curcumin, cyclic adenosine monophosphate, cycloheximide, 
denatonium benzoate, digoxin, fluoxetine, horse serum, lithium chloride, 
loperamide hydrochloride, Luria-Burtani (LB) broth tablets, magnesium chloride, 
metformin, methotrexate, N,N,N’,N’-tetramethyl-etheline-1,2-diamine (TEMED), 
nicotine, PGF2α, phenylthiourea, potassium chloride, pyrogallol, quinine 
hydrochloride, resiniferatoxin, rolipram, sodium chloride, sodium dihydrogen 
phosphate, sodium dodecyl sulphate (SDS), sodium phosphate basic, 
streptozocin, sucrose, trichloroacetic acid, trisma base, triton-100, TWEEN20, 
veratridine, vincristine, zinc sulphate monohydrate.  
2.1.1.2. Reagents purchased from other suppliers 
Agarose, deoxynucleotide triphosphatases (dNTPs) (Bioline, London, England) 
Ethdium bromide (Bio-Rad Laboratories, Hemel Hempsted, England) 
6x Loading dye (Fermentas, Sunderland, England) 
Axenic medium, SM medium (ForMedium, Norfolk, England) 
Complete Mini Protease inhibitor cocktail, Complete Mini Phosphatase inhibitor 
cocktail (Roche, West Sussex, England) 
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Glycine, tris-borate-EDTA (TBE) 10x (ThermoFischer Scientific, Loughborough, 
England) 
5-hydroxytryptamine, apomorphine hydrochloride, substance P (Tocris 
Bioscience Ltd, Bristol, England) 
Acetic acid, acetone, bromophenol blue, chloroform, dimethylsulphoxide 
(DMSO), ethanol, glucose, glycerol, hydrochloric acid, isopropyl β-D-1-
thiogalactopyranoside (IPTG), methanol, potassium dihydrogen phosphate, 
sodium hydroxide (VWR International Ltd, Leicestershire, England) 
2.1.1.3. Antibiotics 
Geneticin (Invitrogen Gröningen, Netherlands) 
Blasticidin, penicillin/streptomycin solution 100x (PAA Laboratories Ltd, 
Somerset, England)  
Ampicillin (Sigma-Aldrich Co. Ltd, Dorset, England) 
2.1.1.4. Molecular weight standards 
Generuler 100bp plus and 1kb DNA Ladder, PageRuler Plus prestained protein 
ladder (Fermentas, Sunderland, England)  
2.1.1.5. Restriction enzymes 
All restriction enzymes and corresponding buffers (Fermentas, Sunderland, 
England) 
  
60 
 
2.1.1.6. Other enzymes 
BioTaq polymerase (Bioline, London, England) 
Phusion Hot Start II, Proteinase K, T4 DNA ligase (Fermentas, Sunderland, 
England) 
RNase A, DNase (Sigma-Aldrich Co. Ltd, Dorset, England) 
2.1.1.7. Antibodies 
IRDye800 Goat Anti-Mouse (Licor bioscience Ltd, Nebraska, USA) 
M2 FLAG monoclonal antibody (Sigma-Aldrich Co.Ltd, Dorset, England) 
2.1.1.8. Kits 
DNAse treated with DNA-free kit (Ambion, England) 
PIP3 Mass ELISA Kit (Echeolon, USA) 
First Strand cDNA Synthesis Kit (Fermentas, Sunderland, England) 
Illustra MicroSpin S-400 HR columns (GE Healthcare, Buckinghamshire, UK) 
Genome DNA Kit (MP Biomedicals, Illkirch, France) 
QIAfilter Plasmid Maxi Kit and MinElute PCR Purification Kit (QIAgen Ltd, West 
Sussex, England) 
High Pure RNA Isolation Kit (Roche, West Sussex, UK) 
GeneEluteHP Plasmid Maxiprep kit (Sigma Aldrich Co. Ltd Dorset, England) 
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2.1.1.9. Escherichia coli (E.coli) strains 
TOP10 chemically competent E.coli, chemically competent JM107 cells 
(Invitrogen, Gröningen, Netherlands) 
XL10 Gold ultra-competent cells (Agilent, USA) 
2.1.1.10. Primers 
Primers were all purchased from VWR International Ltd. (Leicestershire, 
England) 
2.1.1.11. Equipment 
Bio-Rad gel casting system, Bio-Rad wide mini-sub cell electrophoresis system, 
GelDoc XR system, PowerPac 300 power supply, GenePulser Xcell 
electroporator (Bio-Rad Laboratories, Hemel Hempsted, England) 
Neubauer improved haemocytometer, Dunn chamber (Hawksley, Sussex, 
England)  
Centrifuge (Biofuge 13, Jencons) 
Odyssey Infrared Imaging System (Li-Cor Biosciences, Nebraska, USA) 
47mm black nitrocellulose filters (Millipore, Oxfordshire, England) 
Olympus IX71 microscope (U-RFP-T laser, 482nm emission, QImaging 
RetegaExi Fast1394 digital camera (Olympus, Southend-on-sea, England) 
PeqSTAR 2x thermocycler, PeqSTAR 96 universal thermocycler, 4mm 
electroporation cuvettes (PEQLAB Ltd, Portsmouth, England) 
GeneFlash gel documentation system (Syngene Bio Imaging) 
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LabTek 8-well chambered coverglass (ThermoFisher Scientific, Loughborough, 
England) 
2.2. Methods 
2.2.1.  Dictyostelium methods  
2.2.1.1. Cell culture  
 Dictyostelium stocks were stored in freezing medium (7% DMSO, horse 
serum) at -80oC.  Every four weeks, frozen stocks were scraped onto SM agar 
plates, on which 300µL Raoultella planticola had been streaked.  Colonies were 
allowed to form at 22oC over 3-4 days, where cells from the growth zone of 
colonies were then transferred to liquid plates containing Ax medium and 
100µg/mL penicillin/streptomycin.  Liquid plates were washed three times per 
week and also maintained in log phase (1-4x106 cells/mL) in shaking flasks 
(120rpm).  Cell concentrations were determined using a Neubauer improved 
haemocytometer. 
 2.2.1.2. Growth curve assays  
For proliferation assays in chapter 4, Dictyostelium cells were harvested and 
diluted in axenic medium to 1x105 cells/mL.  10ml aliquots of cells were 
transferred to conical flasks containing consistent concentrations of solvent 
(DMSO) in addition to phenylthiourea or denatonium benzoate.   Cells were 
then grown in shaking suspension (120rpm) and cell density calculated over 
seven days at 22oC. 
For proliferation assays in chapter 5, Dictyostelium cells were harvested and 
diluted in axenic medium to 3x105 cells/mL and allowed to grow in shaking 
suspension until cells reached approximately 50% of maximal cell density.  
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10mL aliquots of cells were then transferred to conical flasks containing 
consistent concentrations of solvent (DMSO) and phenylthiourea.  Cell density 
was calculated until stationary phase was reached under control conditions. 
2.2.1.3. Colony formation assays  
SM agar was heated and allowed to cool to approximately 50oC before addition 
of desired quantities of DMSO (control) or phenylthiourea.  Agar was then 
poured into Petri dishes allowed to set.  Approximately 30 Dictyostelium cells 
were suspended in 300µL of R. planticola, spread onto the previously prepared 
SM agar plates and allowed to grow over four days at 22oC. 
2.2.1.4. Development assays  
 Approximately 1x107 Dictyostelium cells were harvested from cells in 
shaking suspension, washed and resuspended in 1mL KK2 (16.2mM KH2PO4, 
4mM K2HPO4).  Cells were then evenly distributed onto 47mm black 
nitrocellulose filters that were soaked in KK2 or KK2 containing specific 
concentrations of a compound.  Cells were then incubated at 22oC over twenty 
four hours. 
2.2.1.5. Spore shape 
Following development of fruiting bodies after twenty four hours, Dictyostelium 
spores were harvested and suspended in 20µL KK2 before being transferred to 
coverslips.  Images of spores were taken using light microscopy at 40x 
magnification. 
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2.2.1.6. Motility assays 
Approximately 1x107 Dictyostelium cells were harvested from cells in 
shaking suspension, washed and resuspended in 6mL KK2.  Cells were then 
pulsed for five hours with 30nM cAMP at 6 min intervals whilst shaking at 
120rpm before being washed in phosphate buffer and resuspended in 1mL 
KK2.  Cells were then transferred to a Dunn chamber as previously described 
(Zicha et al., 1991), with cells migrating towards 5µM cAMP.  A stable 
chemotactic gradient was allowed to form over a thirty minute period, prior to 
recording cell behaviour using an Olympus IX71 microscope at 40x 
magnification with a QImaging RetigaExi Fast1394 digital camera. Cell images 
were recorded every six seconds over a fifteen minute period, with the initial five 
minutes period recorded prior to addition of test compounds.  At five minutes, a 
10µL aliquot of test compound, diluted in 5µM cAMP, was added to the outer 
well of the Dunn chamber and subsequent images recorded over the following 
ten min period for each compound.  Solvent only controls were carried out for all 
experiments to ensure readouts were based upon compounds. 
2.2.1.7. Random cell movement assays 
Cells were harvested and pulsed as described above.  After pulsing, 
Dictyostelium cells were washed and resuspended in 4 mL prior to a 10x 
dilution in KK2.  250µL cells were then transferred to 8-well chambered 
coverglass slides and allowed to adhere and begin random cell movement.  Cell 
imaging was then recorded every eighteen seconds for the desired time period. 
For assays assessing recovery to bitter tastants, cell behaviour was 
recorded for 35 minutes, where 250µL (double concentrated) tastant, 
suspended in KK2, was added after 288 seconds to give a desired 
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concentration.  Cell behaviour was then monitored for a further fifteen frames, 
before replacement of all media from the chamber with KK2.  Cell behaviour 
was then monitored for the remainder of the assay. 
For assays assessing the response of a compound to a bitter tastant, cell 
behaviour was recorded for fifteen minutes, where 250µL (double concentrated) 
tastant, suspended in KK2, was added after 288 seconds to give a desired 
concentration.  Cell behaviour was then monitored for the remainder of the 
assay.  Finally for assessment of naringenin-mediated effects on Dictyostelium 
behaviour, cells were incubated in naringenin for one hour, prior to addition to 
the 8-well chambered coverglass.  Cell behaviour was then monitored over five 
minutes. 
2.2.1.8. Cell viability assays 
Dictyostelium cells were pulsed as described above and resuspended in 
4mL KK2, before exposure to each tastant for seven or twenty seven minutes.  
Cells were then stained with 0.4% trypan blue solution (final concentration 
0.067%) for three minutes prior to counting using a Neubauer improved 
haemocytometer. Dead cells were identified as a distinctive blue colour since 
live cells did not change colour.   
2.2.1.9. PHCRACGFP global stimulation experiments 
Dictyostelium cells expressing PHCRACGFP were pulsed as previously 
described in random cell movement assays.  200µl cells were then added to 8-
well chambered coverglass, suspended in KK2 or phenylthiourea.  Cells were 
allowed to adhere for ten minutes and cell fluorescence was subsequently 
recorded at 60x magnification, using a GFP filter, with images being taken every 
66 
 
two seconds for two minutes.  After 30 seconds, 50µl of 5µM cAMP was added 
to the cell suspension and changes in fluorescence monitored.   
2.2.1.10. PIP3 mass ELISA 
6x108 Dictyostelium cells were harvested, washed and pulsed for five 
hours. Cell signalling was basalated with incubation of caffeine (3mM final 
concentration) for thirty minutes before being washed and resuspended in 
phosphate buffer at 4x107 cells/ml with cells either incubated in phosphate 
buffer or phenylthiourea (3mM final concentration) for ten minutes.  2.5ml cells 
were added to a tube containing 250µl cAMP (1µM final concentration) and cell 
signalling was stopped by addition of 3ml trichloroacetic acid (0.5M), vortexed 
and incubated for five minutes on ice at time points 0, 5 and 20 seconds after 
cAMP addition. Samples were then spun and washed with 5% trichloroacetic 
acid before following the lipid extraction protocol for mass ELISA as described 
in the PIP3 mass ELISA kit. 
2.2.2.  Molecular biology methods 
2.2.2.1. Polymerase chain reaction 
 Amplification of DNA using polymerase chain reaction (PCR) was 
achieved under the following conditions for standard reactions:  2-5µL DNA, 
2µL 2mM dNTPs, 2µL NH4 BIOTAQ reaction buffer, 1µL MgCl2, 0.2-0.5µL 
BIOTAQ DNA polymerase (5U µL-1), 2µL 5’ primer (10pmol), 2µL 3’ primer 
(10pmol) and double distilled water up to 20µL (total volume).  For PCR using a 
proof reading polymerase, the following conditions were used:  2-5µL DNA, 2µL 
dNTPs, 4µL Phusion HF buffer, 0.2µL Phusion Hot Start II Polymerase, 1µL 5’ 
primer (10pmol), 1µL 3’ primer (10pmol) and double distilled water up to 20µL 
(total volume). 
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 The PCR was carried out using the following cyclical conditions for 
standard PCR reactions:  initial denature, 10 minutes at 95oC followed by 30 
cycles as follows:  denature 30 seconds, 95oC, anneal 30 seconds, 50-60oC 
(dependent on primer melting points), extension 4 minutes, 68oC (or 1 minute 
72oC depending on the primer).  The PCR was completed with a final extension 
of 10 minutes at 68oC (or 72oC).  Samples were then stored at 4oC.  For 
Phusion Hot Start II polymerase reactions, PCR was carried out according to 
manufacturer’s instructions.  
2.2.2.2. Agarose gel electrophoresis 
 To separate and visualize DNA, 1% agarose gels containing ethidium 
bromide and 1x TBE buffer were used.  5-10µL DNA was added to 1-2µL 
5xDNA loading dye.  100bp plus or 1kb DNA ladders (Fermentas) were used as 
molecular marker to determine DNA fragment size on the agarose gels.  Gels 
were run in an electrophoresis tank for 40 minutes at 110V and visualized with 
UV light using a GeneFlash gel documentation system (Syngene Bio Imaging). 
2.2.2.3. Transformation of competent E.Coli 
 Luria-Burtani (LB) plates were prepared by pouring LB agar media 
containing 1.0µL/mL ampicillin into 90mm Petri dishes.  Chemically competent 
JM107 E.coli cells were thawed on ice and used for transformations.  10µL 
ligated DNA was added to 100µL competent cells, incubated on ice for 30 
minutes before heat-shock treatment at 42oC for 30 seconds.  Cells were then 
rapidly stored on ice for 2 minutes, before addition of 250µL LB media and 
incubated in a shaking incubator at 37oC for 1 hour.  After incubation, cells were 
briefly spun down in a centrifuge, LB media aspirated and resuspended in 
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100µL fresh LB media, streaked onto LB agar plates (containing ampicillin) and 
incubated at 37oC overnight. 
 For larger DNA cloning vectors, XL10 Gold chemically competent E. coli 
cells were used for transformations.  This was achieved according to the 
manufacturer’s instructions. 
2.2.2.4. Plasmid preparation 
 Sigma GenElute Plasmid Miniprep Kits, Qiagen QIAfilter Plasmid Midi 
kits or Qiagen QIAfilter Plasmid Maxi kits columns were used to prepare 
plasmids for cloning and sequencing according to the manufacturer’s 
instructions.   
 To verify positive transformants from E.coli without the use of commercial 
kits, 1.5mL culture was spun down for 2 minutes at 13 000rpm, supernatant 
aspirated and resuspended in 100µL P1 buffer (50mM Tris-Cl pH8.0, 10mM 
EDTA, 100µg/mL RNase A).  Cells were lysed with 200µL P2 buffer (200mM 
NaOH, 1% SDS (W/V)) before incubation for 5 minutes at room temperature.  
The lysis mixture was then neutralized by addition of 150µL P3 buffer (3M 
potassium acetate pH5.5), mixed by inversion and spun down for 3 minutes at 
13 000rpm.  Supernatants were then transferred into fresh tubes, before DNA 
precipitation by addition of 1mL ethanol.  The mixture was then vortexed, spun 
down for a further 3 minutes and supernatant.  Residual ethanol was removed 
by a further spin and removal of supernatant before DNA was resuspended in 
50µL double distilled water. 
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2.2.2.5. Restriction digests  
 All restriction digests were prepared according to the following 
conditions:  5µL DNA, 0.2-0.5µL each restriction enzyme (100µL-1) (Fermentas), 
1µL appropriate buffer (according the manufacturer’s instructions) (Fermentas).  
Reactions were incubated at 37oC for 20 minutes to 2 hours, depending on the 
type of restriction enzyme (FastDigest enzymes were used in shorter 
incubations). 
2.2.2.6. Construction of knockout vectors 
 Two fragments of the open reading frame of the gene of interest, using 
Ax2 genomic DNA, were amplified using PCR.  Primers were designed to 
contain restriction sites for cloning into the pLPBLP vector.  PCR products were 
purified using GE Healthcare s400 MicroSpin columns or the GenElute PCR 
purification kit (Qiagen).  The pLPBLP vector and gene fragments were double-
digested with appropriate restriction enzymes, BamHI, PstI (for N-terminal 
fragments) and NcoI, KpnI (for C-terminal fragments).  Gene fragments were 
then ligated into the pLPBLP vector backbone using 0.4µL T4DNA ligase (1U 
µL-1) (Fermentas), 1µL T4DNA ligase buffer (Fermentas) at ratios of 1:10 and/or 
1:100 insert: vector.  Ligation mixtures were made up to 10µL using double 
distilled water and incubated at 16oC overnight.  Ligation mixtures were then 
heat inactivated at 70oC for 15 minutes before being transformed into JM107 
chemically competent E.coli cells.  Colonies formed during overnight incubation 
were picked and grown in LB media containing 2-4µL/mL ampicillin before 
plasmid preparation.  To test the insertion of a fragment of Dictyostelium 
genomic DNA, restriction digests were performed with previously used 
restriction enzymes.  This process was repeated to insert the second gene 
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fragment into the pLPBLP vector backbone.  Once both N and C terminal 
fragments had been inserted into the vector, the knockout construct was 
prepared using the QIAfilter Plasmid Maxi kit and electroporated into 
Dictyostelium cells. 
2.2.2.7. Transformation of knockout constructs into 
Dictyostelium 
 Knockout constructs created using pLPBLP were excised from the vector 
backbone using restriction enzymes BamHI and KpnI.  The digested knockout 
construct (20µg) was purified using isopropanol precipitation. 
 For electroporation, 1x107 Dictyostelium cells were incubated on ice for 
10 minutes before centrifugation at 1000xg for 3 minutes at 4oC.  Cells were 
then washed twice with phosphate buffer (KK2) at 4oC prior to a further two 
washes with sterile filtered electroporation buffer (10mM sodium phosphate 
buffer pH 6.1, 50mM sucrose).  Finally, the pellet was resuspended in 700µL 
electroporation buffer, transferred to a 0.4cm cuvette along with the previously 
digested and purified knockout construct (20µg) and incubated on ice for 10 
minutes prior to electroporation.  Dictyostelium cells were electroporated with a 
BIO-RAD GenePulser Xcell electroporator using 1 pulse, 850V and 25µF.  Cells 
were incubated on ice for 10 minutes before addition of 8µL CaCl2 (100mM) and 
8µL MgCl2 (100mM) followed by a further 15 minute incubation at room 
temperature.  Cells were added to 10mL Ax medium containing 
penicillin/streptomycin (100x) and 100µL culture transferred to each well of a 
96-well plate.  After 24-hours, 100µL of double concentrated blasticidin 
(20µg/mL) in Ax media (containing penicillin/streptomycin) was added to each 
well of the 96-well plate.   
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2.2.2.8. Transformation of overexpression constructs by 
calcium chloride precipitation 
 Overexpression vectors containing a C-terminally fused GFP tag 
(pDEX27) or an N-terminally fused FLAG (PDM320) tag were obtained from 
www.dictybase.org.  Full length cDNA was amplified by PCR using primers 
containing appropriate restriction sites.  Overexpression constructs were double 
digested with restriction enzymes before ligation into the vector backbones.  
Overexpression constructs were prepared using QIAfilter Plasmid Maxi kits. 
 For calcium transformation, 1x107 cells were harvested in Ax media and 
allowed to adhere to a 9cm Petri dish over 30 minutes.   Ax media was replaced 
with 10mL filter sterilized MES-HL5 (0.6% (w/v) yeast extract, 22.2mM glucose,  
1% (w/v) bacteriological peptone, 6.65mM MES; pH 7.1) and incubated at 22oC 
for 1.5 hours.  The DNA was prepared for transformation by adding 20µg DNA 
to 600µL double distilled water and 600µL 2x HBS (237mM NaCl, 9.65mM KCl, 
1.6mM Na2H2PO4, 41mM HEPES, 11.1mM D-glucose, pH 7.05) and 
precipitated using 76µL 2M CaCl2.  The solution was incubated for 25 minutes 
at 22oC.  After 1.5 hours, MES-HL5 medium used for incubation was replaced 
with 1.2mL DNA solution and incubated for 30 minutes.  10mL MES-HL5 was 
then added to cells and incubated for a further 3 hours at 22oC before the 
medium was gently replaced with 2mL 15% glycerol stock (2.5mL 60% glycerol,  
2.5mL double distilled water, 5mL 2x HBS).  After 2 minutes, the glycerol stock 
was carefully removed, replaced with 10mL Ax media and allowed to recover 
overnight.  Cells were then equally distributed onto 10 Micrococcus luteus lawns 
(geneticin resistant) on SM agar plates (containing 25µg/mL geneticin) and 
incubated at 22oC. 
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2.2.2.9. Extraction of DNA from potential transformants 
 Surviving colonies growing in 96-well plates after transformation were 
allowed to reach confluence before removal of 200µL cells and centrifugation at 
1000g for 3 minutes.  The pellet was resuspended in 48µL of lysis buffer (50mM 
KCl, 10mM Tris pH 8.3, 2.5M MgCl2, 0.45% Nonidet P 40, 0.45% TWEEN 20) 
and 2µL Proteinase K (822U/mL) before 5 minute incubation at room 
temperature.  Samples were further incubated at 95oC for 1 minute and the 
extracted DNA used in PCR reactions to screen for correctly transformed 
constructs.  
2.2.2.10. Screening for correct mutants 
 Primers were designed to determine the whether transformed 
Dictyostelium cells contained the knock out construct with a correctly 
incorporated cassette encoding blasticidin resistance.  Genomic DNA was 
extracted and used in PCR analysis based upon 3 different primer pairs to 
screen for the knockout construct: genomic, vector controls and an additional 
knockout diagnostic primer set.   Genomic control primers were designed to 
flank 5’ and 3’ fragments cloned into the pLPBLP vector, which would confirm 
the presence of a non-deleted region of the gene.  Vector control fragments 
were used to confirm the presence of the knockout cassette using primers 
flanking regions inside genomic DNA fragment and the cassette encoding 
blasticidin.  The diagnostic knockout fragment was designed using the genomic 
control primer and the blasticidin resistance cassette primer.  These primer 
pairs were created for both N and C terminal fragments of the knockout 
construct. 
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2.2.2.11. Sub-cloning of correct transformants 
 Once correct transformants had been confirmed by PCR, colonies were 
selected and plated onto sterile SM agar plates containing 200µL Raoultella 
planticola.  The plates were incubated at 22oC for 3-4 days to allow individual 
colonies to form, before the resulting cloned sub-colonies were screened again 
using the PCR primers previously described (Section 2.2.2.10) 
2.2.2.12. RNA extraction 
 Dictyostelium cells were harvested and resuspended at 1x107 cells/mL 
prior to washing with phosphate buffer (KK2) at 4oC.  RNA was extracted using 
the High Pure RNA isolation kit (Roche) according to the manufacturer’s 
instructions.  
2.2.2.13. Reverse transcription PCR 
 cDNA was synthesised using 1µg of extracted RNA using a First Strand 
cDNA synthesis kit (Fermentas).   2µL synthesized cDNA was then used in 
PCR reactions as previously described. 
2.2.3. Proteomics 
2.2.3.1. Western blot analysis 
 Sodium dodecyl sulphate polyacrylamide gels (SDS-PAGE) (12.5%) 
were prepared (Resolving gel – 2.215mL 30% acrylamide solution, 0.95mL Tris 
pH 8.8, 1.825mL water, 100µL 10% SDS, 50µL 10% ammonium persulphate, 
5µL TEMED, stacking gel - 425µL 30% acrylamide solution, 157.5µL Tris pH 
6.8, 1.875mL water, 25µL 10% SDS, 25µL 10% ammonium persulphate, 7.5µL 
TEMED) for electrophoresis.  Protein samples were prepared by boiling at 95oC 
in 5x loading buffer (0.8mL 2M Tris pH6.8, 3mL 80% glycerol, 5mL 10% SDS, 
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1.25mL β-mercaptoethanol, water to 10 mL, bromophenol blue) for 15 minutes.  
Protein samples and the molecular marker, PageRuler Plus Prestained Protein 
Ladder (Fermentas) were loaded into the stacking gel and the gel run at 200 
volts for 60 minutes in 1x running buffer (10x – 30g Trisma base, 144g glycine, 
100mL 10% SDS, made up to 1L).  The separated protein was blotted onto a 
PVDF membrane (Immobilon-FL Transfer membrane), which was activated by 
saturation in methanol. Blotting paper (3mm), sponges and the activated 
membrane were soaked in transfer buffer containing 10% ETB buffer (10x 75g 
trisma base, 360g glycine, 25mL 10% SDS) and 10% methanol.  The transfer 
blot was prepared and added to a tank containing ice cold transfer buffer and 
run at 400mA for 1 hour. 
 After blotting, the PVDF membrane was incubated using 5mL blocking 
buffer (Li-cor Biosciences) for 1 hour.  The appropriate primary antibody was 
then added at a 1:1000 dilution and incubated at 4oC overnight.  Primary 
antibody was then washed away with 1xPBS (10x PBS – 14.4g Na2HPO4, 80g 
NaCl, 2gKCl, 2.4g KH2PO4 made up to 1L with double distilled water, pH 7.4) 
followed by 3x10 minute incubations with PBST (1x PBS with 1% TWEEN 20).  
The appropriate secondary antibody was then added at a 1:5000 dilution in 
blocking buffer and incubated at room temperature for 1 hour.  Secondary 
antibody was them washed away with 1xPBS followed by 3x10 minute 
incubations with PBST.  Images were then taken with Odyssey Infrared Imaging 
System (Li-cor Bioscienes). 
2.3. Software 
 Microscopy and quantification of motility assays were analyzed using 
ImagePro Plus (Media Cybernetics).  Random cell movement and global 
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stimulation microscopy experiments were quantified with Fiji, using the QuimP 
11b software (Warwick University, Warwick, England) and MATLAB 
(Mathworks, Cambridge, England).  Graphical and statistical analysis was 
performed using GraphPad Prism 5 (GraphPad Software Inc). 
2.4. Websites 
Dictyostelium gene and protein information 
www.dictybase.org 
Dictyostelium gene expression information 
www.dictyexpress.biolab.sl 
Basic Local Alignment Search Tool (BLAST) analysis 
www.dictybase.org/tools/blast 
www.ebi.ac.uk/tools/sss/psiblast 
www.ncbi.nlm.nih.gov/BLAST 
Protein sequence alignment 
www.ebi.ac.uk/tools/msa/clustalw2 
Protein domain analysis 
www.smart.embl-heidelberg.de 
www.pfam.sanger.ac.uk 
Glycosylation analysis 
http://www.cbs.dtu.dk/services/NetNGlyc/ 
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Organismal gene and protein information 
www.uniprot.org 
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Chapter 3 
Dictyostelium as a model for screening 
emetic compounds 
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 Emetic research employs a range of unpleasant experiments on multiple 
animal models, with a large variation in response to different compounds and 
doses in different models (Holmes et al. 2009).  Sentient models range from 
those animals that vomit (e.g. dog, ferret, house musk shrew) to those that 
exhibit conditioned taste aversion/conditioned food avoidance and pica (e.g. rat) 
(Holmes et al. 2009).  Development of a suitable screen to predict emetic 
liability of novel compounds, prior to performing in vivo experiments, could 
provide substantial preliminary data, which could in turn help to reduce the 
number of animals required at a later stage in drug development. 
No studies have explored the utility for Dictyostelium as a high 
throughput screen for specific side-effects, such as emesis.  In addition, whilst 
the various stages of Dictyostelium development have been extensively studied, 
relatively few have examined compound-specific or structure-activity related 
effects on motility.  Compounds that affect Dictyostelium motility include 
transmethylation inhibitors (inhibitors that prevent methyl group transfers 
between structures) (van and van Haastert, 1984), formaldehyde (Waligorska et 
al., 2008), potassium permanganate (Waligorska et al., 2008), ammonia (Feit et 
al., 2001) and adenosine derivatives (Theibert and Devreotes, 1984).  In 
addition, therapeutic compounds such as valproic acid (used in the treatment of 
epilepsy) (Xu et al., 2007), lithium (used in the treatment for bipolar disorder) 
(Williams et al., 2002; King et al., 2009), chlorpromazine (an antipsychotic) 
(Gayatri and Chatterjee, 1991), naringenin (a flavonoid with anti-cancer 
potential) (Misty et al., 2006) and nitric oxide (a vasodilator) (Tao et al., 1996) 
can block Dictyostelium motility.   
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Numerous methods for measuring Dictyostelium cell motility exist, 
including the Dunn chamber (Zicha et al., 1991), the Zigmond chamber 
(Zigmond, 1977), needle point assays (Gerisch and Keller, 1981) and under 
agarose assays (Nelson et al., 1975).  Measuring motility using a Dunn or 
Zigmond chamber allows for the establishment of a stable linear chemotactic 
gradient enabling cell migration in a uniform environment (Postma and van 
Haastert, 2009).  
In this chapter Dictyostelium motility was assessed using a range of 
structurally diverse emetic compounds to investigate the model as an early 
screen to predict emetic liability.  A Dunn chamber motility assay was 
developed to quantify cell behaviour following exposure to compounds shown to 
be emetic in mammals. 
3.2. Development of a Suitable Motility Assay 
To monitor Dictyostelium chemotactic behaviour, cells were developed to 
chemotactic competency (King et al., 2009; Pakes et al., 2012b; Robery et al., 
2011) and added to the Dunn chamber (Chapter 2) migrating towards cAMP 
(Zicha et al., 1991).  To visualise Dictyostelium behaviour, phase contrast 
microscopy was used to record cell motility over a 15 minute period (Figure 
3.1).   
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Figure 3.1. Dictyostelium cell migration over a 15 minute period. Phase contrast imaging 
was used to track cell migration over a 15 minute period during the assay.  Under control 
conditions, cells migrated across the Dunn chamber.  Each image is representative of 1 minute 
(A-O).  2 separate cells have been highlighted by arrows to show individual cell migration 
towards cAMP.  Bar = 10µm 
To quantify Dictyostelium motility, ImagePro Plus was used to track the 
outlines of cells between individual frames (Figure 3.2A).  Outlines of individual 
cells throughout the 15 minute period were then used to determine the speed 
(velocity), cell shape (aspect), direction of migration (angle) and overall 
directionality across the assay (direction) (Figure 3.2B).  Velocity was defined 
as the distance travelled by the cell (measured from the centroid) between time 
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point 1 and time point 2 between each frame.  Since individual cells migrated in 
slightly different directions, it is important to note the average velocity was 
actually a measurement for cell speed, because a single direction for all cells 
could not accurately be determined.  Since ImagePro plus was used to 
calculate the velocity of individual cells, this measurement has been referred to 
as velocity throughout this thesis, when calculating the mean.  The aspect of 
chemotaxing cells was described as the ratio of the lengths of the major and 
minor axes at each time point, where a value of 1 indicates a circle.  The angle 
of cell movement was characterised by comparing the direction at which an 
individual cell was moving in comparison with the vertical axis.  For this latter 
measurement, loss of movement would cause the value to deviate towards 0 as 
a direction would be indeterminable.  As an additional, more illustrative way of 
describing cell behaviour, image overlays were produced, where outlines of a 
cell at every third time point were provided in a single image.   
Figure 3.2. Analysis of Dictyostelium cell behaviour.   (A) Cells moving under a chemotactic 
gradient were tracked using ImagePro Plus software (B)  Measurements taken to determine cell 
behaviour were velocity (µm/sec); aspect (shape measured as a ratio between the length of 
cells across each axis); cell angle (degrees-where cell migration was measured in comparison 
to the y-axis); and cell direction (where still images were overlaid over one another to visually 
depict cell movement throughout the assay).  Bar = 10µm. 
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To quantify cell behaviour, a sufficient number of cells were required to 
encompass cell movement throughout the assay.  A minimum of 24 cells were 
tracked with mean velocity (speed) and aspect values at each time point and 
plotted onto a histogram (Figure 3.3).  To ensure data was distributed 
parametrically, a D’Agostino and Pearson omnibus normality test was 
performed.  Each motility assay was also performed in at least triplicate to 
ensure cell behaviour was consistent and any changes in behaviour observed 
were genuine. 
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Figure 3.3.  Histogram of Dictyostelium cell velocity and aspect.  Mean cell velocity (speed) 
and aspect was recorded for 24 cells and the mean at each time point throughout the duration 
of the motility assay plotted.  A D’Agostino and Pearson omnibus normality test showed data 
was normally distributed (P<0.05).  
3.3. Control Conditions 
To investigate any changes in Dictyostelium behaviour upon addition of a 
vehicle only control, experiments were performed by adding phosphate buffer 
(KK2) to the outer well of the chamber at 300 seconds (Figure 3.4A-C).  Two-
tailed Student t-tests were performed between the first and final 300 seconds of 
the assay for cell velocity, aspect and angle to assess potential behavioural 
changes after the addition of a control vehicle.  No significant changes in cell 
behaviour were observed during the assay.  Illustrative examples of individual 
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cell behaviour are shown for four cells pre- and post-addition of vehicle-only 
control (Figure 3.4D). In addition to phosphate buffer, these control 
experiments were all repeated using 1% DMSO, 0.9% ascorbic acid and 0.1% 
sodium hydroxide (all in phosphate buffer) as alternative solvents for 
compounds tested.  These vehicles were all used in the presence of phosphate 
buffer in the attempt to neutralise any pH-specific effects that may be caused by 
the addition of compounds.  None of these vehicles showed significant changes 
in cell behaviour comparing the 300 seconds pre-addition and 300-600 seconds 
post-addition based on the paired 2-tailed Student t-tests. 
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Figure 3.4.  Analysis of Dictyostelium cell behaviour during motility under control 
conditions.  Cell behaviour was measured under a stable chemotactic gradient in a Dunn 
chamber, with data from 85 cells quantified every 6 seconds over a 900 second period with the 
addition of vehicle only control (shown here for KK2) at 300 seconds.  (A)  Cell velocity; (B) cell 
aspect; (C) cell angular movement; (D) cell directionality.  Cell outlines of 4 representative cells 
(C1-4) migrating under control conditions were overlaid and split into the first 300 and final 600 
second intervals.  Overlay images have been adjusted so that the chemotactic gradient is 
following the marked arrows. Cell behaviour showed no significant differences in velocity, 
aspect or angle observed between the first and final 300 seconds of the assay. Data from A-C is 
presented as mean of triplicate experiments analysing a minimum of 24 cells in each.  Statistical 
analyses were performed using paired two-tailed Student t-tests comparing average values 
from T=0-300 and T=600-900 seconds as indicated. ns = not significant 
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Initial analysis of the assay for compounds showing chemotactic 
inhibition showed variability in chemotactic effects in the incubation period used.  
To investigate diffusion rates of compounds across the Dunn chamber, the time 
taken for 5x DNA loading dye (added to the outer well of the chamber) to 
completely diffuse was assessed.  This experiment revealed a 3 minute delay in 
complete diffusion of the loading dye around the Dunn chamber (Figure 3.5A-
E).   Due to this diffusion delay, subsequent experiments were monitored in a 
defined region of the Dunn chamber to provide a consistent exposure to test 
compounds (Figure 3.5F). 
Figure 3.5. Diffusion of 5x loading dye around a Dunn Chamber. Loading dye was added to 
the outer well of a Dunn chamber containing KK2 and 5nM cAMP in order to simulate 
compound diffusion throughout the chamber.  Images show conditions (A) prior to loading dye 
application, (B) upon addition and (C) 1 minute, (D) 2 minutes and (E) 3 minutes post-addition.   
(F) Schematic showing the region within the Dunn chamber used for imaging and subsequent 
quantification to ensure consistent exposure to test compounds. 
 
3.4. Compounds and screening 
A range of structurally diverse emetic and aversive compounds was used 
to assess the suitability of using Dictyostelium in a Dunn chamber for use in a 
high throughput motility screen to identify emetic compounds.  The compounds 
chosen had a variety of primary pharmacological or molecular actions, which 
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may be responsible for emetic effects, summarised in Table 3.1.  The 
mammalian species in which a compound has been shown to have emetic or 
related effects are also shown. The concentrations of compounds used in these 
tests were based upon emetic-inducing doses shown previously either in vivo 
(e.g. copper sulphate (Araya et al., 2001)), or in plasma concentrations (e.g. 
cisplatin (Percie du Sert et al., 2010)) or at concentrations shown to be active in 
vitro in mammalian tissue relevant to the emetic reflex (e.g. RTX on neurones 
(Smith et al., 2002), denatonium benzoate on intestinal epithelial cells (Chen et 
al., 2006)).  
In all experiments, compounds were added to the outer well of the Dunn 
chamber after 300 seconds of recorded cell behaviour, providing an inbuilt 
control for each experiment.  29 compounds were screened, encompassing a 
wide range of targets and molecular mechanisms (Table 3.1).  Six compounds, 
copper sulphate (1.6-5mM), copper chloride (1.6mM), denatonium benzoate 
(0.5-10mM), phenylthiourea (1-5mM), quinine hydrochloride (0.1-1mM) and 
capsaicin (0.05-0.3mM) showed a significant change in cell velocity and aspect 
comparing pre-compound addition and 300-600 seconds post-compound 
addition (Table 3.1).  The remaining 22 compounds were repeated at 10 to 200-
fold higher concentrations to reduce the risk of obtaining false negative results.  
From this, rolipram was shown to inhibit Dictyostelium cell behaviour at an 
elevated concentration (0.7mM).  Statistical analysis of cell behaviour was 
based on average velocity and aspect in the first and final five minutes of the 
assay used in a paired two-tailed Student t-test (P≤0.05).  As cell velocity 
approached 0µm/sec and aspect approached 1, cell angle measurements 
became unreliable and statistical analysis was therefore not performed on this 
measurement.   
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Target Receptor/ 
Mechanism of Action 
Common Name Concentration 
Effect on 
Dictyostelium 
Species Dose Range Reference 
5-HT Receptor Agonist 
5-
hydroxytryptamine 
1µM, 100µM N S 4-10mg/kg 
(Torii et al., 1991; Javid and Naylor, 2002; Fujiwara-Sawada et al., 
2003)  
CNS depressant Lithium chloride 10mM N R,S,H 50-200mg/kg (Karniol et al., 1978; Seeley et al., 2000; Yamamoto et al., 2004)  
Cytotoxic 5-Fluorouracil 250µM N F,R,S,H 35-100mg/kg (Matsuki et al., 1988; Pollera et al., 1989; Yamamoto et al., 2007)  
 Actinomycin D 10µM N D,R 
0.13-
0.25mg/kg 
(Eglen et al., 1993; Yamamoto et al., 2007)  
 Cisplatin 50µM, 300µM N F,D,R,S, H 3-20mg/kg 
(Andrews et al., 1990; Fukui et al., 1993a; Knox et al., 1993; Eglen 
et al., 1993; Kris et al., 1996; Andrews et al., 2000b; Nakayama et 
al., 2004; Horn et al., 2004; Parker et al., 2009; Percie du Sert et al., 
2010)  
 Cycloheximide 5mM N F,D 20mg/kg (Andrews et al., 1990) 
 Methotrexate 50µM, 250µM N S,H 80mg/kg (Matsuki et al., 1988; Pollera et al., 1989)  
 Streptozotocin 1µM N H 14-17mg/kg (Borison and McCarthy, 1983; Seymour, 1993; Carter et al., 1981)  
 Vincristine 1µM N R 0.1-1mg/kg (Yamamoto et al., 2007) 
Dopamine Receptor 
Agonist 
Apomorphine HCl 10µM, 1mM N F,D,R,H 0.1-10mg/kg 
(Andrews et al., 1990; Eglen et al., 1993; Knox et al., 1993; Andrews 
et al., 2001; Nakayama et al., 2004; Horn et al., 2009; Osinski et al., 
2005)  
Enteroendocrine Cell 
Stimulant 
Metformin 500µM, 10mM N H* 1-30µM (Cubeddu et al., 1992; Hoffmann et al., 2003) 
Extracellular Enzyme 
Inhibitor 
Digoxin 1µM N C,H 0.2-0.6mg/kg (Gold et al., 1952; Parsons and Summers, 1971)  
Free Radical 
Generator 
Pyrogallol 500µM, 10mM N S 128mg/kg (Torii et al., 1994; Andrews et al., 2000a)  
Ligand Gated Ion 
Channel Activator 
Veratridine HCl 30µM, 500µM N D, C 
0.02-
0.25mg/kg 
(Borison and Fairbanks, 1952; Swiss, 1952; Bobkov, 1964)  
Gastric mucosal irritant Copper Sulphate 0.16- 5mM Y F,D,R,S, H 5-120mg/kg 
(Torii et al., 1991; Andrews and Bhandari, 1993; Kan et al., 2002; 
Araya et al., 2003; Nakayama et al., 2004; Yamamoto et al., 2004)  
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 Copper Chloride 1.6mM Y   
Based on concentration of copper sulphate: (Torii et al., 1991; 
Andrews and Bhandari, 1993; Kan et al., 2002; Araya et al., 2003; 
Nakayama et al., 2004; Yamamoto et al., 2004) 
 Zinc Sulphate 1.6mM N 1% H (Cushny, 1918; Gaddum, 1961) 
Neurokinin Receptor 
Agonist 
Substance P 1µM N D 0.03-0.2mg/kg (Andrews and Rudd, 2004) 
Nicotinic Receptor 
Agonist 
Nicotine 6µM, 100µM N F,D,R,S,H 1.5-20mg/kg 
(Laffan and Borison, 1957; Torii et al., 1991; Jorenby et al., 1995; 
Andrews et al., 1996; Andrews et al., 2000b; Saito et al., 2003; 
Yamamoto et al., 2004; Parker et al., 2009)  
Opioid Receptor 
Agonist 
Loperamide HCl 1µM, 100µM N F 0.5mg/kg 
(Bhandari et al., 1992; Andrews and Bhandari, 1993; Nakayama et 
al., 2004)  
PDEIV Inhibitor Rolipram 10µM, 700µM Y F,D,R,S 0.5-10mg/kg 
(Heaslip and Evans, 1995; Aoki et al., 2001; Hirose et al., 2007; 
Davis et al., 2009)  
Prostaglandin PGF2α 1µM, 100µM N F,S 1-13.5mg/kg (Kan et al., 2002; Kan et al., 2003)  
SSRI/Transmitter 
Uptake Inhibitor 
Fluoxetine 6.5µM N S 60mg/kg (Fujiwara-Sawada et al., 2003) 
T2R Receptor ligand 
Denatonium 
Benzoate 
0.05-10mM Y R*, H* 0.01-10mM 
(Sibert and Frude, 1991; Chen et al., 2006; Tordoff et al., 2008; 
Glendinning et al., 2008)  
 Phenylthiourea 0.05-5mM Y H* 2-5mM (Chen et al., 2006)  
 Quinine HCl 0.05-1mM Y R* 
0.0082-
250mM 
(Scott and Giza, 1987; Tordoff et al., 2008)  
 Xanthohumol 0.05-0.15mM N NA NA (Miranda et al., 1999; Intelmann et al., 2009) 
TRPV1 Receptor 
Agonist 
Capsaicin 0.01-0.3mM Y S 0.04-0.4mg/kg (Rudd and Wai, 2001; Smith et al., 2002)  
 Resiniferatoxin 1µM, 10µM N S 0.1-1000µg/kg 
(Andrews and Bhandari, 1993; Andrews et al., 1996; Andrews et al., 
2000b; Cheng et al., 2005)  
Table 3.1.  Emetic or taste aversive compounds assessed for effects on Dictyostelium behaviour during motility.  Compounds were grouped by target 
receptor/mechanism of action.  Compound concentrations, used to test for acute effects on Dictyostelium motility, were derived from experiments in other species: F 
= Ferret; D = Dog; R = Rat; S = Suncus murinus [House musk shrew]; C = Cat; H = Human.  N/A =Not applicable.  Note that for in vivo experiments in the rat, the 
table refers to the dose at which pica was observed, for all other species it refers to the emetic dose.  A significant effect on motility (defined as a significant change 
in cell velocity following acute treatment (see Figure 2-5)) is represented by Y (Yes), with no effect denoted N (No).  * Caused conditioned taste aversion responses 
in the rat or data derived from in vitro studies.  
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3.4.1. Gastric mucosal irritants 
Copper is a gastric irritant shown to cause emesis or conditioned taste 
aversion in the ferret, dog, rat, shrew, and nausea in humans at high 
concentrations (Torii et al., 1991; Andrews and Bhandari, 1993; Kan et al., 
2003; Araya et al., 2003; Nakayama et al., 2004; Yamamoto et al., 2004).  Zinc 
is another gastric mucosal irritant, shown to cause emesis in humans (Cushny, 
1918; Gaddum, 1961).  Dictyostelium cell motility was significantly decreased 
by the copper based salts copper sulphate and chloride but not zinc.  In these 
assays, cell behaviour was constant over the first 5 minutes, where addition of 
copper salts caused a decrease in velocity and induced cell rounding.  This is 
summarised in a series of phase contrast time lapse frames (Figure 3.6).   
Three independent repeats of this experiment, where cells were tracked 
and behaviour quantified illustrated a significant decrease in cell velocity, from 
0.18±0.01µm/sec to 0.05±0.01µm/sec (P<0.01), and aspect, from 2.6±0.2 to 
1.7±0.1 (P<0.05), upon addition of 5mM copper sulphate (Figure 3.7A, B).  A 
loss of cell behaviour also correlated with a deviation in angularity towards zero 
(Figure 3.7C).  This rapid block in cell directionality and distance travelled 
caused by copper sulphate when compared Dictyostelium cells migrating under 
control conditions is represented in a cell image overlay plot (Figure 3.7D). 
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Figure 3.6.  Dictyostelium cell motility with addition of 5mM copper sulphate after 300 
seconds.  Phase contrast images shown at 60 second intervals over 15 minutes under control 
conditions (A-D).  After 300 seconds (E), (highlighted) 5mM copper sulphate was added to the 
outer well of the Dunn chamber and cell behaviour recorded over the remainder of the assay (F-
O).  Addition of copper sulphate caused a reduction in cell migration and a loss of cell shape. 
Each image represents images taken at 1 minute intervals.   Bar = 20µm 
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Figure 3.7.  Analysis of Dictyostelium cell behaviour following active exposure to 5mM 
copper sulphate.  Cell behaviour was measured under a stable chemotactic gradient in a Dunn 
chamber, with data from 124 cells quantified every 6 seconds over a 900 second period with the 
addition of 5mM copper sulphate at 300 seconds.  (A)  Cell velocity; (B) cell aspect; (C) cell 
angular movement; (D) cell directionality.  Cell outlines of 2 representative cells from (C1-2) 
control experiments and (D1-2) copper sulphate were overlaid and split into the first 300 and 
final 600 second intervals.  Overlay images have been adjusted so that the chemotactic 
gradient is following the marked arrows. Cell behaviour showed significant differences in 
velocity (P=0.0051) and aspect (P=0.0179) observed between the first and final 300 seconds of 
the assay. Data from A-C is presented as mean of triplicate experiments analysing a minimum 
of 30 cells in each.  Statistical analyses were performed using paired two-tailed Student t-tests 
comparing average values from T=0-300 and T=600-900 seconds as indicated by the horizontal 
bars in panels A and B. * P<0.05, ** P<0.01. 
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To investigate concentration-related responses to copper sulphate, these 
experiments were repeated with a range of concentrations from 0.16-5mM.  A 
significant inhibition of cell velocity was observed at 1.6mM and above; and 
2.4mM and above for velocity and aspect respectively (Table 3.2).  
Compound 
Concentration 
(mM) 
Velocity 
(pre) 
(µm/sec) 
Velocity 
(post) 
(µm/sec) 
P-value 
(Velocity) 
 
Aspect 
(pre) 
 
Aspect 
(post)  
P-Value 
(Aspect) 
Copper 0.16 0.22±0.03 0.21±0.02 ns 2.5±0.1 2.5±0.3 ns 
Sulphate 0.8 0.21±0.02 0.16±0.00 ns 3.2±0.2 2.9±0.3 ns 
 1.2 0.17±0.01 0.14±0.04 ns 2.7±0.2 2.6±0.3 ns 
 1.6 0.19±0.04 0.08±0.02 0.0319 2.5±0.0 1.9±0.3 ns 
 2.4 0.17±0.02 0.03±0.01 0.0284 3.0±0.1 1.5±0.1 0.0111 
 3.4 0.15±0.01 0.04±0.01 0.0069 3.1±0.2 1.8±0.5 ns 
 5.0 0.18±0.01 0.05±0.01 0.0051 2.6±0.2 1.7±0.1 0.0179 
Copper 1.6 0.24±0.03 0.08±0.03 0.0450 2.6±0.1 2.0±0.1 0.0163 
Chloride        
Table 3.2.  Copper-dependent effect of Dictyostelium cell behaviour (velocity and aspect). 
Concentration range of copper sulphate and copper chloride, showing a significant acute effect 
on Dictyostelium cell velocity and aspect between the first 300 (pre) and final 300 (post) 
seconds of the assay.  Statistical analyses were performed using 2-tailed paired Student t-tests, 
where a minimum of 30 cells were measured in each of three replicates.  ns = not significant. 
 
In order to investigate the specificity for the inhibition of Dictyostelium 
motility for the metal cation copper, rather than sulphate, cells were also 
exposed to 1.6mM copper chloride.  At this concentration, copper chloride 
caused a significant decrease in velocity, from 0.24±0.03µm/sec to 
0.08±0.03µm/sec (P<0.05), and aspect, from 2.6±0.1 to 2.0±0.1 (P<0.05) 
(Figure 3.8, Table 3.2). 
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Figure 3.8.  Analysis of Dictyostelium cell behaviour following active exposure to 1.6mM 
copper chloride.  Cell behaviour was measured under a stable chemotactic gradient in a Dunn 
chamber, with data from 49 cells quantified every 6 seconds over a 900 second period with the 
addition of 5mM copper sulphate at 300 seconds.  (A)  cell velocity; (B) cell aspect; (C) cell 
angular movement; (D) cell directionality.  Cell outlines of 2 representative cells from (C1-2) 
control experiments and (D1-2) copper sulphate were overlaid and split into the first 300 and 
final 600 second intervals.  Overlay images have been adjusted so that the chemotactic 
gradient is following the marked arrows. Cell behaviour showed significant differences in 
velocity (P=0.0450) and aspect (P=0.0163) observed between the first and final 300 seconds of 
the assay. Data from A-C is presented as mean of triplicate experiments analysing a minimum 
of 15 cells in each.  Statistical analyses were performed using paired two-tailed Student t-tests 
comparing average values from T=0-300 and T=600-900 seconds as indicated by the horizontal 
bars in panels A and B. * P<0.05 
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The dose dependency of copper on Dictyostelium chemotactic behaviour 
shown in Table 3.2 was then analysed by plotting the total reduction in velocity 
when compared to initial control conditions.  This was used to construct a 
concentration-response curve to measure the potency of Dictyostelium motility 
inhibition.  It was shown that the inhibition of migration was concentration-
dependent on copper sulphate concentration, with an IC50 value of 1433±3µM, 
R2=0.54 based on a three parameter non-linear regression calculated in 
GraphPad prism (Materials and Methods) (Figure 3.9). 
 
Figure 3.9.   Concentration-
dependent reduction of cell velocity 
for copper sulphate.  Reduction in 
cell velocity compared to control 
conditions was plotted against log10 
copper sulphate concentration (0.16-
5mM). All data is presented as a mean 
± S.E.M of triplicate experiments, 
comparing mean cell velocity during 
the first 5 minutes and final 5 minutes 
with increasing concentration.  
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3.4.2. TRPV1 Receptor Agonists 
 Capsaicin and its ultra-potent analogue resiniferatoxin were both 
analysed for their acute effects on Dictyostelium motility (Table 3.1).   Both 
capsaicin and resiniferatoxin are vanilloid compounds shown to cause emesis in 
Suncus murinus (Rudd and Wai, 2001; Smith et al., 2002; Andrews et al., 1996; 
Andrews et al., 2000b; Cheng et al., 2005).  Capsaicin, the constituent 
responsible for the pungency in chillies, was shown to be a potent inhibitor of 
motility.  At 300µM, capsaicin caused a rapid and strong reduction in cell 
velocity, from 0.16±0.01µm/sec to 0.03±0.00µm/sec (P<0.01), and aspect, from 
2.4±0.1 to 1.7±0.1 (P<0.05) (Figure 3.10A-B).  In addition, angularity deviated 
towards 0 degrees and cell directionality was substantially reduced upon 
capsaicin exposure when compared to control conditions (Figure 3.10C-D).  
Resiniferatoxin, did not cause any significant (P<0.05) changes in cell migration 
at 1µM or 10µM (higher concentrations could not be used due to a lack of 
solubility). 
Dictyostelium behaviour was then recorded upon exposure to multiple 
concentrations of capsaicin, ranging from 10-300µM (Table 3.3). In these 
experiments capsaicin evoked significant reductions in velocity and aspect 
above 50µM and 100µM respectively.   
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Figure 3.10.  Analysis of Dictyostelium cell behaviour following active exposure to 300µM 
capsaicin.  Cell behaviour was measured under a stable chemotactic gradient in a Dunn 
chamber, with data from 113 cells quantified every 6 seconds over a 900 second period with the 
addition of 5mM copper sulphate at 300 seconds.  (A)  Cell velocity; (B) cell aspect; (C) cell 
angular movement; (D) cell directionality.  Cell outlines of 2 representative cells from (C1-2) 
control experiments and (D1-2) capsaicin were overlaid and split into the first 300 and final 600 
second intervals.  Overlay images have been adjusted so that the chemotactic gradient is 
following the marked arrows. Cell behaviour showed significant differences in velocity 
(P=0.0056) and aspect (P=0.0.0401) observed between the first and final 300 seconds of the 
assay. Data from A-C is presented as mean of triplicate experiments analysing approximately a 
minimum of 30 cells in each.  Statistical analyses were performed using paired two-tailed 
Student t-tests comparing average values from T=0-300 and T=600-900 seconds as indicated 
by the horizontal bars in panels A and B.  * P<0.05 
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Compound 
Concentration 
(mM) 
Velocity 
(pre) 
(µm/sec) 
Velocity 
(post) 
(µm/sec) 
P-value 
(Velocity) 
 
Aspect 
(pre) 
 
Aspect 
(post)  
P-Value 
(Aspect) 
Capsaicin 0.01 0.15±0.04 0.07±0.05 ns 2.4±0.1 2.3±0.1 ns 
 0.05 0.20±0.01 0.10±0.01 0.0247 2.5±0.1 2.3±0.1 ns 
 0.1 0.12±0.03 0.01±0.00 0.0407 2.5±0.2 1.8 ±0.1 0.0313 
 0.2 0.18±0.00 0.04±0.00 0.0005 2.6±0.1 1.8±0.0 0.0321 
 0.3 0.16±0.01 0.03±0.00 0.0056 2.4±0.1 1.7±0.1 0.0401 
 
Table 3.3:  Capsaicin-dependent effect of Dictyostelium cell behaviour (velocity and 
aspect). Concentration range of capsaicin showing a significant acute effect on Dictyostelium 
cell velocity and aspect between the first 300 (pre) and final 300 (post) seconds of the assay.  
Statistical analyses were performed using 2-tailed paired Student t-tests, where a minimum of 
30 cells were measured in each of three replicates.  ns = not significant. 
The rate at which Dictyostelium cell velocity dropped was then assessed 
for the effect of capsaicin on cell behaviour to establish a concentration-
response relationship.  Capsaicin caused a concentration-dependent response, 
where increasing concentrations of capsaicin evoked decreases in cell velocity 
(Figure 3.11).  Capsaicin was a potent inhibitor of Dictyostelium motility 
(IC50=11.9±4.0µM, R
2=0.78).  
Figure 3.11.   Concentration-
dependent reduction of cell 
velocity for capsaicin.  Reduction 
in cell velocity compared to control 
conditions was plotted against log10 
capsaicin concentration (0.01-
0.3mM). All data is presented as a 
mean ± S.E.M of triplicate 
experiments, comparing mean cell 
velocity during the first 5 minutes 
and final 5 minutes with increasing 
concentration. 
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3.4.3. T2R Receptor Agonists 
 Chemotaxing Dictyostelium cells were exposed to four compounds 
commonly used as examples of bitter tastants.  These compounds cause taste 
aversion in rats as well as emetic episodes in humans at high concentrations, 
activating T2R receptors (Scott and Giza, 1987; Sibert and Frude, 1991; Chen 
et al., 2006; Tordoff et al., 2008; Glendinning et al., 2008).  Denatonium 
benzoate, phenylthiourea and quinine hydrochloride all affected cell behaviour, 
causing significant reductions in cell velocity and aspect as well as reducing cell 
directionality at multiple concentrations.  A final bitter tastant, xanthohumol had 
no effect on Dictyostelium motility.  It is important to note, that whilst 
phenylthiourea, quinine hydrochloride and denatonium benzoate all contain 
nitrogenous and potentially alkaline structures, the presence of phosphate 
buffer should have neutralised any potential pH-specific effects that may occur 
as a result of tastant exposure to Dictyostelium cells. 
Denatonium benzoate is a synthetic bitter tastant known to activate 
multiple mammalian T2R receptors (Meyerhof et al., 2010).  Analysis of 
denatonium benzoate effects on Dictyostelium chemotactic behaviour showed 
that 5mM caused a sharp, significant reduction in cell velocity, from 
0.15±0.01µm/sec to 0.05±0.01µm/sec (P<0.05), and aspect, from 3.2±0.2 to 
1.9±0.1 (P<0.01) (Figure 3.12A-B).  Angularity also rapidly deviated towards 0 
degrees and the overall reduction in cell movement is represented by the steep 
reduction cell directionality when compared to control conditions (Figure 3.12C-
D).   
A second naturally occurring bitter tastant, phenylthiourea, is commonly 
known to activate the TAS2R38 receptor in humans, where polymorphisms in 
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the responsible gene have been shown to cause varying levels of sensitivity to 
the bitterness of the compound (Pronin et al., 2004; Bufe et al., 2005; Meyerhof 
et al., 2010).  At a 5mM, phenylthiourea also caused significant, acute 
reductions in cell velocity, from 0.17±0.02µm/sec to 0.06±0.02µm/sec (P<0.05), 
and aspect, from 3.1±0.1 to 2.1±0.1 (P<0.01) (Figure 3.13A-B).  In addition, cell 
angularity deviated towards 0 and cell directionality was also reduced post 
exposure (Figure 3.13C-D).   
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Figure 3.12.  Analysis of Dictyostelium cell behaviour following active exposure to 5mM 
denatonium benzoate.  Cell behaviour was measured under a stable chemotactic gradient in a 
Dunn chamber, with data from 89 cells quantified every 6 seconds over a 900 second period 
with the addition of 5mM denatonium benzoate at 300 seconds.  (A)  Cell velocity; (B) cell 
aspect; (C) cell angular movement; (D) cell directionality.  Cell outlines of 2 representative cells 
from (C1-2) control experiments and (D1-2) denatonium benzoate were overlaid and split into 
the first 300 and final 600 second intervals.  Overlay images have been adjusted so that the 
chemotactic gradient is following the marked arrows. Cell behaviour showed significant 
differences in velocity (P=0.0212) and aspect (P=0.0095) observed between the first and final 
300 seconds of the assay. Data from A-C is presented as mean of triplicate experiments 
analysing a minimum of 25 cells in each.  Statistical analyses were performed using paired two-
tailed Student t-tests comparing average values from T=0-300 and T=600-900 seconds as 
indicated by the horizontal bars in panels A and B. * P<0.05, ** P<0.01. 
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Figure 3.13.  Analysis of Dictyostelium cell behaviour following active exposure to 5mM 
phenylthiourea.  Cell behaviour was measured under a stable chemotactic gradient in a Dunn 
chamber, with data from 59 cells quantified every 6 seconds over a 900 second period with the 
addition of 5mM phenylthiourea at 300 seconds.  (A)  Cell velocity; (B) cell aspect; (C) cell 
angular movement; (D) cell directionality.  Cell outlines of 2 representative cells from (C1-2) 
control experiments and (D1-2) copper sulphate were overlaid and split into the first 300 and 
final 600 second intervals.  Overlay images have been adjusted so that the chemotactic 
gradient is following the marked arrows. Cell behaviour showed significant differences in 
velocity (P=0.0402) and aspect (P=0.0037) observed between the first and final 300 seconds of 
the assay. Data from A-C is presented as mean of triplicate experiments analysing a minimum 
of 19 cells in each.  Statistical analyses were performed using paired two-tailed Student t-tests 
comparing average values from T=0-300 and T=600-900 seconds as indicated by the horizontal 
bars in panels A and B. * P<0.05, ** P<0.01 
 
  
102 
 
Quinine hydrochloride is another naturally occurring bitter tastant 
responsible for activating multiple T2R receptors (Meyerhof et al., 2010).  At 
0.5mM, quinine hydrochloride caused a significant decrease in Dictyostelium 
cell velocity, from 0.15±0.02µm/sec to 0.08±0.00µm/sec (P<0.05) (Figure 
3.14A).  Interestingly, aspect was not affected, whilst cell angularity deviated 
towards 0 and cell directionality was predominantly reduced (Figure 3.14B-D).   
Since all three bitter tastants were shown to acutely block Dictyostelium 
motility, each compound was assayed at a range of concentrations to compare 
activities.  Of the three T2R receptor ligands, quinine hydrochloride appeared to 
evoke the most potent response in Dictyostelium motility requiring just 0.1mM to 
cause a significant reduction in velocity (Table 3.4).  Interestingly, quinine 
hydrochloride did not appear to cause significant rounding of cells at any 
concentration within the range used in this report.   
Denatonium benzoate was also a strong inhibitor of Dictyostelium motility 
where exposure to of 0.5mM and above caused significant reductions in both 
velocity and aspect (Table 3.4).  Finally, phenylthiourea was shown to be the 
weakest of the three bitter tastants at inhibiting Dictyostelium motility as a 
concentration of 1mM and above was required to significantly affect cell velocity 
and aspect.   
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Figure 3.14.  Analysis of Dictyostelium cell behaviour following active exposure to 0.5mM 
quinine hydrochloride.  Cell behaviour was measured under a stable chemotactic gradient in a 
Dunn chamber, with data from 81 cells quantified every 6 seconds over a 900 second period 
with the addition of 0.5mM quinine hydrochloride at 300 seconds.  (A)  Cell velocity; (B) cell 
aspect; (C) cell angular movement; (D) cell directionality.  Cell outlines of 2 representative cells 
from (C1-2) control experiments and (D1-2) quinine hydrochloride were overlaid and split into 
the first 300 and final 600 second intervals.  Overlay images have been adjusted so that the 
chemotactic gradient is following the marked arrows. Cell behaviour showed a significant 
difference in velocity (P=0.0286) observed between the first and final 300 seconds of the assay. 
Data from A-C is presented as mean of triplicate experiments analysing a minimum of 25 cells 
in each.  Statistical analyses were performed using paired two-tailed Student t-tests comparing 
average values from T=0-300 and T=600-900 seconds as indicated by the horizontal bars in 
panels A and B. ns = not significant, * P<0.05. 
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Compound 
Concentration 
(mM) 
Velocity 
(pre) 
(µm/sec) 
Velocity 
(post) 
(µm/sec) 
P-value 
(Velocity) 
 
Aspect 
(pre) 
 
Aspect 
(post)  
P-Value 
(Aspect) 
Denatonium  0.05 0.21±0.02 0.19±0.02 ns 2.4±0.1 2.3±0.2 ns 
Benzoate 0.5 0.16±0.01 0.06±0.01 0.0151 3.1±0.2 2.1±0.2 0.0108 
  1.0 0.17±0.03 0.04±0.00 0.0369 2.6±0.1 1.4±0.1 0.0185 
  5.0 0.15±0.01 0.05±0.01 0.0212 3.2±0.2 1.9±0.1 0.0095 
  10 0.22±0.00 0.07±0.01 0.0060 2.5±0.0 1.2±0.1 0.0040 
Phenylthiourea 0.05 0.17±0.03 0.13±0.02 ns 3.1±.02 2. ±0.3 ns 
  0.2 0.11±0.02 0.11±0.03 ns 2.5±0.2 2.5±0.4 ns 
  0.5 0.18±0.02 0.15±0.01 ns 3.3±0.1 3.0±0.2 ns 
  1.0 0.16±0.01 0.07±0.02 0.0239 3.4±0.3 2.4±0.1 0.0126 
  2.0 0.15±0.00 0.08±0.01 0.0108 3.1±0.2 1.7±0.1 0.0142 
  5.0 0.17±0.02 0.06±0.02 0.0402 3.1±0.1 2.1±0.1 0.0037 
Quinine 0.05 0.19±0.01 0.19±0.02 ns 2.9±0.4 2.7±0.3 ns 
Hydrochloride 0.1 0.10±0.01 0.06±0.01 0.0491 2.4±0.1 2.2±0.3 ns 
  0.2 0.13±0.02 0.06±0.00 0.0332 2.6±0.3 2.2±0.1 ns 
  0.5 0.15±0.02 0.08±0.00 0.0286 2.6±0.2 2.3±0.1 ns 
  1.0 0.20±0.00 0.11±0.01 0.0353 2.5±0.1 2.1±0.2 ns 
 
Table 3.4.  Bitter tastant-dependent effect of Dictyostelium cell behaviour (velocity and aspect). Concentration range of denatonium benzoate, phenylthiourea 
and quinine hydrochloride showing a significant acute effect on Dictyostelium cell velocity and aspect between the first 300 (pre) and final 300 (post) seconds of the 
assay.  Statistical analyses were performed using 2-tailed paired Student t-tests, where a minimum of 25 cells were measured in each of three replicates.  Ns = not 
significant. 
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 All three compounds were further analysed for their potency to inhibit 
Dictyostelium motility, where they showed a concentration-dependent 
relationship (Figure 3.15).  Subsequent IC50 calculations indicate the potency of 
inhibition was quinine hydrochloride (IC50=44.3±6.8µM, R
2=0.61) > denatonium 
benzoate (IC50=129±4µM, R
2=0.65) > phenylthiourea (IC50=366±6µM, R
2=0.50).  
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Figure 3.15.   Concentration-dependent reduction of cell velocity for bitter tastants.  
Reduction in cell velocity compared to control conditions was plotted against log10 denatonium 
benzoate (0.05-10mM), phenylthiourea (0.2-5mM) and quinine hydrochloride (0.05-1mM) 
respectively. All data is presented as a mean ± S.E.M of triplicate experiments, comparing mean 
cell velocity during the first 5 minutes and final 5 minutes with increasing concentration.  
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3.4.4. Phosphodiesterase IV Inhibitors 
 Rolipram is a phosphodiesterase IV inhibitor, an anti-inflammatory agent 
used in the treatment of airway disorders such as asthma.  The therapeutic 
compound has also been associated with emetic episodes in the ferret, dog, rat 
and Suncus murinus (Heaslip and Evans, 1995; Aoki et al., 2001; Hirose et al., 
2007; Davis et al., 2009).  Dictyostelium motility assays were performed at a 
concentration of 0.01mM and 0.7mM.  No significant effects (P>0.05) were 
observed in any measurements between the first 5 minutes and final 5 minutes 
at 0.01mM concentration.  However upon increasing the concentration, 0.7mM, 
rolipram evoked a significant reduction in cell velocity, from 0.16±0.01µm/sec to 
0.02±0.01µm/sec, and aspect, from 2.5±0.2 to 1.7±0.2, as well as reducing cell 
directionality (Figure 3.16).  
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Figure 3.16.  Analysis of Dictyostelium cell behaviour following active exposure to 0.7mM 
rolipram.  Cell behaviour was measured under a stable chemotactic gradient in a Dunn 
chamber, with data from 82 cells quantified every 6 seconds over a 900 second period with the 
addition of 0.7mM rolipram at 300 seconds.  (A)  Cell velocity; (B) cell aspect; (C) cell angular 
movement; (D) cell directionality.  Cell outlines of 2 representative cells from (C1-2) control 
experiments and (D1-2) rolipram were overlaid and split into the first 300 and final 600 second 
intervals.  Overlay images have been adjusted so that the chemotactic gradient is following the 
marked arrows. Cell behaviour showed significant differences in velocity (P=0.0069) and aspect 
(P=0.0195) observed between the first and final 300 seconds of the assay. Data from A-C is 
presented as mean of triplicate experiments analysing a minimum of 25 cells in each.  Statistical 
analyses were performed using paired two-tailed Student t-tests comparing average values 
from T=0-300 and T=600-900 seconds as indicated by the horizontal bars in panels A and B.  * 
P<0.05, ** P<0.01. 
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3.4.5. Cytotoxic Compounds 
 Seven different cytotoxic compounds, 5-fluorouracil (250µM), 
actinomycin D (10µM, 700µM), cisplatin (50µM, 300µM), cycloheximide (5mM), 
methotrexate (50µM, 250µM), streptozotocin (1µM) and vincristine (1µM) were 
tested for acute effects on Dictyostelium behaviour during motility (Table 3.1, 
Appendix 1).  None of these compounds evoked any significant reductions in 
Dictyostelium cell velocity or aspect, or altered cell directionality in the 
incubation period used.  
3.4.6. Receptor Agonists 
 Various receptor agonists were screened for their effects on 
Dictyostelium motility (Table 3.1, Appendix 1).   Apart from those previously 
identified (T2R receptor ligands and the TRPV1 receptor agonist, capsaicin) 
receptor agonists, 5-hydroxytryptamine (1µM, 100µM), apomorphine 
hydrochloride (10µM, 1mM), substance P (1µM), nicotine (6µM, 100µM), 
loperamide hydrochloride (1µM, 100µM); and the sodium channel activator 
veratridine hydrochloride (30µM, 500µM), did not cause any significant 
reductions in Dictyostelium cell velocity, aspect or angle of movement in the 
incubation period used.   
3.4.7. Inhibitors 
Apart from the significant behavioural effects observed with a high 
concentration of the phosphodiesterase inhibitor, rolipram; no other therapeutic 
targets affected Dictyostelium motility in the incubation period used (Table 3.1, 
Appendix 1).  These were the selective serotonin reuptake inhibitor (SSRI), 
fluoxetine (6.5µM), as well as the extracellular enzyme inhibitor, digoxin (1µM). 
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3.4.8. Free Radical Generator 
Pyrogallol (500µM, 10mM), a generator of harmful free radicals did not 
affect Dictyostelium cell motility, where no significant changes to cell velocity, 
aspect or angle of movement occurred (Table 3.1, Appendix 1).   
3.4.9. Other compounds 
 The remaining three compounds reported in Table 3.1 were the central 
nervous system depressant, lithium chloride (10mM); the enteroendocrine cell 
stimulant, metformin (500µM, 10mM) and the prostaglandin PGF2α (1µM, 
100µM) (Appendix 1).  All three compounds did not elicit any significant 
changes in Dictyostelium cell behaviour in the Dunn chamber motility assay. 
3.5. Cell viability 
An acute block in Dictyostelium motility caused by compounds could be 
due to a variety of mechanisms including cell toxicity or death.  To determine 
whether the effect chemotactic inhibition of cells was caused by death, cell 
viability was assessed by using trypan blue staining (Materials and methods) 
after acute (10 minute) and prolonged (30 minute) exposure (Table 3.5).  
Chemotactically-competent cells were treated with denatonium benzoate, 
phenylthiourea, quinine hydrochloride and capsaicin chosen at around at 8xIC50 
concentrations, where a minimal increase in cell response was shown at 
increasing concentrations (i.e. maximum response) (Figures 3.9, 3.11, 3.15).   
Analysis of survival rates following bitter and hot tastant exposure showed some 
treatments reduced survival. All compounds apart from capsaicin caused a <5% 
drop in cell survival cells after 10 and 30 minute exposures.  Capsaicin (100µM) 
caused a significant drop of approximately 50% in cell survival after 30 minutes. 
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Cell viability assays with capsaicin were repeated (50µM) producing only a 2% 
drop in cell survival.  
Compound/ 
Exposure 
Cell 
Count  
(alive) 
S.E.M 
 
Cell 
Count  
(dead) 
S.E.M 
 
Cell 
Total 
Cell Viability 
(%Survival) 
Significance 
 
Time (Min) 
Control        
10 135 2.2 1 0.6 136 99 NA 
30 135 4.3 0 0 135 100 NA 
1mM DB        
10 181 16.5 7 0 188 96 ns 
30 183 5.9 16 3.2 199 92 ns 
350µM QHCl        
10 139 12.1 1 1 140 99 ns 
30 146 2.59 3 1.2 150 97 ns 
3mM PTU        
10 128 8.7 0 0 128 100 ns 
30 119 7.1 4 0.9 123 97 ns 
100µM 
Capsaicin        
10 87 1.5 83 7.7 170 51 * 
30 74 4.1 57 1.8 131 57 ** 
50µM 
Capsaicin        
10 174 1.3 3 1.5 177 98 ns 
30 150 8.9 3 0.8 153 98 ns 
        
Table 3.5.  Dictyostelium cell viability upon acute exposure to hot and bitter tastants.  
Chemotactically competent cells were treated with 1% DMSO in KK2 (control), 1mM 
denatonium benzoate (DB), 350µM quinine hydrochloride (QHCl), 3mM phenylthiourea (PTU), 
100µM capsaicin or 50µM capsaicin and exposed for 10 and 30 minutes.  Initial 10 minute 
exposures revealed a no significant decrease in live cells when compared to control conditions.  
After 30 minutes exposure, a significant decrease in live cells had occurred in 100µM capsaicin 
(difference in rank sum = 15.00) when compared to control conditions.   Compound 
concentrations were based on 8x previously determined IC50 calculations. All experiments were 
performed in triplicate and statistical analyses performed were Kruskal-Wallis tests with a Post-
hoc Dunns multiple comparison test.  Kruskal-Wallis statistics were 15.32 (P=0.0091) and 14.91 
(P=0.0108) for 10 minute and 30 minute measurements respectively. NA = not applicable, ns = 
not significant, * P<0.05, ** P<0.01. 
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3.6 Reversibility of Inhibition of Cell Movement  
To investigate further the effects of bitter and hot tastants on 
Dictyostelium behaviour, an assay was developed to determine whether tastant-
induced effects could be reversed upon aspiration of each compound.  This was 
not possible using the Dunn chamber assay since the compound-containing 
medium could not be removed without severely affecting the cAMP gradient 
across the chamber.  To overcome this, random cell movement of 
chemotactically competent cells was recorded in the absence of a cAMP 
gradient during random movement.  Cell velocity was used to measure initial 
control conditions for 4.5 minutes.  Cells were then exposed to each tastant at 
8x IC50 concentration (as described previously) for 4.5 minutes, before the 
media was aspirated and replaced with fresh KK2.  Cells were monitored for the 
remainder of the assay (Figure 3.17). 
Dictyostelium cells were capable of recovering following bitter and hot 
tastant exposure.  Upon addition of each tastant, a significant (P<0.05) 
reduction in cell velocity was observed during random cell movement.  After 
tastant aspiration and replacement with phosphate buffer, Dictyostelium cell 
behaviour recovered in all conditions.  This assay also demonstrated that cell 
motility was affected in random cell movement in addition to cAMP-orientated 
motility. 
Finally, to examine long-term exposure to tastants, Dictyostelium behaviour was 
monitored in development assays.  In these experiments, cells were developed 
on a nitrocellulose membrane in the absence and presence of each tastant over 
24 hours and fruiting body formation was observed at the concentrations used 
previously (Figure 3.18).    
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Figure 3.17. Dictyostelium cell behaviour reversibility following bitter and hot tastant 
exposure.  Mean cell velocity during random cell movement over a 35 min period.  Control 
conditions were established for an initial 4.5 minutes prior to addition of tastants (-4.5-0 
minutes) and either phenylthiourea (3mM), denatonium benzoate (1mM), quinine hydrochloride 
(350µM) or capsaicin (50µM) added to the cells and monitored for a further 4.5 minutes (0-4.5 
minutes) (D). Media was then aspirated (W) and replaced with KK2 whereby cell behaviour was 
then monitored for a further 26 minutes.  Initial cell velocity (-4.5min) was then compared to 
drug exposure (0) and the final time point (31) (highlighted by the grey bars).  In all conditions, 
cell velocity was significantly reduced upon addition of tastants (P<0.05) and recovered by the 
end of the assay as there was no significant difference in cell velocity under control conditions 
and the final time point measured.  Data is presented as a mean ± S.E.M for each 4.5 min 
period, with triplicate experiments analysing approximately 30 cells in each. N/S = not 
significant, * = P<0.05. 
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Figure 3.18.  Tastant exposure to Dictyostelium development.  Cells were allowed to 
develop over 24 hours on a nitrocellulose membrane in the presence of control conditions, 
phenylthiourea (3mM), denatonium benzoate (1mM), quinine hydrochloride (350µM) and 
capsaicin (100µM).  Dictyostelium development was observed under all conditions, however 
when compared to control conditions, fruiting bodies appeared slightly smaller in size at 
concentrations exposed to quinine hydrochloride.  Under denatonium benzoate conditions, 
development only appeared to reach the mound and culmination phases.  All images are 
representative of triplicate experiments indicating cell survival after 24-hours exposure to each 
compound.  Scale bar represents 1mm. 
  
Control Phenylthiourea 
Denatonium Benzoate Quinine Hydrochloride 
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Exposure of developing Dictyostelium cells to bitter and hot tastants at 
concentrations shown to block behaviour did not grossly affect development.  
Development assays indicated that 24-hour exposure to each compound 
allowed for maturation to occur where the stalk and fruiting body structures 
remained intact.  In addition, abnormal development was observed under 
denatonium benzoate conditions, where immature fruiting bodies were shown.  
48-hour exposure to denatonium benzoate allowed the development of normal 
fruiting bodies when compared to control conditions.  These results suggest that 
denatonium benzoate may interfere with Dictyostelium development by delaying 
the rate of development; however no long term toxicity occurred as fruiting 
bodies developed normally after 48 hours.   
3.7. Discussion  
To assess the suitability of using Dictyostelium in acute exposure 
experiments for predicting emetic liability, 29 emetic or taste aversive 
compounds were examined.  Compounds were selected from each major class 
of emesis-inducing chemical group.  Each compound was screened for any 
acute effects on Dictyostelium behaviour over a ten minute period.  Of the 29 
compounds screened, seven blocked Dictyostelium motility by reducing cell 
velocity and inducing cell rounding.  These seven compounds could be divided 
into four distinct categories, which included copper containing compounds 
(Figures 3.7, 3.8), a TRPV1 receptor agonist (capsaicin) (Figure 3.10), three 
T2R receptor ligands (denatonium benzoate (Figure 3.12), phenylthiourea 
(Figure 3.13) and quinine (Figure 3.14), as well as the phosphodiesterase IV 
inhibitor, rolipram (Figure 3.16).  Compounds were also shown to function in a 
concentration-dependent manner, enabling IC50 values to be approximated 
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(Figures 3.9, 3.11, 3.15).   The potency of the compounds was ranked 
capsaicin (IC50=11.9±4.0µM) > quinine hydrochloride (IC50=44.3±6.8µM) > 
denatonium benzoate (IC50=129±4µM) > phenylthiourea (IC50=366±5µM) > 
copper sulphate (IC50=1433±3µM).  The low R
2 values for these calculations 
were derived from a three-parameter non-linear regression, suggesting that the 
IC50 values are not entirely accurate and should be used for approximation only.  
The concentration-dependent inhibition of Dictyostelium cell behaviour does 
however suggest a possible role for direct activation or inhibition of cell surface 
receptors, which would allow for greater inhibition of cell movement with higher 
compound concentration.  
3.7.2. Compounds and screening 
The concentrations of emetic or aversive compounds used in this study 
were based upon previous in vivo and in vitro experiments (Table 3.1). 
Compound concentrations shown to block Dictyostelium motility fall within these 
previously reported ranges in other biomedical models, indicating this amoeboid 
assay may be as sensitive as others at detecting targets.  For example, mouse 
STC-1 cells have been shown to respond to 1-20mM denatonium benzoate, 
which falls well within the 0.1-10mM concentration range used in this study 
(Masuho et al. 2005; Chen et al, 2006).  The tastant capsaicin has also been 
used in human based taste experiments at a concentration of 300µM, at which 
Dictyostelium motility is strongly inhibited (Green and Hayes, 2003).  
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3.7.3. Gastric Mucosal Irritants 
In humans, copper containing compounds are responsible for 
gastrointestinal upsets, including nausea and vomiting at higher concentrations 
(Araya et al., 2001; Araya et al., 2003).  This has led to the formation of 
guidelines to the concentration of copper found in drinking water of 4mg/L 
(Araya et al., 2001; Kayashima et al., 1978b; Kayashima et al., 1978a; Niijima et 
al., 1987; Makale and King, 1992; Araya et al., 2003).  The chloride and 
sulphate salts of copper caused a significant concentration-dependent block in 
Dictyostelium behaviour suggesting copper and not its salts inhibit motility 
(Figure 3.7, 3.8, 3.9).   
In mammalian systems, research at the beginning of the 20th century 
suggested the gastro-duodenal luminal concentration of copper was a vital 
inducing factor in emesis (Cushny, 1918); however the specific molecular 
mechanisms underlying copper-induced emesis in mammalian systems remains 
unclear.  Gastric perfusion studies have shown that copper may trigger a gut-
mucosal emetic response by stimulating vagal afferents neurones (Niijima et al., 
1987).   
 The mechanism of action behind the copper-mediated block in 
Dictyostelium motility remains unknown; however, the amoeba has been shown 
to express a degree of resistance to copper due to high cellular export 
(Burlando et al. 2002).  The molecular mechanism behind this may be the 
potential inhibition of ATP ion currents, controlled by cell surface cation P2X 
receptors, which subsequently affect calcium influx (Burlando et al., 2002; 
Bavan et al., 2009; Ludlow et al., 2009).  The concentration-dependent effects 
of copper may provide a useful indicator for the identification of high copper 
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concentrations in polluted water (Araya et al., 2003; Blaise et al., 2008).  The 
sensitivity of Dictyostelium to copper would however not be sufficient to 
determine a raised copper level in drinking water based upon a 4mg/L 
(0.062mM) threshold concentration (Araya et al., 2001). 
The closely related metal, zinc, which has also been associated with 
emesis, did not affect Dictyostelium motility (Cushny, 1918, Gadum 1961).  Zinc 
sulphate was however only studied at one concentration in this thesis so it 
remains to be determined whether zinc would affect Dictyostelium motility at 
higher concentrations.   
3.7.4. TRPV1 Receptor Agonists 
 Capsaicin is the active compound associated with the burning sensation 
found in chillies and other spicy foods.  This vanilloid is shown to be an agonist 
for the transient potential receptor vanilloid 1 (TRPV1) receptor, responsible for 
burning sensations associated with taste and pain (Szolcsanyi, 2004).  
Activation of this receptor has also been shown to cause emesis through the 
release of endogenous substance P (Smith et al., 2002).  In addition, capsaicin 
and some of its related vanilloids evoke a bitter sensation when in contact with 
the taste buds on the tongue (Green and Hayes, 2003).  Addition of capsaicin to 
the Dunn chamber in Dictyostelium motility screens caused a strong and potent 
concentration dependent block in cell behaviour (Figure 3.10, 3.11).   
 In Suncus murinus, capsaicin induces emesis at concentrations as low 
as 10nM when injected intracerebroventricuarly, where it has been suggested to 
act via the nucleus tractus solitarius (Andrews et al., 2000b; Rudd and Wai, 
2001).  Mammalian sensitivity to capsaicin within the brain is therefore 5000-
fold more sensitive than concentrations reported to block Dictyostelium 
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behaviour in these studies.  Concentrations used in these studies have however 
been applied directly at the site of action, and therefore may not be 
representative of an emetic threshold for conventional methods of capsaicin 
administration in humans. 
TRPV1 channels belong to the transient receptor potential (TRP) 
superfamily of receptors, a group of calcium permeable channels located both 
on the cell membrane as well as within a cell (Dong et al., 2010).  These 
receptors are located throughout the body (Pingle et al., 2007) and are 
conserved across mammalian species such as Suncus murinus (Andrews and 
Bhandari, 1993; Andrews et al., 2000b) as well as in Caenorhabditis elegans.  
Homology searches of the Dictyostelium proteome however did not identify any 
human homologues (Ezak et al., 2010) of the TRPV1-6 proteins nor the C. 
elegans candidates (OSM-9, OCR-2) (Appendix 2).   
Five other sub-families of TRP receptor also exist in mammalian 
systems: canonical, melastatin, mucolipin, polycystin and ankryin receptors.  
The Dictyostelium genome encodes a Polycystin-2  and a mucolipin channel 
(Wilczynska et al., 2005), although these channels have not been shown to be 
affected by capsaicin.  This suggests an alternative molecular target for 
capsaicin in Dictyostelium may be responsible for the block in cell motility.  
Identification of this mechanism may provide further insight into the action of 
emetic and pain responses as well describing the sensory pathway for pungent 
compounds. 
Other structurally related vanilloid compounds piperine and olvanil were 
also tested in the motility assay.  Piperine is used at concentrations ranging 
from 0.1mM in HEK293 cell lines showing intracellular calcium release (Correa 
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et al., 2010), to 70mM in human taste sensation studies (Green and Hayes, 
2003).  Olvanil has potential anti-emetic effects at concentrations ranging from 
0.05mg/kg to 5mg/kg in the ferret (Chu et al., 2010a; Chu et al., 2010b).  
Dictyostelium motility assays using Dunn chamber was also performed with 
application of olvanil and piperine, however due to the highly insoluble nature of 
these compounds, the assay was only performed at low concentrations (100µM 
olvanil, 500µM piperine), which were not sufficient to elicit any responses.   
Surprisingly, the emetic and the ultra-potent analogue of capsaicin, 
resiniferatoxin, did not affect Dictyostelium motility at 1-10µM.  Like capsaicin, 
resiniferatoxin is also an agonist of the TRPV1 receptor, containing a 
homovanillic acid group, which has been proposed to be a key structure in the 
activation of the TRPV1 channel (Szallasi, 1994).  Whilst resiniferatoxin is 
substantially more potent at causing TRPV1 desensitization than capsaicin, it 
causes substantially less irritation than capsaicin at therapeutic concentrations 
(Kissin and Szallasi, 2011).  A differential response to the two vanilloids could 
therefore be explained by the irritability caused by capsaicin that is not caused 
by resiniferatoxin, or by a non-TRPV1 target, regulated by capsaicin and not 
resiniferatoxin.  Structure activity relationship studies have also shown that 
resiniferatoxin, capsaicin and their analogues can have varying effects on 
different types of TRPV1 receptor (Tomohiro et al., 2013; Czikora et al., 2012).  
This suggests a possible alternative theory, where a TRPV1 receptor of low 
amino acid homology to known receptors, is sensitive to variations in structures 
between capsaicin and resiniferatoxin.   
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3.7.5. T2R Receptor Agonists 
Most bitter tasting compounds are ligands of the human taste type 2 
(T2R) receptor, a family of G-protein coupled receptors shown to exist in 
humans since a pre-Neanderthal age, as a mechanism for identifying potentially 
toxic substances (Hilliard et al., 2004; Shi and Zhang, 2006; McBride et al., 
2007; Oike et al., 2007; Tordoff et al., 2008; Lalueza-Fox et al., 2009b; Ezak et 
al., 2010; Isono and Morita, 2010).  In humans, 25 of these T2R receptors have 
been identified where different bitter tastants can bind to one or a combination 
of receptors (Meyerhof et al., 2010).  In addition to mammals, many organisms 
also avoid or show aversive behaviour towards bitter tasting compounds, 
ranging from fish (Oike et al., 2007), to the fruit fly Drosophila (McBride et al., 
2007) and the nematode worm C. elegans (Hilliard et al., 2004).  Three bitter 
tasting T2R receptor agonists, denatonium benzoate, quinine hydrochloride and 
phenylthiourea, all caused significant blocks in Dictyostelium motility (Figures 
3.12, 3.13, 3.14).  In addition, the concentration-dependent block in 
Dictyostelium motility observed for the three reported compounds suggests a 
mechanism for detection of bitter compounds (Figure 3.15).   
In humans, it has been proposed that a key T2R receptor, human 
TAS2R38 is predominantly responsible for how and what humans perceive as 
bitter tasting (Kim et al., 2003).  Single nucleotide polymorphisms in the 
TAS2R38 gene results in different phenotypic responses to certain bitter tasting 
compounds such as phenylthiourea (also known as phenylthiocarbamide) and 
its structurally related analogue, propylthiouracil, resulting in supertaster, taster 
and non-taster status (Kim et al., 2003; Hayes et al., 2008; Bufe et al., 2005).  
Another receptor ligand of the TAS2R38 receptor also includes denatonium 
benzoate, suggesting a potentially parallel mechanism of action for these two 
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tastants (Meyerhof et al. 2010). In addition, quinine hydrochloride, which 
blocked Dictyostelium motility but did not induce cell rounding, does not activate 
this receptor (Meyerhof et al. 2010). 
Of the 25 different genes encoding T2R receptor ligands in humans, no 
homologues were found within the Dictyostelium proteome suggesting an 
alternative mechanism of action for the recognition of bitter tasting compounds.  
In addition, no homologues were found for bitter-sensing receptors that exist in 
either the mammal (e.g. TA2R102); zebra fish, Danio rerio (e.g. T2R200.1), or 
the fly, D. melanogaster (GR47A), or the nematode worm, C. elegans (QUI-1) 
were found (Appendix 3).  Identifying the molecular targets for these 
compounds may therefore provide a novel signalling mechanism for the 
detection of bitter tasting compounds.  Significantly, the multiple organisms 
described above have developed their own receptors responsible for bitter 
tastant detection and therefore Dictyostelium may also have its own.  
Subsequent downstream signalling pathways resulting from receptor activation 
may however be conserved across some species, which may provide valuable 
insight into molecular signalling pathways involved in bitter tastant detection.     
In humans, T2R receptor signalling is also regulated by a receptor 
belonging to TRP superfamily, TRPM5, suggesting that both bitter and pungent 
compounds may share a common signalling pathway (Liman, 2007; Talavera et 
al., 2008).  Analysis of the Dictyostelium proteome again did not identify any 
potential homologues (Appendix 4).  Since neither T2R, nor TRPM5 receptor 
homologues can be found in Dictyostelium, it is likely that other molecular 
targets are responsible for the effect of these compounds. 
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Another interesting observation was that the bitter tastant, xanthohumol 
(Tabata et al., 1997; Miranda et al., 1999) did not generate a significant block in 
Dictyostelium motility (Table 3.1).  In addition, the cytotoxic compound, 
cycloheximide, which is also a T2R receptor ligand, did not inhibit Dictyostelium 
motility (Table 3.1).  Interestingly, the nematode worm, C. Elegans will migrate 
in the presence of cycloheximide, but not quinine hydrochloride (Tajima et al., 
2001), which has also been confirmed in the Dictyostelium motility assay 
reported in this study.   
A final group of compounds not reported here are the bitter tastant 
curcumin and its derivatives, which are not believed to be T2R receptor 
agonists (Meyerhof et al. 2010).  Upon addition to randomly migrating 
Dictyostelium cells, curcumin also caused an acute block in cell behaviour 
(Appendix 5).  In addition, a colleague within the laboratory screened a number 
of curcumin derivatives, where Dictyostelium correctly distinguished between a 
highly emetic and a non-emetic analogue based upon the inhibition of cell 
movement (James Snyder, Emory University, personal communication).  This 
data therefore identifies the potential utility for using Dictyostelium in structure-
activity relationship and translational studies. 
3.7.6. Phosphodiesterase IV Inhibitors 
Rolipram, a phosphodiesterase IV inhibitor, is an anti-inflammatory agent 
that causes nausea and vomiting as a side effect (Aoki et al., 2001).  At a low 
concentration (10µM), rolipram did not exert an effect on Dictyostelium cells, but 
blocked cell movement at higher concentrations (700µM) (Figure 3.16).  
In Dictyostelium, phosphodiesterases have three distinct roles in the 
dephosphorylation of cyclic nucleotides, which include extra- and intracellular 
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cAMP during aggregation and development respectively; as well as intracellular 
cGMP, which is involved in motility (Bader et al., 2007).  Each cyclic nucleotide 
is degraded by one of seven phosphodiesterases in Dictyostelium, which can 
be divided into two main classes: Class I (to which three enzymes belong) and 
Class II (to which four enzymes belong). There is one candidate 
phosphodiesterase IV homologue in Dictyostelium, which shares a 33-35% 
homology with the four isoforms (A-D) found in mammals.  Inhibition of 
Dictyostelium phosphodiesterases would therefore be expected to elevate 
extracellular cAMP (and potentially intracellular cAMP and cGMP) levels.  
Subsequent expected saturation of cAMP receptors in Dictyostelium would 
therefore lead to the observed inhibition of cell behaviour shown in the assay.  
The high concentration required for this effect may thus reflect a potential non-
specific action of rolipram on non-mammalian phosphodiesterases such as 
those found in Dictyostelium.   
3.7.7. Other Compounds 
A range of emetic and aversive compounds did not have a significant 
effect on Dictyostelium cell behaviour.  These compounds included cytotoxic 
agents, receptor agonist, inhibitors, a free radical generator, a CNS depressant, 
an enteroendocrine cell stimulant and a prostaglandin.  Many of these 
compounds have known molecular targets, such as apomorphine, which is 
known to activate the dopamine D2 receptor, inducing emesis at concentrations 
ranging from 0.1-10mg/kg in a range of sentient models (Andrews et al., 1990; 
Eglen et al., 1993; Knox et al., 1993; Andrews et al., 2001; Nakayama et al., 
2004; Horn et al., 2009; Osinski et al., 2005).  The lack of efficacy for these 
compounds in Dictyostelium at equivalent concentrations could be due to either 
the absence of the target protein, a non-essential role for the protein in acute 
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motility experiments, or structural differences in the proteins altering the activity 
of the compound. 
Alternatively, another explanation for a lack of acute effect is the short 
term nature (ten minutes) of the experiment in comparison to previous reports 
that employ longer incubation periods of 1-24 hours.  This provides an important 
limitation in this assay since the acute nature of the assay may not expose the 
chronic or delayed effects of compounds.  For example, cytotoxic agents such 
as cisplatin used in anti-cancer treatments, did not block Dictyostelium motility 
within the ten minute response time recorded. However cisplatin is previously 
shown to cause a chronic block in development following twenty four hour 
exposure (Li et al., 2000). 
3.7.8 Cell Viability 
 The mechanism of action for inhibition of Dictyostelium motility by five 
different tastants is currently unknown.  Acute motility inhibition could occur 
through a range of mechanisms, such as interaction with cell surface receptors, 
downstream molecular targets or alternatively by cell death.   To determine 
whether the tastants involved in Dictyostelium motility inhibition were toxic and 
causing cell death, a cell viability assay was performed and the 10 and 30 
minute exposures to each tastant showed no tastants decreased cell viability 
apart from capsaicin; where a high concentration (100µM) produced a 
significant loss in cell survival after ten and thirty minutes (Table 3.5).  However 
reduced concentrations (50µM) showed that cells were viable after 10 and 30 
minute exposures.  It is likely that the cell death of approximately 50% observed 
in 100µM capsaicin after 10 minutes was one that was maximal, as cell death 
did not increase substantially further after 30 minutes.  Upon halving the 
125 
 
capsaicin concentration, 98% cells were viable after both exposure times.  
These results suggest that cells predominantly survive short term (up to 30 
minute) exposure to each compound. 
3.7.9 Reversibility of Inhibition of Cell Movement 
  Despite cells having been shown to be viable after 30 minutes, the 
reversibility of the effects on Dictyostelium cell behaviour with each compound 
was unknown.  Using a separate cell movement assay, the block in Dictyostelium 
behaviour was shown to be reversible upon removal of each tastant (Figure 
3.17).  This data, combined with the cell viability assay, showed clearly cells were 
displaying no toxicological effects upon short term exposure to bitter and hot 
tastants.  In addition, the acute and reversible nature of the inhibition of 
Dictyostelium behaviour strongly suggests the involvement of compounds binding 
to cell surface receptors.  
  To assess long-term exposure to each compound, Dictyostelium cells 
were allowed to develop over 24 hours in the presence of each tastant (Figure 
3.18).  In all cases Dictyostelium cells developed fully, although the 
developmental process was delayed in the presence of denatonium benzoate, 
where cells had only reached culmination phase after 24 hour exposure (Figure 
3.18).   
Long term exposure to bitter and hot tastants allowed for the 
development of fruiting bodies after 24 hours indicating cells had overcome the 
inhibitory effects of each tastant.  This could be due to a possible internalisation 
of cell surface receptors or a possible change in gene expression of cells which 
subsequently allowed development in the presence each tastant.  In addition, 
the compound effects observed cannot have been sustained for a prolonged 
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period of time as fruiting bodies were fully developed, apart from those 
developing in the presence of denatonium benzoate.  The delayed effects on 
Dictyostelium development in the presence of denatonium benzoate could 
possibly be due to a high concentration (which may have been observed at 
higher concentrations for other tastants), or alternatively, the inhibition of 
multiple cell signalling mechanisms producing a delayed developmental effect. 
3.9. Summary 
A broad range of emetic and taste aversive compounds were tested for 
their acute effects of Dictyostelium cell behaviour during motility using the Dunn 
chamber.  Of these compounds, seven caused significant (P<0.05) reductions 
in cell velocity and/or aspect as well as a decrease in cell directionality.  These 
compounds could be sub-divided into four chemically distinct groups, which 
were copper salts, T2R receptor ligands, a TRPV1 receptor agonist and a 
phosphodiesterase IV inhibitor. It was found that copper, bitter and hot tastants 
blocked Dictyostelium motility in a concentration-dependent manner, where an 
order of potency was established to be capsaicin >quinine hydrochloride > 
denatonium benzoate > phenylthiourea > copper sulphate.  Upon further 
analysis of the bitter and hot tastants, it was shown that these compounds do 
not block Dictyostelium cell migration by induction of cell death or by an 
irreversible mechanism.  Finally the unknown mechanisms of action for bitter 
and hot tastants in Dictyostelium may provide novel receptors or targets for use 
bitter and hot tastant action.   
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Chapter 4 
Identification of molecular mechanisms 
involved in bitter tastant detection in 
Dictyostelium 
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  Motility assays using a Dunn chamber were used to screen a range of 
structurally diverse emetic and aversive compounds for acute effects on 
Dictyostelium cell behaviour.  This screening process identified seven out of 
twenty nine compounds that caused a rapid and concentration-dependent block 
in cell movement with effects shown to be reversible and non-toxic (Chapter 3).  
Since bitter tastants were shown to block Dictyostelium behaviour, these 
compounds were selected for further investigation.   
In this chapter, the potency of phenylthiourea and denatonium benzoate 
for inhibiting Dictyostelium cell growth in shaking suspension was established, 
enabling a restriction enzyme-mediated integration (REMI) mutagenesis screen 
to identify proteins controlling bitter tastant function.  From this screen an 
extended list of mutants was then chosen, and screened for acute resistance to 
tastants during motility using a Dunn chamber, as previously described 
(Chapter 3).   
4.2. Tastant potency analysis 
  Since previous experiments examining the effects of bitter tastants on 
Dictyostelium focused on monitoring cell movement, viability and development 
(Robery et al., 2011), it was necessary to characterise the effects of these 
compounds on cell growth.  The inhibitory effects (IC50) of two bitter tastants, 
phenylthiourea and denatonium benzoate was determined on Dictyostelium 
growth in shaking suspension.  These compounds were selected based upon 
binding affinities to different mammalian T2R receptors (Meyerhof et al., 2010).   
 In the analysis of bitter tastant potency, Dictyostelium cells were grown in 
shaking suspension following exposure to a range of concentrations of 
denatonium benzoate (0-10mM) or phenylthiourea (0-5mM) for a 168 hour (7 
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day) period until proliferating cells under control conditions reached stationary 
phase (Figure 4.1).  Concentrations were chosen to provide a range of effects 
from no effect to a complete block in cell growth based upon data obtained in 
motility assays. Data derived from these experiments were also used to 
produce secondary plots where Dictyostelium cell division during growth phase 
was used to estimate the potency (IC50) value of 1.46mM for denatonium 
benzoate and 1.95mM for phenylthiourea (Figure 4.1).  Additional analysis of 
the block in Dictyostelium growth showed significant reductions (P<0.05) at 
1mM and 2mM during phenylthiourea growth.  At higher concentrations, 
denatonium benzoate (5mM, 10mM) and phenylthiourea (5mM) caused cell 
death.  In an independent but parallel study, cells were also grown in axenic 
media in the presence of a range of concentrations for two bitter, non-T2R 
receptor agonists, naringenin (Meyerhof et al., 2010) and valproic acid 
(Johannessen and Henriksen, 1979) by colleagues within the laboratory.  Based 
upon these values, a REMI mutant screen was carried out at 1mM for both 
denatonium benzoate and phenylthiourea.  In these experiments, a library of 
REMI mutants was formed by random integration of a cassette encoding 
blasticidin resistance throughout the Dictyostelium genome.  Mutants were then 
grown in the presence of each tastant for 21 days and surviving colonies used 
to determine potential loci controlling molecular mechanisms for bitter tastants.  
The REMI screen was also performed in the presence of naringenin and 
valproic acid.   
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Figure 4.1. Dictyostelium proliferation in varying concentrations of denatonium benzoate 
and phenylthiourea.  Dictyostelium cells were grown in axenic media over 168 hours in 
shaking suspension in the presence of denatonium benzoate and phenylthiourea.  (A) 
Denatonium benzoate concentrations from 0.05-10mM provided a range of inhibitory effects on 
cell growth, where it was found that 5 and 10mM concentrations caused cell death. (B) A 
secondary plot during log growth phase (90-138 hours) for control-1mM denatonium benzoate 
showing the change in cell density at each concentration was produced to determine a potency 
of inhibition (IC50) of 1.46±1.37mM.  (C) Phenylthiourea concentrations from 0.5-5mM provided 
a range of inhibitory effects on cell growth, where it was found that 5mM caused cell death. (D) 
A secondary plot during log growth phase (66-114 hours) for control-2mM phenylthiourea 
showing the change in cell density at each concentration was produced to determine a potency 
of inhibition (IC50) of 1.95±0.57mM.  In addition, a significant (P=0.05) decrease in cell growth 
was observed for 1mM and 2mM 5mM phenylthiourea based upon a Mann-Whitney test.  Data 
from A-D is presented as a mean of triplicate experiments with vertical bars representing 
standard errors of the mean (SEM).   
4.3. Initial characterisation of REMI mutants 
Preliminary analysis of REMI mutants surviving the growth screens 
suggested the involvement of 187 loci controlling resistance to one or multiple 
of the bitter tastants denatonium benzoate, phenylthiourea, naringenin and 
valproic acid (Appendix 6).  In some mutants, the inserted resistance cassette 
was found in intergenic regions between two genes so it was unclear which of 
the two genes may be responsible for compound resistance.   
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REMI mutants showing resistance to bitter tastants in cell growth were 
shown to involve a number of proteins controlling a variety of functions, from 
receptors to enzymes involved in DNA replication (Appendix 6).  Since the 
compounds were shown to cause an acute inhibition of cell movement (Robery 
et al., 2011), a shortlist of twenty mutants was constructed based upon gene 
ontology (GO).  Molecular functions, biological processes and cellular 
components for proteins of interest were those that could generate an acute 
response to bitter tastants found previously (Chapter 3).  These included 
receptor activity, cell membrane localisation, G-protein coupled receptor 
subunits,  involvement in vesicle function, second messengers (e.g. small 
GTPase activity), enzyme activity (phosphorylation, transferase, acyltransferase 
or ATPase), or involvement in actin organisation, ion transport or cell motility 
(Table 4.1 & 4.2).  As a first step in the analysis of these mutants, any available 
cells lines with ablated genes identified in the screen were then tested for 
resistance to selected bitter compounds.  
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  Gene    
 Compound Name Gene Product Function 
D agpB Acyltransferase Enzyme activity 
D, V agpC Acyltransferase Enzyme activity 
D, N, P, P, V DDB_G0267590 GRAM domain containing protein Phagocytic vesicles 
D, N, V, V, V DDB_G0269760 BTB/POZ domain-containing protein Potassium channel 
D, N, V DDB_G0284149 Orthologue of yeast VID24 VID vesicles 
D DDB_G0284605 P-type-, Calcium ATPase Enzyme activity 
D DDB_G0288003 EGF-like domain-containing protein Macropinocytosis 
D DDB_G0291203 Transmembrane protein Transmembrane  
D forJ Formin domain-containing protein Actin binding 
D, D, D, D Fuk Fucokinase Enzyme activity 
D gpaC G-protein subunit alpha 3 Second messenger 
P gpaI G-protein subunit alpha 9 Second messenger 
D, P gpaK G-protein subunit alpha 11 Second messenger 
P grlJ GABAB-like family protein  Receptor 
D, N, V gxcI RhoGEF domain-containing protein I Small GTPase 
V, V gxcP PH domain-containing protein P Small GTPase 
D memo1 Orthologue of Homo sapiens MEMO1 Cell motility 
D, D, N, P, V pkd2 Polycystin-2-like protein Calcium channel 
D, D rvb2 ATPase domain-containing protein Macropinocytosis 
D ublcp1-2 Ubiquitin-like CTD phosphatase 1 Enzyme activity 
Table 4.1.  Shortlist of bitter tastant resistant mutants identified in the REMI mutant 
screen.  A shortlist of 20 mutants was constructed for further analysis based on their resistance 
in growth to one or multiple bitter tastants denatonium benzoate (D), phenylthiourea (P), 
naringenin (N), valproic acid (V).  In each case, the number of occasions each gene was 
recovered in the screen (represented by multiple listing of a compound), the gene name, a brief 
description of each gene product and the protein function is described (obtained from 
www.dictybase.org).  
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    Protein description 
  Gene of  
 
Cell 
 
Actin        Enzyme Cell 
Compound Interest Receptor Membrane Sub-unit Organisation Vesicles Transport GAP/GEF Activity Motility 
D agpB               X   
D, V agpC               X   
D, N, P, V DDB_G0267590   X     X         
D, N, V DDB_G0269760 X X       X       
D, N, V DDB_G0284149         X         
D DDB_G0284605   X       X       
D DDB_G0288003   X               
D DDB_G0291203   X               
D forJ       X           
D Fuk               X   
D gpaC   X X             
P gpaI   X X             
D, P gpaK   X X             
P grlJ X X               
D, N, V gxcI             X     
V gxcP             X     
D memo1                 X 
D, N, P, V pkd2 X X       X       
D rvb2               X   
D ublcp1-2                 X 
Table 4.2.  Shortlist of bitter tastant resistant mutants identified in REMI mutant screen.  A shortlist of 20 mutants was constructed for further analysis based 
on ability to grow in the presence of one or multiple of the bitter tastants denatonium benzoate (D), phenylthiourea (P), naringenin (N), or valproic acid (V).  In each 
case, the predicted/inferred protein function for identified mutated genes in the REMI mutant screen is shown based upon gene ontology (obtained from 
www.dictybase.org).
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4.4. Initial screening of available mutants 
  A research-community based bank of cell lines is available through 
Dictybase (www.dictybase.org), which facilitated initial screening of shortlisted 
mutants, where motility assays were used to determine the effects of bitter 
tastants.  Mutants were initially screened against the bitter tastants to which 
they showed resistance in the REMI mutant screen. Four of ten screened 
mutants showed resistance to denatonium benzoate (1mM), phenylthiourea 
(2mM) and/or naringenin (0.2mM). Where a mutant displayed resistance to a 
single tastant, a second motility assay using a different compound was 
performed to determine whether cells showed specificity to a single tastant or 
showed a broader resistance.  These experiments identified grlJ- showing 
resistance to phenylthiourea; gxcP- and gxcKK- showing resistance to 
denatonium benzoate; and pkd2- showing resistance to naringenin.  In addition 
to the selected REMI mutants, additional cell lines with ablated homologous 
genes or with functions associated with the protein products identified in the 
screen were also examined.    
4.4.1. grlJ- 
 Since the REMI mutant screen identified the grlJ- mutant as resistant to 
phenylthiourea, the effect of this tastant on Dictyostelium motility was analysed 
using a Dunn chamber in both wild type and grlJ- cells.  Since previously 
reported reductions in cell movement resulted in a deviation of cell angle 
towards zero degrees (Chapter 3), this measurement was no longer used.  To 
ensure that no false (non-compound related) chemotactic behaviour was 
observed, mean velocity and aspect from the initial 300 seconds of the assay 
was used to normalise all measurements taken throughout the assay and 
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subsequent experiments.  Without normalisation, a REMI mutant may have 
appeared to show resistance to bitter tastants due to an inherent defect in 
motility, which is shown in numerous mutants (Hoeller and Kay, 2007; Tang et 
al., 2008; Teo et al., 2010; Garcia et al., 2013).   
Addition of phenylthiourea (2mM) to wild type cells during motility caused 
a rapid and significant reduction in velocity, from 0.99±0.01 to 0.52±0.01 
(P<0.01), and aspect, from 1.00±0.01 to 0.57±0.00 (P<0.01) (Figure 4.2A-B).  
Under the same conditions, grlJ- cells showed partial resistance. Whilst a 
significant reduction in velocity, from 1.00±0.02 to 0.69±0.01 (P<0.01) was 
shown in grlJ-, cells maintained the ability to migrate towards cAMP (Figure 
4.2A, C).  In addition, no significant change in aspect was observed after 
phenylthiourea exposure (1.00±0.01 to 0.86±0.01), which was contrasting to 
effects shown wild type cells (Figure 4.2B).  grlJ- cells were also exposed to 
another bitter tastant, denatonium benzoate (1mM), where cells did not show 
any resistance to the compound, resulting in a block in cell behaviour similar to 
wild type cells.   
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 Figure 4.2.  Analysis of Dictyostelium wild-type and grlJ- cells during motility following 
acute exposure to 2mM phenylthiourea.  Cell behaviour (velocity and aspect) was measured 
under a stable chemotactic gradient in a Dunn chamber, where data from a total of 48 wild type 
and 87 grlJ
-
 cells was quantified every 6 seconds over a 900 second period with the addition of 
2mM phenylthiourea at 300 seconds.  Velocity and aspect were normalised to the mean of the 
measurements from first 300 seconds before phenylthiourea addition for each individual 
replicate. (A)  Normalised cell velocity; (B) Normalised cell aspect; (C) Cell directionality.  Cell 
outlines of 2 representative cells from wild-type (WT) control and grlJ
-
 mutant cells were overlaid 
and split into the first 300 and final 600 second intervals.  Overlay images have been adjusted 
so that the chemotactic gradient is following the marked arrows. Cell behaviour showed 
significant decreases in wild type (p = 0.0093) and grlJ
-
 (p = 0.0066) velocity; as well as a 
significant decrease in wild-type (p = 0.0065) but not grlJ
-
 aspect observed between the first and 
final 300 seconds of the assay.  Data from A-B is presented as mean of triplicate experiments.  
Statistical analyses were performed using paired two-tailed Student t-tests comparing average 
values from T=0-300 and T=600-900 seconds as previously described.  The significance of 
statistical analysis between the two time points in each cell line are illustrated on the graphs (  |  
) in wild type, followed by grlJ
-
 cells. n/s = not significant, ** P<0.01. 
GrlJ belongs to a group of seventeen Family 3 GPCRs (grlA-R) present 
in Dictyostelium (Prabhu et al., 2007b).  To determine whether the other 
members of the Grl family of receptors controlled resistance to phenylthiourea, 
a second mutant, grlE- (Fountain, 2010), was also screened in motility assays 
using phenylthiourea (2mM) and denatonium benzoate (1mM).  In each case, 
grlE- cells did not show resistance to either tastant, with treatment causing a 
significant decrease in cell behaviour similar to wild-type cells.  These data 
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suggest that grlJ- cells may be partially resistant to phenylthiourea (but not 
denatonium benzoate), exhibiting a phenotype not shared by at least one other 
Dictyostelium grl- mutant.  
4.4.2. Guanine exchange factors for Rac (RacGEF) 
The REMI mutant screen also identified GxcP and GxcI, two RacGEFs 
that may be involved in controlling resistance to denatonium benzoate, 
naringenin and/or valproic acid during cell growth.  Analysis of the available 
mutant, gxcP-, in motility assays showed no significant change in normalised 
velocity (from 0.91±0.02 to 0.78±0.02) or aspect (from 1.00±0.02 to 0.92±0.01) 
upon the addition of denatonium benzoate (1mM), and cells continued to 
migrate down a cAMP gradient, in contrast to wild-type cells (where normalised 
velocity changed from 1.00±0.01 to 0.22±0.01 and aspect changed from 
1.00±0.01 to 0.54±0.00), which did not (Figure 4.3).  To measure the behaviour 
of gxcP- cells in the presence of a second bitter tastant, the mutant was also 
exposed to phenylthiourea (2mM) during motility, where cells were not resistant, 
showing a reduction in cell behaviour similar to wild type cells.  These results 
suggest that GxcP is likely to be involved in denatonium benzoate but not 
phenylthiourea-mediated inhibition of cell movement.   
Since ablation of the gene encoding GxcP provides resistance to 
denatonium benzoate, other related proteins were also investigated for a similar 
role.  Dictyostelium contains an extensive family of RacGEFs, of which 42 
contain the RhoGEF domain present in GxcP (Vlahou and Rivero, 2006).  Two 
cell lines with a gene ablated sharing homology with gxcP, gxcB- (Strehle et al., 
2006) and gxcKK-, were also tested for resistance to denatonium benzoate 
(1mM) in motility assays.  Whilst gxcB- cells showed no resistance to the 
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tastant, gxcKK- cells were unaffected by the addition of denatonium benzoate 
(1mM) (Figure 4.4).  In order to measure specificity to denatonium benzoate, 
gxcKK- cells were also exposed to phenylthiourea (2mM) during motility assays, 
where the mutant showed a significant reduction in cell behaviour comparable 
to wild-type cells.  This data suggests the involvement of GxcP and GxcKK in 
the detection of denatonium benzoate. 
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 Figure 4.3.  Analysis of Dictyostelium wild-type and gxcP
-
 cells during motility following 
acute exposure to 1mM denatonium benzoate.  Cell behaviour (velocity and aspect) was 
measured under a stable chemotactic gradient in a Dunn chamber, where data from a total of 
40 wild-type and 91 gxcP
-
 cells was quantified every 6 seconds over a 900 second period with 
the addition of 1mM denatonium benzoate at 300 seconds.  Velocity and aspect were 
normalised to the mean of the measurements from first 300 seconds before denatonium 
benzoate addition for each individual replicate.  (A)  Normalised cell velocity; (B) Normalised 
cell aspect; (C) Cell directionality.  Outlines of 2 representative cells from WT and gxcP
-
 were 
overlaid and split into the first 300 and final 600 second intervals.  Overlay images have been 
adjusted so that the chemotactic gradient is following the marked arrows. Cell behaviour 
showed significant decreases in wild-type but not gxcP
-
 for velocity (p = 0.0012) and aspect (p = 
0.0135) observed between the first and final 300 seconds of the assay. Data from A-B is 
presented as mean of triplicate experiments.  Statistical analyses were performed using paired 
two-tailed Student t-tests comparing average values from T=0-300 and T=600-900 seconds as 
previously described.  The significance of statistical analysis between the two time points in 
each cell line are illustrated on the graphs (  |  ) in wild type, followed by gxcP
-
 cells. n/s = not 
significant, * P<0.05, **P<0.01. 
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 Figure 4.4.  Analysis of Dictyostelium wild wild-type and gxcKK
-
 cells during motility 
following acute exposure to 1mM denatonium benzoate.  Cell behaviour (velocity and 
aspect) was measured under a stable chemotactic gradient in a Dunn chamber, where data 
from a total of 40 wild-type and 39 gxcKK
-
 cells was quantified every 6 seconds over a 900 
second period with the addition of 1mM denatonium benzoate at 300 seconds.  Velocity and 
aspect were normalised to the mean of the measurements from first 300 seconds before 
phenylthiourea addition for each individual replicate.  (A)  Normalised cell velocity; (B)  
Normalised cell aspect; (C) Cell directionality.  Outlines of 2 representative cells from WT and 
gxcKK
-
 were overlaid and split into the first 300 and final 600 second intervals.  Overlay images 
have been adjusted so that the chemotactic gradient is following the marked arrows. Cell 
behaviour showed significant decreases in wild-type but not gxcKK
-
 for velocity (p = 0.0012) and 
aspect (p = 0.0135) observed between the first and final 300 seconds of the assay. Data from 
A-B is presented as mean of triplicate experiments.  Statistical analyses were performed using 
paired two-tailed Student t-tests comparing average values from T=0-300 and T=600-900 
seconds as previously described.  The significance of statistical analysis between the two time 
points in each cell line are illustrated on the graphs (  |  ) in wild type, followed by gxcKK
-
 cells. 
n/s = not significant, * P<0.05, **P<0.01. 
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4.4.3. pkd2- 
The pkd2 gene was identified in the REMI mutant screen as showing 
putative resistance to denatonium benzoate, phenylthiourea, naringenin and 
valproic acid (Table 1 and 2).  To investigate this, a pkd2- mutant was obtained 
and screened in separate motility assays with exposure to denatonium 
benzoate (1mM) and phenylthiourea (2mM), where in both cases cells showed 
no resistance to either tastant.  This data indicated the Pkd2 channel is not 
involved the response to phenylthiourea or denatonium benzoate.  
Pkd2 is one of several calcium channels that exist in Dictyostelium.  In 
order to investigate the role of another calcium channel, IplA (Wilczynska et al., 
2005), motility assays were also performed using an iplA- mutant exposed to 
denatonium benzoate (1mM), where cells displayed no resistance.  The TRP 
channel mutants, pkd2-, and iplA- were also both screened against capsaicin 
(0.1mM) due to this compound’s binding affinity for a related channel, TRPV1 
(Pingle et al., 2007).  Neither cell line was found to display any resistance to the 
capsaicin. 
In a parallel experiment, to those described here, a REMI mutant screen 
using the bitter tastant naringenin also identified pkd2-.  To examine this, the 
acute effects of naringenin (0.2mM) on Dictyostelium cell behaviour were 
monitored using a Dunn chamber motility assay. Naringenin (0.2mM) had no 
effect on wild-type Dictyostelium cell behaviour following acute (ten minute) 
exposure.  Prolonged one hour exposure to naringenin (0.2mM) has previously 
been shown to cause a near complete block in Dictyostelium motility (Misty et 
al., 2006).   A new assay was therefore developed by modifying the random cell 
movement assay used previously (Chapter 3).  Following a one-hour incubation 
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of cells in naringenin (0.2mM), Dictyostelium cell behaviour was recorded for 
five minutes and analysed using QuimP software, which was used to quantify 
cell displacement, circularity, protrusion formation and motility (defined as the 
magnitude of all membrane protrusions and retractions summed up over time).  
Wild-type Dictyostelium random cell movement was strongly inhibited following 
incubation with naringenin (0.2mM), showing a significant near-complete block 
in displacement (11.13±1.5µm solvent control, 1.79±0.24µm naringenin 
exposure) protrusion formation (5.42±0.05 solvent control, 0.061±0.01 
naringenin) and motility (0.47±0.03 solvent control, 0.04±0.01 naringenin), as 
well as significant cell rounding (0.75±0.00 solvent control, 0.94±0.00 
naringenin) when compared to control (solvent only) conditions (Figure 4.5).  
Under the same conditions, pkd2- cells displayed resistance to naringenin 
(0.2mM), where no significant change was observed in comparison to control 
pkd2- conditions in displacement (8.83±1.2µm solvent control, 7.77±1.1µm 
naringenin), circularity (0.74±0.00 solvent control, 0.72±0.01 naringenin), 
number of protrusions (5.57±0.05 solvent control, 3.34±0.05 naringenin), or cell 
motility (0.45±0.03 solvent control, 0.37±0.03 naringenin) (Figure 4.5).  In 
addition, a significant difference between wild-type and pkd2- cells was 
observed after naringenin (0.2mM) incubation for displacement (P<0.01), 
circularity (P<0.001), protrusion formation (P<0.05) and motility (P<0.01).  This 
data indicated that the Pkd2 receptor may be involved in naringenin detection 
(Figure 4.5).   
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Figure 4.5.  Analysis of Dictyostelium wild-type and pkd2
-
 cells during random cell 
movement after one hour incubation with 200µM naringenin.  Cell behaviour (displacement, 
circularity, number of protrusions and motility) was measured during random cell movement 
following one hour incubation, with data representing 30 cells per experimental condition 
quantified every 15 seconds over a 300 second period.  (A)  Cell displacement; (B)  Cell 
circularity; (C) Number of cellular protrusions formed in a 10 frame window; (D) Cell motility.    A 
one-way analysis identified a significant difference in displacement (F=25.62, p < 0.0001), 
circularity (F=26.04, p < 0.0001), number of protrusions formed (F=19.12, p = 0.0001), and 
motility (F=14.96, p = 0.0003) with a post-hoc Tukey’s multiple comparison test showing a 
significant decrease in wild-type but not pkd2
-
 displacement (p < 0.01), circularity (p < 0.001), 
number of protrusions formed (p < 0.05) and cell motility (p < 0.01).  (E) Image overlays of WT 
cells showing quantification of measurements taken over the course of the assay.  Data from A-
D is presented as mean of triplicate experiments with vertical bars representing SEM.   
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4.5. Discussion 
Previous experiments reported here have demonstrated that bitter 
tastants inhibit Dictyostelium cell movement (Chapter 3).  To date, the 
molecular mechanisms for detection of these tastants are unknown in 
Dictyostelium.  In order to identify potential molecular mechanisms for these 
tastants, a REMI mutant library was screened to identify mutants resistant to the 
effect of denatonium benzoate (Meyerhof et al., 2010), phenylthiourea 
(Meyerhof et al., 2010), naringenin (Meyerhof et al., 2010) and valproic acid 
(Johannessen and Henriksen, 1979).  This chapter described the 
characterisation of the potency for two standard bitter compounds, 
phenylthiourea and denatonium benzoate.  These results facilitated screening 
of a mutant library for denatonium benzoate and phenylthiourea resistance 
followed by the initial characterisation of mutants. 
4.5.1. Tastant potency analysis  
 In order to perform a REMI screen, the potency of phenylthiourea was 
estimated through the inhibition of cell proliferation in shaking cultures.  A range 
of phenylthiourea concentrations up to 5mM were used over seven days and 
the log-phase growth rate (Wang and Bushman, 2006) was used to estimate an 
IC50 of 1.95mM (Figure 4.1).  Previous studies had identified an IC50 for 
inhibition of cell movement in Dictyostelium of 0.37mM, which is approximately 
five-fold lower than the concentration required here to inhibit proliferation 
(Chapter 3).  This may be due to the presence of rich growth medium or 
conversely, chemotactic cells may be more sensitive to phenylthiourea than 
growing cells due to the multiple changes in gene expression that occur during 
starvation.  
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In humans, the threshold for phenylthiourea taste detection is at 
concentrations ranging from 3.28µM to 1.3mM depending on genetic 
polymorphisms (Bufe et al., 2005). Aside from bitter tastant activation, 
phenylthiourea is a toxic compound that can cause pulmonary oedema (Scott et 
al., 1990), decrease survival in mouse embryo cells (Smith and Crespi, 2002) 
and inhibit melanin production (Criton and Le Mellay-Hamon, 2008) at 
concentrations ranging from 10µM to 100µM.  In contrast to mammalian 
models, high (10mM) phenylthiourea concentrations have no toxic effects in 
insect cell lines (Rivers et al., 2009).  A phenylthiourea IC50 of 1.95mM in 
Dictyostelium cell proliferation is therefore high in comparison to mammalian 
cell lines but falls within the range of concentrations used in in vitro assays in 
insect cell lines. 
To perform a REMI mutagenesis screen in denatonium benzoate, the cell 
proliferation assay was repeated using concentrations up to 10mM.  Seven day 
incubation of Dictyostelium cells in shaking suspension with denatonium 
benzoate identified the potency for inhibition (IC50) as 1.5mM (Figure 4.1). 
Previous experiments have shown an IC50 for inhibition of Dictyostelium cell 
movement by denatonium benzoate of 0.13mM, which is approximately 10-fold 
lower than the concentration that inhibited proliferation in this study (Chapter 3).  
This variation in IC50 could be also explained by the presence of axenic media 
as described for phenylthiourea or through different levels of target proteins 
present in the two conditions. 
 Denatonium benzoate in rodent models causes aversion in the rat at 
0.1mM (Tordoff et al., 2008) and in hamsters at 3mM (Frank et al., 2004), 
showing different potencies in closely related mammalian species.   In addition, 
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human T2R receptors demonstrate variation in sensitivity to denatonium 
benzoate, where concentrations ranging from 100nM to 1mM causes receptor 
activation (Meyerhof et al., 2010).  Denatonium benzoate is a compound with 
low toxicity (Hansen et al., 1993) since, for example, studies have shown that 
children can comfortably ingest up to 10g without displaying any major side 
effects (Sibert and Frude, 1991).  High denatonium benzoate concentrations up 
to 10mM also have effects on gastric distension in the rat when infused directly 
into the gastrointestinal tract of the rat (Horn et al., 2011).  The IC50 derived in 
this study for denatonium benzoate effects on cell proliferation in Dictyostelium 
is therefore consistent with the concentration ranges studied in other systems.   
4.5.2. Initial characterisation of REMI mutants 
 A range 187 mutants were identified in the REMI screen, which 
potentially control resistance to one or a combination of bitter tastants 
(Appendix 6).  The number of mutants potentially involved in controlling 
phenylthiourea sensitivity suggests the involvement of multiple mechanisms of 
action.  As a result, prolonged phenylthiourea exposure as used in the REMI 
screen, may identify Dictyostelium proteins involved in an acute or a delayed 
response.  In addition, more than one mutation, which could collectively cause 
resistance to phenylthiourea, may also occur in a single mutant as a result of 
the mutagenesis screen.  Finally, prolonged exposure to phenylthiourea may 
induce tolerance in some mutant strains causing in a false-positive mutant 
result.  Since the phenylthiourea response to cell motility was one that occurred 
within minutes of exposure, a shortlist comprising twenty REMI mutants based 
on protein functions likely to target cell movement was used to narrow down 
potential targets involved in acute inhibition of cell movement (Table 4.1 and 
4.2).   
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Previous research has suggested a poor correlation between REMI 
mutant resistance in cell survival (i.e. growth) and a phenotypic resistance in 
motility to a particular compound (Terbach et al., 2011).  Since bitter tastant 
detection in Dictyostelium initially involved motility using a Dunn chamber, this 
approach was chosen to screen available REMI mutants identified. Mutants 
were exposed to denatonium benzoate and/or phenylthiourea in an acute ten 
minute baseline time period (Table 4.3).  Four of the ten mutants screened, grlJ- 
(Figure 4.2), gxcP- (Figure 4.3), gxcKK- (Figure 4.4) and pkd2- (Figure 4.5), 
showed resistance to bitter tastants in velocity and/or aspect when compared to 
the wild-type strain.  No mutants showed resistance to more than one bitter 
tastant, nor did any individual compound lack an effect on cell behaviour in a 
range of mutants (Table 4.3).  These data have identified three different 
tastants acting via separate mechanisms in Dictyostelium, which include a 
seven transmembrane domain GABAB-like protein involved in acute 
phenylthiourea recognition; two small GTPases involved in acute signalling in 
response to denatonium benzoate; and a calcium channel involved in 
naringenin detection upon prolonged exposure.  
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Gene Category Protein Compound Resistant 
agpB Acyltransferase D N 
DDB_G0284605 P-type-, Calcium ATPase D N 
grlJ GABAB-like receptor P, D Y, N 
grlE GABAB-like receptor P, D N, N 
gxcP Pleckstrin homology domain-containing protein P D, P Y, N 
gxcB Pleckstrin homology domain-containing protein B D N 
gxcKK 
Pleckstrin homology domain-containing protein 
KK D Y, N 
iplA inositol 1,4,5-trisphosphate receptor-like protein D, C N, N 
pkd2 polycystin-2-like protein D, N, P, C N,Y,N, N 
rvb2 ATPase domain-containing protein D N 
Table 4.3:  Summary of REMI mutants screened for resistance to bitter tastants in motility 
using a Dunn chamber.  Dictyostelium mutants were screened as previously described with 
1mM denatonium benzoate (D), 2mM phenylthiourea (P), 0.1mM capsaicin (C) and/or 0.2mM 
naringenin (N).  Resistance of motility to a specific compound (defined as a non-significant 
change in cell velocity and/or aspect following acute treatment) is represented by Y (Yes), with 
no effect denoted N (No).  N.B. Dictyostelium naringenin experiments were performed using 
random cell movement (i.e. in the absence of a cAMP gradient) rather than motility. 
4.5.3. grlJ- 
 The G-protein coupled receptor mutant, grlJ-, showed partial resistance 
to the block in cell behaviour caused by phenylthiourea (2mM) (Figure 4.2), but 
did not show resistance to denatonium benzoate (1mM) under the same 
conditions.  These data suggest a role for GrlJ in the detection of 
phenylthiourea.   
 In Dictyostelium, GrlJ plays a role in post aggregation development, so 
that grlJ- cells form broken slugs and have a malformed spore shape (Prabhu et 
al., 2007b).  GrlJ shares a structure similar to GABAB receptors in mammalian 
systems, particularly in the transmembrane domains (Prabhu and Eichinger, 
2006).  It is currently unclear if these conserved regions in GrlJ function as 
ligand binding domains as shown in human T2R receptors, where 
transmembrane regions act as ligand binding pockets in bitter tastant detection 
(Sakurai et al., 2010).   
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 In addition to T2R receptors, previous studies have demonstrated the 
involvement of alternative receptors in bitter tastant detection.  In humans cell 
lines, this includes the calcium-sensing receptor, which responds to denatonium 
benzoate (Rogachevskaja et al., 2011).  Cell lines in frogs are also shown to 
detect bitter tastants through melatonin and adrenergic receptors (Zubare-
Samuelov et al., 2003).  Model systems naturally lacking T2R receptors such as 
fish (Ishimaru et al., 2005), fly (Isono and Morita, 2010) and nematode (Hilliard 
et al., 2004) have more than one GPCR responsible for bitter tastant detection.  
These studies show non-T2R receptors may function as bitter tastant receptors, 
which supports a possible role of GrlJ in phenylthiourea detection.  To 
determine whether GrlJ is the only Grl-family receptor responsible for bitter 
tastant detection, grlE- was also screened for phenylthiourea resistance in 
motility assays, where cells were shown to be sensitive (Table 4.3).  This 
suggests there may be ligand receptor specificity for phenylthiourea towards 
GrlJ, although other Grl-family receptors cannot be discounted.  This will be 
analysed further in Chapter 5 and Chapter 6 by ablating grlJ in the wild type 
cell line used throughout this thesis.   
4.5.4. RacGEFs 
 The RacGEF mutant, gxcP-, showed resistance to the denatonium 
benzoate-mediated block in cell movement found in wild type cells (Figure 4.3).  
Of two related RacGEF mutants, only gxcKK- (not gxcB-) showed resistance to 
the tastant (Figure 4.4, Table 4.3).  RacGEFs such as GxcP, GxcKK and GxcB 
all contain RhoGEF domains, which activate molecular switches by converting 
GDP to GTP (Vlahou and Rivero, 2006).  These are regulated by pleckstrin 
homology domains, also present within the protein, which serve as an anchor at 
the cell membrane allowing molecular interactions (Vlahou and Rivero, 2006).  
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RacGEFs have important roles in motility, cell morphology as well as actin 
organisation (Pakes et al., 2012a; Knetsch et al., 2001).  Little is known about 
the function of GxcP and GxcKK, however inhibition of these RacGEFs by 
denatonium benzoate could result in the block in cell movement observed.  In 
addition, two different RacGEF mutants showing resistance to denatonium 
benzoate suggests GxcP and GxcKK may play parallel roles in controlling the 
response to or detection of denatonium benzoate.   
 GxcB is contains a triple array of calponin domains, which interact with F-
actin and bundle actin filaments (Strehle et al., 2006; Friedberg and Rivero, 
2010).  The calponin domains found in GxcB but not GxcP and GxcKK may 
therefore provide an indication to the mechanism of action for denatonium 
benzoate detection in Dictyostelium, where actin binding of GxcB does not 
affect cell movement (Figure 4.6).   
 
Figure 4.6:  Possible differing mechanisms of action for denatonium benzoate detection 
between RacGEFs.  GxcB binds to F-actin and bundles actin, which may be independent of the 
inhibition of cell movement caused by denatonium benzoate.  GxcKK and GxcP may be directly 
affected by a denatonium benzoate-mediated inhibition of cell movement.  
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4.5.5 pkd2- 
 The calcium channel mutant, pkd2-, was identified in phenylthiourea, 
denatonium benzoate, naringenin and valproic acid growth screens (Table 4.1 
& 4.2).  No acute resistance was observed in denatonium benzoate (1mM) and 
phenylthiourea (1mM) motility assays (Table 4.3).   Since no acute effect of 
naringenin was observed using motility assays in wild type cells, prolonged (one 
hour) exposure to naringenin (0.2mM) identified a distinct resistance in pkd2- 
cells compared to wild-type cells in random cell movement (Figure 4.5).   
 Naringenin is a naturally occurring bitter tasting flavonoid that does not 
activate mammalian T2R receptors (Meyerhof et al., 2010).  The mechanism of 
action for naringenin detection in taste perception is currently unknown.   
Naringenin has a range of therapeutic benefits including as an anti-microbial 
treatment (Yin et al., 2012), as well as possible anti-angiogenic and anti-
metastatic properties (Weng and Yen, 2012).  Naringenin induces apoptosis in 
cancer cell lines at concentrations ranging from 50µM to 200µM (Arul and 
Subramanian, 2013), as well as inhibiting adhesion of Salmonella enterica to 
gastrointestinal epithelial cells  at 735µM (Yin et al., 2012). Arising from the data 
reported in this thesis, naringenin has also been shown to inhibit the formation 
of polycystic cysts in mammalian kidney cell lines at concentrations relevant to 
Dictyostelium inhibition of cell movement (Mark Carew, Kingston University, 
personal communication).  Together these data indicate that the inhibition of 
Dictyostelium cell movement observed at 200µM naringenin is within a 
concentration relevant to mammalian cell lines.   
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4.6. Summary 
Four mutants screened in motility assays showed resistance to bitter 
tastants, with grlJ- cells showing partial resistance to phenylthiourea, gxcP- and 
gxcKK- showing resistance to denatonium benzoate, and pkd2- showing 
resistance to naringenin.  GrlJ is a novel GPCR-like protein belonging to a 
receptor family of which little is known about in Dictyostelium.  Partial resistance 
to phenylthiourea showing specificity for GrlJ suggests there may be ligand 
receptor specificity for the tastant.  This will be analysed further in subsequent 
chapters.  Since gxcP- and gxcKK- both show resistance to denatonium 
benzoate, these results suggest multiple RacGEFs may function in the same or 
parallel pathways.  These parallel pathways may be directly affected by 
denatonium benzoate in RacGEFs that do not contain a calponin domain. 
Finally, pkd2- cells did not show resistance to either denatonium benzoate or 
phenylthiourea, although cells were resistant to naringenin in random cell 
movement following one hour exposure.  Since naringenin required prolonged 
exposure to block cell behaviour, this bitter compound may function through 
different mechanisms to denatonium benzoate and phenylthiourea.  
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Chapter 5 
Ablation of grlJ 
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 Phenylthiourea is a standard bitter compound thought to activate a single 
receptor, TAS2R38 (Bufe et al., 2005).   Different genetic polymorphisms in the 
TAS2R38 gene, result in a variation in taste sensitivity depending on an individual’s 
super taster, taster or non-taster status (Bufe et al., 2005).  This variation between 
taster status and sensitivity to phenylthiourea is however not fully explained by 
TAS2R38 single nucleotide polymorphisms, which has led to the suggestion that 
alternative mechanisms may be involved in detection of these receptor ligands 
(Hayes et al., 2008).   
Previous chapters in this thesis identified a number of bitter tastants to block 
Dictyostelium behaviour in both motility and random cell movement.  In addition, a 
REMI mutagenesis screen identified a number of Dictyostelium mutants showing 
resistance in growth to denatonium benzoate, phenylthiourea, naringenin and 
valproic acid using motility assays in a Dunn chamber (Chapter 4).   Four out of ten 
REMI mutants were identified as showing selective resistance to a single bitter 
tastant in cell movement, where grlJ- cells showed partial resistance to 
phenylthiourea. 
 In this chapter, the role of the poorly characterised protein, GrlJ, is analysed 
as a potential receptor for phenylthiourea detection in Dictyostelium.  grlJ was 
ablated from wild type strains and subsequent phenotypic responses to 
phenylthiourea investigated.  The gene was then recapitulated to confirm rescue of 
the wild type phenotypes.  
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5.1. Creating a grlJ- knockout strain  
 To test the involvement of the REMI mutant, grlJ-, in resistance to 
phenylthiourea as mutant specific and not secondary mutations caused in the REMI 
mutagenesis process or due to differences in the background strain, grlJ was ablated 
in wild type Ax2 cells.  This was achieved by integration of a knockout cassette, 
containing the grlJ gene, where a central region of the gene (encoding part of the N-
terminus and the first four transmembrane domains) was replaced by a gene 
encoding a protein that gives resistance to blasticidin, into Dictyostelium cells.  
Following homologous integration of the knockout cassette into the Dictyostelium 
genome, the expression of grlJ encoding a G-protein coupled receptor, is effectively 
blocked. 
 5’ and 3’ fragments of grlJ were cloned into the pLPBLP vector (Faix et al., 
2004) flanking the cassette encoding blasticidin resistance (Figure 5.1A-B).  
Digestion of the knockout vector with individual restriction enzymes confirmed the 
presence of restriction sites within the pLPBLP vector, where double digests 
identified vector backbone in addition to insertion of 5’ (729bp) and 3’ (545bp) 
fragments of grlJ.  A double digest with BamHI and KpnI also excised the knockout 
cassette (2846bp) from the vector, where only a single band could be identified since 
the vector backbone (2898bp) was not distinguishable by gel electrophoresis. 
(Figure 5.1C).  The linearised vector was then transformed into wild type Ax2 
Dictyostelium cells by electroporation and potential knockout mutants isolated by 
selection with blasticidin.   Surviving colonies, potentially containing the knockout 
cassette, were then screened by PCR to determine whether the knockout cassette 
had homologously integrated into the grlJ gene and thus created a knockout cell line 
(Figure 5.1C). 
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Figure 5.1. Creation of a grlJ
-
 knockout construct.  (A) 5’ and 3’ fragments of grlJ genomic DNA 
were amplified using primers containing BamHI, PstI, NcoI and KpnI cut sites by PCR.   (B) 
Fragments were cloned into either side of the cassette encoding blasticidin (BSR) of pLPBLP.  (C) A 
series of restriction digests were used to confirm incorporation of 5’ and 3’ grlJ DNA fragments into 
the vector.  All restriction digests were run on a 1% agarose gel by electrophoresis using a 1kb DNA 
ladder (L), where single digests BamHI (B), PstI (P), NcoI (N) and KpnI (K); as well as double digests 
BamHI-PstI (B-P), which produced the 5’ fragment (729bp), NcoI-KpnI (N-K) produced the 3’ fragment 
(545bp) and BamHI-KpnI (B-K) produced the linearised knockout fragment (2846bp) for use in 
electroporation.  Uncut vector containing the knockout fragment was also used as a control (U). 
5.1.1. PCR screening and identification of grlJ- knockouts 
Identification of homologously integrated cells was determined by screening 
for blasticidin resistant colonies using PCR (Terbach et al., 2011).  Primers were 
designed to amplify genomic and vector control fragments, as well as a diagnostic 
knockout fragment in PCR screening.  Genomic control primers were designed to 
flank 5’ and 3’ fragments cloned into the pLPBLP vector, which would confirm the 
presence of a non-deleted region of grlJ (Figure 5.2A).  Vector control fragments 
used to confirm the presence of the knockout cassette were amplified, using PCR 
primers designed complementary to regions inside the genomic DNA fragment and 
the cassette encoding blasticidin (Figure 5.2A).  Finally a diagnostic knockout 
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fragment using a 5’ or 3’ primer located outside of the gene and the blasticidin 
resistance cassette primer confirmed homologous integration of the resistance 
cassette (Figure 5.2A).  Screening for a homologously integrated knockout cassette 
(Figure 5.2B), identified two out of several hundred blasticidin-resistant clones 
showing correct homologous integration events on both the 5’ and 3’ sides (Figure 
5.2C).  In order to derive isogenic cell lines from a single cell, these two positive 
transformants were then sub-cloned and grown on Raoultella plates. 
 Since the presence of the blasticidin resistance gene may influence cell 
behaviour, this gene was removed by CRE recombinase (Kimmel and Faix, 2006) 
(Figure 5.2D).  Isogenic grlJ- mutants were electroporated with pDEX-NLS-CRE and 
placed under G418 selection or blasticidin selection.  Colonies that survived under 
G418 (contained within the shuttle vector), but not blasticidin, were harvested and 
complementary DNA (cDNA) synthesised by reverse-transcription (RT) PCR.  To 
confirm loss of the blasticidin resistance gene, PCR primers were designed to flank a 
deleted region of the gene, which showed a band in wild type but not grlJ cDNA after 
gel electrophoresis.  In addition, to confirm deletion of part of the grlJ gene, a second 
set of primers were designed to flank across the deleted region of the gene, which 
identified a band that was smaller (428bp) in grlJ- cDNA in comparison to wild type 
cDNA (Figure 5.2E).  Upon confirmation of blasticidin cassette excision, 
Dictyostelium cells were grown in axenic media, under no selection, where the 
shuttle vector encoding G418 resistance was lost. 
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Figure 5.2. PCR Screening for homologous integrants of grlJ
-
.  Genomic DNA of transformed 
mutants showing resistance to blasticidin was extracted and screened using PCR.  (A) Genomic, 
vector and diagnostic knockout primers were designed to screen for homologous integration.  (B) 
Electrophoresis of PCR products would identify non-homologous integrants showing bands in 
genomic (G) and vector (V) but not diagnostic knockout (KO) PCR products, where homologous 
integrants showed bands in all three PCR products.  (C) Homologous integration was then confirmed 
on both N and C terminal regions of the gene.  (D) Dictyostelium grlJ
-
 mutants were electroporated 
with pDEX-NLS-CRE for excision of the cassette encoding blasticidin resistance.  (E) To identify 
mutants showing excision of the cassette encoding blasticidin resistance, RT-PCR analysis wild type 
(WT) and grlJ
-
 mutants was performed using primers designed within the deleted region of grlJ
-
 
(Excision), which showed a band in WT but not grlJ
-
 cDNA.  Expression of an unrelated control gene 
(IG7) was used to ensure equal cDNA was present in each sample (Control).  Finally, primers were 
designed to flank either side of the deleted region in grlJ (Deleted), which confirmed deletion of part of 
grlJ (428bp) in grlJ
-
 compared to WT cDNA. *3’ primer designed to confirm loss of the gene encoding 
blasticidin was designed within the deleted region of the grlJ gene. 
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5.2. Assessment of grlJ- phenotypic behaviour 
 Creation of a grlJ- cell line using the wild type Ax2 background strain enabled 
the comparison of previously identified phenotypes associated with grlJ- cells.  These 
include the production of malformed spores during development and an increased 
proliferation rate when compared to wild type cells (Prabhu et al., 2007b).   
5.2.1. Analysis of spore shape in grlJ- cells 
To test previously identified malformations in spore shape, wild type and grlJ- 
cells were developed over twenty four hours, to allow the formation of fruiting bodies.  
Spores fruiting bodies were harvested and visualised using light microscopy.  Spore 
shape, determined by the ratio between length and breadth of spores (aspect), of 
214 spores was determined from triplicate experiments in each cell line, showing a 
significant (P=0.0110) difference between grlJ- spores (mean aspect of 2.0±0.03) 
(Figure 5.2B, D) compared to wild type spores (mean aspect of 1.9±0.02) (Figure 
5.3A, C).  This data confirmed grlJ- knockouts developed in the Ax2 background 
supports a previously identified phenotype during development using a similar Ax2 
parent strain (Prabhu et al., 2007b). 
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Figure 5.3.  Quantification of spore shape during Dictyostelium wild type and grlJ
-
 
development.  Dictyostelium cells were allowed to develop over 24 hours before spores were 
suspended in phosphate buffer and placed onto a coverslip. Phase contrast imaging of 214 spores in 
wild type and grlJ
-
 spores were quantified for aspect using ImagePro Plus.  (A) Frequency distribution 
quantifying wild type spore aspect. (B) Frequency distribution quantifying spore grlJ
-
 spore aspect 
identified a significant difference (P=0.0110) in shape when compared to wild type strains.  (C) 
Normal spore shape shown in wild type spores.  (D) Malformed spores developed in grlJ
-
 strains 
showing an increased variability in shape.   Malformed spores are highlighted by the white arrows.  
Statistical analysis was performed using two-way ANOVA comparing spore aspect between wild type 
and grlJ
-
 strains.    
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5.2.2. Analysis of grlJ- cell growth in the presence of 
phenylthiourea 
 Proliferation of wild-type Dictyostelium cells was inhibited over a range of 
phenylthiourea concentrations, with previous work estimating an IC50 of 1.95mM 
(Chapter 4).  In the analysis of bitter tastant potency, wild type and grlJ- cells were 
diluted to 3x105 cells grown in shaking suspension under control conditions for 144 
hours until cells reached stationary phase (Figure 5.4A).  Using the same starting 
cell density, wild type and grlJ- cells were then grown in shaking suspension for 96 
hours under control conditions, until cells reached a density of approximately 50% of 
stationary phase (~1.8x107 cells/mL).   Each cell line was then exposed to a range of 
phenylthiourea concentrations (1µM-10mM) for a further 48 hours and cell density 
determined.  In comparison to control conditions during the first 24 hours, wild type 
and grlJ- cells showed significant (P<0.05) decreases in proliferation at 1mM and 
3mM phenylthiourea respectively (Figure 5.4B-C).   Wild type and grlJ- cell 
proliferation after 24 hours post-phenylthiourea exposure was then expressed as a 
percentage of control (solvent only) conditions, where a 2-way ANOVA identified a 
significant difference between each strain with increasing phenylthiourea 
concentration (P<0.0001) (Figure 5.4D).  This data identified a partial resistance in 
cell growth to phenylthiourea in grlJ- cells when compared to wild type cells. 
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Figure 5.4. Dictyostelium Wild type and grlJ- proliferation in shaking suspension in the 
absence and presence of phenylthiourea.  (A) Dictyostelium wild type and grlJ
-
 cells were grown 
under control conditions until cells reached stationary phase.   (B) wild type cells were then for 96 
hours under control conditions until cells reached approximately 50% of stationary phase, before 
exposure to 10µM, 100µM, 300µM, 1mM, 3mM and 10mM concentrations of phenylthiourea.  A 
significant decrease in cell density was reached at 1mM phenylthiourea (P<0.05) in comparison to 
control conditions after 24 hours exposure.  (C) Under the same conditions, grlJ
-
 cells showed 
resistance to phenylthiourea, where a significant decrease in cell density was reached at 3mM 
(P<0.05).  (D)  Cell density 24 hours after exposure to phenylthiourea was then plotted as a 
percentage of control growth, where a 2-way ANOVA identified a significant difference in cell density 
as the concentration increased between wild type and grlJ
-
 cells (P<0.0001).  
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Dictyostelium growth can be recorded in either shaking suspension, 
consuming media by macropinocytosis, or on bacterial plates, consuming bacteria by 
phagocytosis.  To assess the effect of phenylthiourea on wild type and grlJ- cells 
during growth on a bacterial lawn, cells were allowed to grow over four days in the 
presence of R. planticola.  Dictyostelium cell survival rate (determined by the number 
of colonies formed) and the rate of cell growth (determined by the size of colonies 
formed) were used to compare wild type and grlJ- Dictyostelium cells under control 
and phenylthiourea (3mM) conditions (Figure 5.5A).  Addition of phenylthiourea 
(3mM) to wild type cells caused a significant reduction (P<0.0001) in colony number 
from 107±8.5 to 35.2±4.7 (Figure 5.5B), and in grlJ- cells (P<0.0001) from 120.2±4.6 
to 51.6±2.5 (Figure 5.5C) as assessed by a Mann-Whitney test.  In addition, 
phenylthiourea also caused a significant reduction in colony size formed by wild type 
cells (P<0.0001), from 0.38±0.01cm to 0.14±0.01cm, and grlJ- cells (P<0.0001), from 
0.44±0.01cm to 0.22±0.01cm.  Upon comparison of colony number between wild 
type grlJ- cells, significantly more colonies were formed in the grlJ- strain during 
phenylthiourea incubation (P=0.0159).  Furthermore, colonies produced by grlJ- cells 
in the presence of phenylthiourea were also significantly larger than those produced 
by wild type cells (P=0.0079).  Together this data suggested grlJ- cells showed 
resistance to phenylthiourea in both growth and survival. 
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Figure 5.5. Dictyostelium wild type and grlJ
-
 growth on bacterial lawns in the absence and 
presence of phenylthiourea (3mM).  Wild type and grlJ
-
 cells were grown on bacterial lawns in the 
absence or presence of 3mM phenylthiourea.  (A) Photographs of bacterial plates under each 
condition.  (B) A significant decrease in the number of colonies formed for both wild type (P<0.0001) 
and grlJ
-
 (P<0.0001) strains was observed when grown in the presence of phenylthiourea.   In 
addition, significantly (P=0.0159) more grlJ
-
 colonies were formed in the presence of phenylthiourea 
when compared wild type.  (C)  A significant decrease in colony size for both wild type (P<0.0001) 
and grlJ
-
 (P<0.0001) strains was observed when grown in the presence of phenylthiourea.   A 
significant difference in colony size between wild type and grlJ- strains was also identified post-
phenylthiourea exposure (P=0.0059). Data from B-C is representative of quintuplicate independent 
experiments with vertical bars representing standard error of the mean.  Statistical analysis was 
performed using a Mann-Whitney test. *P<0.05, ** P<0.01, ***P<0.001 
5.2.3. Analysis of random cell movement in grlJ- cells 
 Previous motility experiments identified grlJ- cells to show partial resistance to 
changes in velocity caused by phenylthiourea (2mM) and resistance to changes in 
cell shape (Chapter 4).  In order to quantify cell behaviour, specifically cell shape, in 
more detail, random cell movement assays were adapted from conditions described 
previously (Chapter 3).  Chemotactically competent cell behaviour was monitored in 
the absence of a cAMP gradient using time lapse microscopy, where an image was 
taken every eighteen seconds.  During random cell movement, a control period of 
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288 seconds was established to enable comparison of wild type and grlJ- cell 
behaviour, where no differences were observed.  Phenylthiourea was then added to 
cells to give a final concentration of 3mM, and cell behaviour monitored for a further 
612 seconds.  Quantification of cell behaviour was used to determine changes in 
displacement, circularity, protrusion formation and average cell motility (magnitude of 
all membrane protrusions and retractions summed over time).  Addition of 
phenylthiourea (3mM) at 288 seconds resulted in a near complete block in cell 
behaviour in wild type cells, where displacement changed from 22.1±1.9µm at 288 
seconds to 28.0±4.8µm at 900 seconds.  In addition, phenylthiourea exposure 
caused an increase in cell circularity, from an average of 0.67±0.01 during the first 
288 seconds to 0.91±0.01 during the final 288 seconds (P=0.0017), a decrease in 
protrusion formation, from 4.3±1.1 to 0.6±0.1 (P=0.0441), as well as a decrease in 
motility, from 14.4±3.8nm/sec to 0.08±0.04nm/sec (P=0.0294).  Under the same 
conditions, grlJ- cells showed partial resistance to phenylthiourea, where cell 
displacement at 288 seconds significantly increased by 900 seconds from 
26.4±2.7µm to 51.4±10.1µm (P=0.0225).  In addition, grlJ- cells showed a reduced 
but significant increase in cell circularity, from 0.64±0.02 during the first 288 seconds 
to 0.77±0.01 during the final 288 seconds (P=0.0011) as well as a significant change 
in motility, from 18.3±4.1nm/sec to 8.8±1.3nm/sec (P=0.0134).  Comparison of 
protrusion formation between the first and final 288 seconds of the assay did not 
identify any significant changes in grlJ- cells, from 5.0±1.2 to 4.2±0.3.  Furthermore, 
statistical comparison of wild type and grlJ- behaviour in response to phenylthiourea 
identified a significant difference in displacement (P=0.0288), circularity (P=0.0085), 
protrusion formation (P=0.0101) and motility (P=0.0146) during the final 288 seconds 
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of the assay (Figure 5.6).  These results suggest a partial resistance of grlJ- cells to 
phenylthiourea in comparison to wild type cells. 
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Figure 5.6. Dictyostelium WT and GrlJ
-
 random cell movement following exposure to 
phenylthiourea (3mM) after 288 seconds.  Random movement of Dictyostelium cells was monitored 
under control conditions for 288 seconds before the addition of double concentrated phenylthiourea 
(3mM final concentration), where cell behaviour was monitored for the remainder of the assay. (A) 
Displacement.  A significant (P=0.0228) difference in displacement at the final cumulative time point 
was observed between WT and grlJ
-
 cells.  (B) Circularity.  WT cells were found to show significantly 
(P<0.0085) increased circularity compared to GrlJ
-
 cells during the final 612-900 seconds. (C) Number 
of Protrusions within a 10 frame window.  Significantly (P=0.0101) fewer protrusions were formed in 
WT cells than GrlJ
-
 cells during the final 612-900 seconds.  (D) Motility.  WT cells were found to be 
significantly (P=0.0146) less active than GrlJ
-
 cells during the final 612-900 seconds. (E)  Data 
quantification showing mean measurements taken during the final 612-900 seconds of the assay for 
displacement, circularity, number of protrusions and motility.  In all measurements, no significant 
difference was observed between WT and GrlJ
-
 cells under control conditions (0-288 seconds). 
Measurements were derived from an average of 40 cells measured from quadruplicate experiments.  
Statistical analysis was performed using an unpaired two-tailed t-test.  Vertical bars represent the 
standard error of the mean, *p < 0.05, **p < 0.01. 
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5.3. Complementation of grlJ- cells with grlJ 
 In order to determine whether the phenotypic responses observed in grlJ- 
cells was due to ablation of the gene, cells were complemented with grlJ 
overexpression construct, tagged with a C-terminal GFP.  Full length grlJ cDNA 
containing EcoRI restriction sites at both 5’ and 3’ ends, was amplified and cloned 
into a pDEX_27 vector (Muller-Taubenberger, 2006) (Figure 5.7A).  To determine 
correct orientation of the construct, restriction digest using BglII was performed, 
identifying a small fragment in correctly orientated overexpression constructs (Figure 
5.7B).  Overexpression constructs were then transformed into wild type and grlJ- 
cells to create grlJ-/+ and WT/grlJ+ cell lines.  Expression of grlJ was then confirmed 
by RT-PCR using a primer located within the deleted region of the gene (Figure 
5.7C).  Finally, fluorescence microscopy was used to confirm protein localisation on 
the membrane as previously described (Prabhu et al., 2007b) (5.7D, E).   
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Figure 5.7. Overexpression of grlJ in wild type and grlJ
-
 cell lines.  (A) Schematic of an 
overexpression construct created using pDEX_27; using EcoRI restriction sites to insert grlJ.  Both 
pDEX_27 and grlJ contained a BglII restriction site, which was used to determine correct orientation 
of the grlJ insert.  (B) Restriction digests using BglII on candidate grlJ
-/+
 constructs identified 
constructs containing either no insert (NI), large inserts with the incorrect orientation (IO) and small 
inserts containing inserts with correct orientation (CO).  Correctly orientated constructs were used for 
transformation into grlJ
-
 cells which produced the grlJ
-/+
 cell line.  (C) RT-PCR showing grlJ gene 
expression in both WT and grlJ
-/+
 but not grlJ
-
 cell lines.  Control bands represent constitutively active 
gene, IG7.  (D) grlJ
-/+
 cells showed membrane bound GFP fluorescence when compared to WT cells 
containing an empty GFP vector.  (E) Quantification of membrane fluorescence showed significantly 
less (P<0.0001) fluorescence was observed in the cytosol in grlJ
-/+
 cells using a Mann-Whitney test 
based upon quantification of 10 cells.   
5.3.1. Analysis cell behaviour in grlJ-/+ cells  
 To test that the phenotypes observed in the grlJ- cell line was due to gene 
loss, the grlJ-/+ cell line was analysed for spore shape and cell behaviour.  In the 
analysis of spore shape, wild type spores were identified to have a mean aspect of 
1.9±0.02, grlJ- showed a mean aspect of 2.0±0.03, and grlJ-/+ cells had a mean 
aspect of 1.9±0.03. A 1-way analysis of variance, identified a significant difference 
(P<0.05) between wild type and grlJ- as well as grlJ- and grlJ-/+ strains (Figure 5.8).  
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This data indicated the normal spore shape observed in wild type cells that was 
altered in grlJ- cells, was restored upon recapitulation of the grlJ gene in grlJ-/+ cell 
lines. 
  To determine whether resistance to phenylthiourea in random cell movement 
shown in the grlJ- mutant was reversed by recapitulation of grlJ, grlJ-/+ cells were 
exposed to phenylthiourea (3mM) cells as described previously.  Addition of 
phenylthiourea resulted an inhibition in grlJ-/+ cell behaviour where no significant 
changes in displacement, from 12.0±2.8µm at 288 seconds to 22.3±3.6µm at 900 
seconds.  In addition, grlJ-/+ cells showed significant changes in circularity, from 
0.72±0.002 to 0.81±0.001 (P=0.0198), protrusion formation, from 3.21±0.1 to 
4.7±0.02 (P=0.0139) but not motility, from 4.3±0.5nm/sec to 0.04±0.01nm/sec.  
Further statistical analysis using a one-way analysis of variance identified a 
significant difference in displacement between wild type and grlJ- (P<0.05), as well 
as grlJ- and grlJ-/+ (P<0.01); protrusion formation between WT and grlJ- (P<0.01) as 
well as grlJ- and grlJ-/+ (P<0.01) cell lines; and motility between WT and grlJ- 
(P<0.05) as well as grlJ- and grlJ-/+ (P<0.05)  (Figure 5.8).  These results indicate the 
wild type phenotypic response to phenylthiourea (3mM) in random cell movement 
lost in the grlJ- mutant, was restored in grlJ-/+ cells, thus confirming a role for GrlJ in 
the involvement of phenylthiourea detection in Dictyostelium. 
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Figure 5.8. Confirmation of grlJ
-/+
 phenotypes.  (A) Spores from wild type, grlJ
-
 and grlJ
-/+
 were 
isolated and imaged using phase contrast microscopy.  Spore aspect was determined and a 1-way 
ANOVA revealing a significant difference spore shape between wild type and grlJ
-
 (P<0.05) as well as 
grlJ
-
 and grlJ
-/+
 (P<0.05) cell lines.  During random cell movement, 3mM phenylthiourea was added to 
cells after 288 seconds and changes in cell behaviour monitored. A one-way ANOVA with subsequent 
post-hoc Tukey’s test was performed for (B) Displacement. A significant difference was observed at 
the final cumulative time point of the assay between WT and grlJ
-
 (P<0.05) as well as grlJ
-
 and grlJ
-/+
 
(P<0.01) cell lines.  (C) Circularity.  A significant difference was observed between wild type and grlJ
-
 
cell circularity (P<0.05) during the final 612-900 seconds. (D) Number of Protrusions within a 10 frame 
window.  Significantly fewer protrusions were produced in wild type and grlJ
-/+
 cells compared to grlJ
-
 
cells during the final 612-900 seconds.  (E) Motility.  A significant difference was identified showing 
WT and grlJ
-/+
 cells to be (P<0.05) less active than grlJ
-
 cells during the final 612-900 seconds. In all 
measurements, no significant difference was observed between WT, grlJ
-
 and grlJ
-/+
 cells under 
control conditions (0-288 seconds). Measurements were derived from 30 cells measured from a 
minimum of triplicate experiments.  Vertical bars represent the standard error of the mean, n/s not 
significant, *p < 0.05, **p < 0.01. 
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5.4. Discussion 
 As previously described (Chapter 4), a REMI mutagenesis screen identified a 
G-protein coupled receptor-like protein, GrlJ, to be involved in the detection of the 
bitter tastant, phenylthiourea.  In order to test the partial resistant nature of the grlJ- 
REMI mutant was mutant specific, grlJ was ablated in wild type cells of an Ax2 cells 
background (Figure 5.1, 5.2).  To test previously identified malformations in spore 
shape produced by grlJ- cells (Prabhu et al., 2007b), wild type and grlJ- cells were 
developed over twenty four hours and spores compared, identifying a significant 
difference in spore shape between the two cell lines (Figure 5.3).  grlJ- cells were 
then assessed for their response to phenylthiourea on cell growth in shaking 
suspension (Figure 5.4), growth on bacteria (Figure 5.5) and in random cell 
movement (Figure 5.6), where significant differences were observed in all assays 
between wild type and grlJ- cells.  To test the effects observed in the mutant cell line 
were due to gene ablation, grlJ, linked to a GFP from a highly active promoter was 
overexpressed  in grlJ- cells, forming grlJ-/+, which showed previously reported 
membrane fluorescence (Prabhu et al., 2007b) (Figure 5.7).  Re-introduction of GrlJ 
restored sensitivity to phenylthiourea in random cell movement assays, thus 
confirming the partial resistance observed in grlJ- cells was due to gene ablation 
(Figure 5.8). 
5.4.1. Assessment of grlJ- phenotypes 
 Previous research has identified grlJ- strains as showing aberrant spore 
shape in comparison to wild type cells (Prabhu et al., 2007b).  To assess this 
phenotype in wild type cell lines, spore shape was analysed, where grlJ- cells 
showed significantly increased variation in spore aspect ratio in comparison to wild 
type spores (Figure 5.3).  Expression of grlJ occurs throughout Dictyostelium 
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development, however it is elevated after aggregation (Prabhu et al., 2007b).  Since 
grlJ may be a negative regulator of Dictyostelium development (Prabhu et al., 
2007b), ablation of grlJ may have affected fruiting body maturation, leading to the 
production of malformed spores.   
 To assess grlJ- response to phenylthiourea during prolonged exposure, cells 
were used in proliferation assays described previously in this thesis (Chapter 4).  
grlJ- cells have been reported to show a higher proliferation rate in comparison to 
wild type cells (Prabhu et al., 2007b), which was not consistent with data reported 
here (Chapter 4).  These differences in cell growth rate may be due to specific 
differences in the parent strain, which can result in different phenotypes in mutants.  
For example, previous research has shown distinct differences in developmental 
morphology upon ablation of the gene, gskA, using two different Dictyostelium parent 
strains (Schilde et al., 2004).  Alternatively, differences in the methodology for 
constructing growth curves may also have resulted in different growth rates to those 
reported in this thesis.  
A range of phenylthiourea concentrations up to 10mM were used in cell 
proliferation assays using both wild type grlJ- cells, where the mutant cell line 
showed partial resistance to the tastant (Figure 5.4).  grlJ- cells also showed 
resistance to phenylthiourea in growth on bacterial lawns in comparison to wild type 
cells (Figure 5.5).  In comparison to growth in shaking suspension, phenylthiourea 
showed a much stronger effect in growth on bacterial lawns, which may be related to 
differences between macropinocytosis and phagocytosis.  Previous research has 
shown grlJ to be transcribed during bacterial growth, which has led to suggestions 
that the receptor may play a role in actin reshaping during phagocytosis (Sillo et al., 
2008).  In addition, the related protein, GrlB, has also been shown to be involved in 
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bacterial phagocytosis (Wu and Janetopoulos, 2013).  If GrlJ was also involved in 
phagocytosis, a significant difference in cell survival rate between wild type and grlJ- 
strains could therefore be related inhibition of phagocytosis, which would inhibit the 
ability for Dictyostelium to consume bacteria.   
Despite random cell movement in wild type and grlJ- cell lines being reduced 
upon addition of phenylthiourea, grlJ- cells showed partial resistance in comparison 
to wild type cells (Figure 5.6).   Cell growth and movement is also inhibited by 
compounds such as naringenin (Misty et al., 2006), and epigallocatechin gallate (a 
green tea catechin) (McQuade et al., 2013), both of which induce cell rounding, 
showing a similar effect to that produced by phenylthiourea in Dictyostelium.  Since 
deactivation of G-protein coupled receptors, using gβ- cells, results in impaired 
phagocytosis and cell movement due to disruption of F-actin remodelling (Peracino 
et al., 1998), compounds such as phenylthiourea may be acting through G-protein 
coupled receptors.  This is supported by GrlJ being a seven-transmembrane 
spanning protein, likely to be a G-protein coupled receptor (Prabhu and Eichinger, 
2006).  GrlJ and its role as a G-protein coupled receptor will be analysed in the next 
chapter.  
5.4.2. Complementation of grlJ- cells with grlJ 
 To date, few Grl-family proteins have been characterised.  Of those that have,  
GrlA (Prabhu et al., 2007a), GrlB (Wu and Janetopoulos, 2013), GrlE (Anjard and 
Loomis, 2006) and GrlJ (Prabhu et al., 2007b) all show protein localisation at the cell 
cortex.  Complementation of the grlJ- cell line with grlJ tagged with GFP also 
suggested protein localisation at the cell cortex (Figure 5.7). Overexpression of grlJ 
restored the wild type phenotypic responses to spore shape previously identified 
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(Figure 5.8).  In addition, grlJ-/+ also restored the wild type response to 
phenylthiourea during random cell movement (Figure 5.8).  Together, this data 
therefore confirms a function for GrlJ in the detection of phenylthiourea.  
5.5. Summary 
 Identification of a REMI mutant, grlJ-, showed partial resistance to 
phenylthiourea during motility in comparison to wild type cells.  To test the role for 
GrlJ in phenylthiourea detection, the gene was successfully ablated, creating a new 
isogenic cell line, grlJ-.  Using grlJ- cells, a previously reported phenotype of 
malformed spores in comparison to wild type cells was confirmed (Prabhu et al., 
2007b).  In determining the response of grlJ- to phenylthiourea, the mutant showed 
partial resistance to cell proliferation in shaking suspension, growth on bacterial 
lawns and random cell movement.  To test these effects were due to gene ablation, 
grlJ, tagged with a C-terminal GFP tag, was overexpressed in grlJ- cells, creating the 
strain, grlJ-/+.  Recapitulation of the grlJ gene restored GrlJ function, resulting in 
normal spore shape as well as restoring sensitivity to phenylthiourea in random cell 
movement.  A mechanism of action for GrlJ-mediated phenylthiourea detection will 
be explored in the following chapter.  
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Chapter 6 
Identification of signalling mechanisms involved 
in GrlJ activation 
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 Phenylthiourea is a bitter tastant, shown to activate the TAS2R38 receptor in 
humans (Bufe et al., 2005).  Five different single nucleotide polymorphisms within 
the TAS2R38 gene give rise to three different phenotypic responses in humans, 
super-taster, taster and non-taster, where supertasters perceive phenylthiourea as 
extremely bitter and non-tasters cannot taste phenylthiourea (Bufe et al., 2005). 
Previous research has shown these polymorphisms do not fully explain the variability 
in phenylthiourea taste-perception, leading to suggestions that other unidentified 
receptors may be involved in detection of the tastant (Hayes et al., 2008).  
Previous chapters in this thesis describe the identification of a GABAB-like 
receptor, GrlJ, shown to play a role in phenylthiourea detection in Dictyostelium.   
Generation of the grlJ- strain in wild type Ax2 background showed partial resistance 
to phenylthiourea in both growth (in shaking suspension and on bacterial lawns) and 
cell movement.  Complementation of the mutant with the wild-type grlJ gene (to 
create a grlJ-/+ strain) restored wild-type sensitivity to phenylthiourea (3mM).  
Addition of the tastant to chemotactically competent cells undergoing random cell 
movement resulted in significant reductions in displacement, protrusion formation 
and motility, in addition to inducing cell rounding (Chapter 5).  These data therefore 
suggest the identification of a putative G-protein coupled receptor involved in 
phenylthiourea detection in Dictyostelium.   
In the chapter described here, the role of a protein that is poorly characterised in 
function, GrlJ, is analysed as a potential receptor involved in phenylthiourea 
detection.  To date, nothing is known about the molecular signalling that occurs upon 
GrlJ activation in Dictyostelium, and therefore, potential downstream targets will be 
explored.   
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6.1. Cell Stress 
 Previous studies have shown hyperosmotic stress results in rapid actin 
reorganisation resulting in cell rounding in Dictyostelium (Aizawa et al., 1999), a 
response previously shown to occur in the presence of bitter tastants (Chapter 3).  
Hyperosmotic stress is shown to cause upregulation of three genes, yakA, gapA and 
rtoA after a 30 minute incubation (Pakes et al., 2011).  To identify whether 
phenylthiourea induced stress in Dictyostelium cells, chemotactically-competent wild-
type cells were incubated for 30 minutes in phenylthiourea (3mM) or the 
hyperosmotic stressor sorbitol (200mM).  Dictyostelium cells were then lysed before 
extraction of RNA, which was then purified and analysed by RT-PCR for expression 
of yakA, gapA and rtoA.  Semi-quantitative analysis for changes in gene expression 
and a repeated-measures two-way ANOVA identified a significant (P<0.01) 72±27% 
increase in rtoA expression during sorbitol incubation in comparison to control 
conditions (Figure 6.1).  No significant changes in gene expression were observed 
in yakA or gapA in the presence of sorbitol or phenylthiourea.  Together, these data 
suggest sorbitol but not phenylthiourea caused increased rtoA expression following 
thirty minute incubation in wild type cells.  
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Figure 6.1. Expression of wild-type Dictyostelium stress-related genes upon incubation with 
sorbitol (200mM) or phenylthiourea (3mM).  Gene expression of yakA, gapA and rtoA was 
monitored by RT-PCR, following 30 minute exposure to sorbitol (200mM) or phenylthiourea (3mM).  A 
repeated measures 2-way ANOVA identified a significant difference between gene expression and 
compound treatments (P<0.001), where a post-hoc Bonferroni tests showed a significant (P<0.01) 
increase in rtoA expression in response to sorbitol incubation.  Results of quadruplicate experiments 
are shown as a percentage gene expression compared to control conditions (100%) where cells were 
incubated in phosphate buffer.  Constitutively expressed IG-7 was used as an expression control for 
normalisation of gene expression levels.  Vertical bars represent standard error of the mean, ** = 
P<0.01. 
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6.2. G-protein coupled receptor signaling in phenylthiourea 
detection 
 Dictyostelium contains a single β-subunit, gβ, that couples to all heterotrimeric 
G-protein coupled receptors, which upon ablation deactivates all G-protein coupled 
receptor -mediated signalling (Lilly et al., 1993).  To investigate the role of GrlJ 
responding to phenylthiourea in a G-protein coupled receptor-mediated manner, 
chemotactically-competent gβ- cells were used in random cell movement assays as 
previously described (Chapter 5).  Application of phenylthiourea (3mM) to gβ- cells 
during random cell movement resulted in a significant increase in displacement 
(P=0.0465), from 13.1±2.0µm to 71.0±24.7µm from 288 seconds to 900 seconds.  
Furthermore no changes in cell behaviour, defined by circularity, protrusion formation 
and motility when comparing the first and final 288 seconds of the assay were 
observed.  Direct comparison of cell behaviour between gβ-  and wild type cells 
identified significant differences in displacement (P=0.0417), circularity (P=0.0066), 
protrusion formation (P=0.0220) and motility (P=0.0029) during the final 288 seconds 
of the assay (Figure 6.2).  This evidence supports a role for GrlJ as a G-protein 
coupled receptor activated in response to phenylthiourea detection.   
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Figure 6.2. Dictyostelium WT and gβ
-
 random cell movement following exposure to 
phenylthiourea (3mM) after 288 seconds.  Random movement of Dictyostelium cells was monitored 
under control conditions for 288 seconds before the addition of phenylthiourea (3mM final 
concentration), and cell behaviour was monitored for the remaining 612 seconds of the assay. (A) 
Displacement.  A significant difference in displacement at the final time point was observed between 
WT and gβ
-
 cells (P=0.0417).  (B) Circularity.  WT cells showed significantly (P=0.0066) increased 
circularity compared to gβ
- 
cells during the final 612-900 seconds. (C) Number of protrusions within a 
10 frame window.  Significantly fewer protrusions were formed in WT cells than gβ
- 
cells during the 
final 612-900 seconds (P=0.0220).  (D) Motility.  WT cells were found to be significantly less active 
than gβ
-
 cells during the final 612-900 seconds (P=0.0029). (E)  Data quantification showing mean 
measurements taken during the final 612-900 seconds of the assay for displacement, circularity, 
number of protrusions and motility.  In all measurements, no significant difference was observed 
between WT and gβ
-
 cells under control conditions (0-288 seconds). Measurements were derived 
from an average of 30 cells measured from triplicate experiments.  Statistical analysis was performed 
using unpaired two-tailed Student t-tests.  Vertical bars represent the standard error of the mean, *p < 
0.05, **p < 0.01, ***p < 0.001. 
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6.3. Involvement of the PI3K pathway in phenylthiourea detection 
  Resistance of gβ- cells to phenylthiourea strongly supports a role for GrlJ in 
G-protein coupled receptor-mediated inhibition of cell movement.  In Dictyostelium, 
G-protein coupled receptor activation causes dissociation of heterotrimeric G-
proteins, resulting in multiple downstream signalling pathways, including cell polarity 
(Manahan et al., 2004).  One of the key amplification pathways involved in the 
generation of Dictyostelium cell polarity is the PI3K pathway, responsible for the 
production of phosphatidylinositols (Jin et al., 2009).  Since phenylthiourea is shown 
to block Dictyostelium motility and random cell movement through G-protein coupled 
receptors signalling in chemotactically competent cells, the PI3K pathway was 
investigated.   
To investigate a possible role for the PI3K pathway in phenylthiourea 
detection, a  PI3K-/PTEN- cell line that lacks all five type 1 PI3-kinases as well as the 
phosphatase and tensin homologue (PTEN) (Hoeller and Kay, 2007) was used.  
Application of phenylthiourea (3mM) to PI3K-/PTEN- cells during random cell 
movement resulted in a significant increase in displacement (P=0.0053), from 
5.7±0.89µm to 39.2±7.0µm from 288 seconds to 900 seconds.  In addition, cell 
behaviour, as defined by circularity, protrusion formation and motility when 
comparing the first and final 288 seconds of the assay was not affected.  
Furthermore, direct comparison of cell behaviour between PI3K-/PTEN- and wild type 
cells identified significant differences in circularity (P=0.0374), protrusion formation 
(P=0.0009) and motility (P=0.0004) during the final 288 seconds of the assay 
(Figure 6.2).  This evidence supports a role for GrlJ as a G-protein coupled receptor 
activated in response to phenylthiourea detection, which results in the inhibition of 
the PI3K pathway and subsequent loss of cell behaviour. 
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Figure 6.3. Dictyostelium WT and PI3K
-
/PTEN
-
 random cell movement upon exposure to 
phenylthiourea (3mM) after 288 seconds.  Random movement of Dictyostelium cells was monitored 
under control conditions for 288 seconds before the addition of phenylthiourea (3mM final 
concentration), where cell behaviour was monitored for the remaining 612 seconds of the assay. (A) 
Displacement.   No significant difference in displacement at the final time point was observed between 
WT and PI3K
-
/PTEN
-
 cells.  (B) Circularity.  WT cells were found to show significantly increased 
circularity compared to PI3K
-
/PTEN
-
 cells during the final 612-900 seconds (P=0.0374). (C) Number of 
Protrusions within a 10 frame window.  Significantly fewer protrusions were formed in WT cells than 
PI3K
-
/PTEN
-
 cells during the final 612-900 seconds (P=0.0009).  (D) Motility.  WT cells were found to 
be significantly less active than PI3K
-
/PTEN
-
 cells during the final 612-900 seconds (P=0.0004) . (E)  
Data quantification showing mean measurements taken during the final 612-900 seconds of the assay 
for displacement, circularity, number of protrusions and motility.  In all measurements, no significant 
difference was observed between WT and PI3K
-
/PTEN
-
 cells under control conditions (0-288 
seconds). Measurements were derived from an average of 30 cells measured from triplicate 
experiments.  Statistical analysis was performed using unpaired two-tailed Student t-tests.  Vertical 
bars represent the standard error of the mean, *p < 0.05, **p < 0.01, n/s not significant. 
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 To monitor dynamic cAMP-induced changes in PIP3 production following 
exposure to phenylthiourea, Dictyostelium wild type and grlJ- cells were 
electroporated with PHCRACGFP (Dormann et al., 2002), a molecular target for PIP3 
binding, composed of GFP fused to the PH domain of cytosolic activator of adenylyl 
cyclase (CRAC).  Electroporated cells were then placed under G418 selection and 
surviving cells screened for GFP localisation using fluorescence microscopy, 
creating the strains WT/PHcracGFP and grlJ
-/PHcracGFP. 
 Chemotactically-competent WT/PHCRACGFP and grlJ
-/PHCRACGFP cells were 
then incubated in control phosphate buffer alone or supplemented with 
phenylthiourea (3mM) for ten minutes in glass-bottomed chambers.  Cells were 
visualised by fluorescence microscopy under control conditions for 30 seconds 
before addition of cAMP (1µM final concentration).  This global cAMP stimulation 
caused a temporary increase in fluorescence at the membrane, providing a 
quantifiable real-time readout for the transient production of PIP3 at the cell 
membrane.  Approximately ten seconds following the addition of cAMP, significant 
increases in membrane fluorescence were identified in WT/PHCRACGFP, from 
1.15±0.06 to 1.46±0.09 (P=0.0017) and grlJ-/PHCRACGFP  from 1.17±0.08 to 
1.31±0.08 (P=0.0016) (Figure 6.4).  Pre-treatment with phenylthiourea (3mM) 
blocked the transient increase in membrane fluorescence observed in 
WT/PHCRACGFP cells, but not in grlJ
-/PHCRACGFP cells, where a significant 
(P=0.0012) increase was identified, from 1.01±0.05 to 1.18±0.04 approximately ten 
seconds following addition of cAMP (Figure 6.4).  This data identified phenylthiourea 
detection by GrlJ causes inhibition of CRAC translocation to the cell membrane 
during global stimulation with cAMP. 
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Figure 6.4.  PHCRAC membrane fluorescence during global cAMP stimulation in wild type and 
grlJ
-
 cells following incubation in phosphate buffer or phenylthiourea (3mM).  WT/PHCRACGFP 
and grlJ
-
/PHCRACGFP were stimulated with 1µM cAMP after an initial 30 second control period.  (A) 
Relative WT/PHCRACGFP fluorescence of cells during control conditions and after 10 minute 
incubation with phenylthiourea (3mM).  WT cells showed a significant (P=0.0017) increase in 
membrane fluorescence upon cAMP stimulation under control conditions after approximately 10 
seconds.  Upon pre-treatment with 3mM phenylthiourea, cells showed no significant changes in 
membrane fluorescence after cAMP stimulation, where membrane fluorescence had been inhibited.  
(B) grlJ
-
/PHCRACGFP cells showed significant (P=0.0016 and P=0.0012) increases in membrane 
fluorescence upon cAMP stimulation for both control and phenylthiourea conditions respectively.  
Figures are representative of 5 independent experiments measuring a minimum total of ten cells.  2-
tailed Student t-tests were used for statistical comparisons.  Error bars represent standard error of the 
mean (SEM). ** P<0.01. 
 To test PIP3 production was inhibited by GrlJ-mediated phenylthiourea 
detection, phospholipids were extracted from cells during global stimulation and 
quantified using mass ELISA.  Chemotactically-competent wild-type, grlJ- and grlJ-/+ 
cells were incubated in control medium or phenylthiourea (3mM) for ten minutes 
before the cells were incubated in trichloroacetic acid at 0, 5 and 20 seconds after 
global stimulation with cAMP (1µM).  Lipids were then extracted and PIP3 levels 
quantified.  Under control conditions, PIP3 production rose from 4.8±3.9pmol to 
13.8±1.2pmol after 5 seconds post-cAMP stimulation in wild type cells.  In addition, 
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PIP3 production rose from 2.1±0.05pmol to 10.3±3.4pmol after 5 seconds post-cAMP 
stimulation in grlJ- cells and from 2.7±1.3pmol to 11.0±4.5pmol in grlJ-/+ cells.  A two-
way ANOVA identified significant increases in PIP3 production 5 seconds post-cAMP 
addition in wild type (P<0.05), grlJ- (P<0.05) and grlJ-/+ (P<0.05) (Figure 6.5A).  Ten 
minutes pre-incubation with phenylthiourea (3mM) blocked PIP3 production in wild 
type and grlJ-/+ cells but not grlJ- cells, where PIP3 levels rose from 1.3±0.4pmol to 
6.6±2.6pmol 5 seconds post-cAMP stimulation.  Subsequent statistical analysis 
identified a significant increase in PIP3 production 5 seconds post-cAMP addition in 
grlJ- cells (P<0.01) only (Figure 6.5B).  This evidence further supports a role for 
phenylthiourea causing inhibition of the PI3K pathway upon detection by GrlJ. 
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Figure 6.5. PIP3 production during global stimulation with cAMP in wild type, grlJ
-
 and grlJ
-/+
 
cells following ten minute incubation with phosphate buffer or phenylthiourea (3mM).  Mass 
ELISA was used to quantify PIP3 production 0, 5 and 20 seconds post stimulation with 1µM cAMP.  
(A) Under control conditions, significant changes (P=0.0003) in PIP3 production at each time point 
was observed, where a post-hoc Bonferroni test identified a significant increase in PIP3 production at 
5 seconds following global stimulation in wild type (P<0.05), grlJ
-
 (P<0.05) and grlJ
-/+
 (P<0.05) cells.  
(B) Incubation with phenylthiourea (3mM).  Significant changes (P=0.0202) in PIP3 production at each 
time points was observed, where a post-hoc Bonferroni test identified a significant increase in PIP3 
production at 5 seconds following global stimulation in grlJ
-
 (P<0.05) but not wild-type or grlJ
-/+
 cell 
lines.  Figures are representative of triplicate experiments using a 2-way ANOVA for statistical 
comparisons.  Error bars represent standard error of the mean (SEM). * P<0.05 ** P<0.01. 
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6.4. Discussion 
 Generation of the Dictyostelium grlJ- and grlJ-/+ mutants in the Ax2 
background strain, used previously to screen for responses to emetic and aversive 
compounds (Chapter 3), enabled a comparison of phenylthiourea detection between 
these cell lines.  GrlJ was previously shown to be partially responsible for a reduction 
in Dictyostelium growth and cell movement in the presence of phenylthiourea 
(Chapter 5).  To establish the molecular mechanism of the GrlJ-mediated response 
to phenylthiourea, responses to cell stress (Figure 6.1), through G-protein coupled 
receptor involvement (Figure 6.2) and the PI3K pathway (Figure 6.3, 6.4, 6.5) were 
explored.  These experiments confirmed that phenylthiourea detection occurs 
through G-protein coupled receptor involvement and identified inhibition of the PI3K 
pathway to be involved in cell behavioural responses to phenylthiourea. 
6.4.1. Cell Stress 
 Hyperosmotic stress results in cell rounding and a subsequent loss of cell 
shape in Dictyostelium (Aizawa et al., 1999).  Exposure of wild type cells to 
hyperosmotic stress conditions using sorbitol (0.2mM) caused significant 
upregulation of rtoA but not yakA or gapA, which had previously also shown 
increased expression under these conditions (Pakes et al., 2011) (Figure 6.1).  
Conflicting evidence has also suggested that YakA does not play a role in the 
response to osmotic shock (Taminato et al., 2002), which is supported by the results 
of the cell stress experiments in this chapter.   
 Osmotic stress initiates the activation of STATc signalling in Dictyostelium, 
which subsequently affects regulation of gapA and rtoA (Na et al., 2007; Kawata, 
2011).  STATc activation is regulated by intracellular cyclic guanosine 
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monophosphate and calcium levels (Araki et al., 2010).  Although currently unknown, 
it is likely detection of hyperosmotic stress is mediated by G-protein coupled receptor 
activation, due to activation of the monomeric G-protein, Rap1 (Kang et al., 2002).  
Initiation of osmotic stress in Dictyostelium increases actin phosphorylation and 
produces major cytoskeletal changes (Zischka et al., 1999), resulting in increased 
cell rounding (Rivero et al., 1996), which is consistent with the acute cellular 
response to phenylthiourea observed.   
Since expression of yakA, gapA or rtoA was unaffected by phenylthiourea, it 
is likely the tastant does not block Dictyostelium behaviour by the induction of 
osmotic stress or via increased STATc activity.  In addition, osmotically-stressed 
cells also maintain their ability to migrate towards cAMP, albeit at a reduced rate 
(Kuwayama and van Haastert, 1998; Rivero et al., 1996), which is inconsistent with 
the phenylthiourea-mediated block in Dictyostelium behaviour previously shown in 
Dunn chamber motility (Robery et al., 2011).  Together, this evidence demonstrates 
that hyperosmotic stress or its components in signalling are unlikely to be involved in 
the phenylthiourea-mediated inhibition of cell behaviour in Dictyostelium. 
6.4.2. G-protein coupled receptor signalling in phenylthiourea 
detection  
Cell rounding in Dictyostelium can be mediated by both G-protein coupled 
receptor dependent and independent targets.  For example, the membrane 
permeable compound, latrunculin, commonly used in Dictyostelium, induces cell 
rounding by inhibition of actin polymerisation and the destabilisation of existing 
filaments (Langridge and Kay, 2007; Xu et al., 2007).  Conversely, G-protein coupled 
receptor binding compounds such as derivatives of cAMP (van Haastert et al., 1982) 
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or high concentrations of cAMP can also initiate cell rounding (Langridge and Kay, 
2006; Varnum and Soll, 1984).  To test a role for GrlJ as a G-protein coupled 
receptor involved in phenylthiourea detection, random cell movement assays were 
performed using the gβ- mutant.  Dictyostelium contains a single Gβ subunit (Lilly et 
al., 1993), which is essential for all G-protein coupled receptor mediated signalling.  
gβ- cells showed no change in behaviour in random movement upon exposure to 
phenylthiourea (3mM), whereas significant differences in all movement parameters 
were observed for wild-type cells (Figure 6.2).  This data suggested that 
phenylthiourea detection was occurring through heterotrimeric G-proteins, which 
further supports a role for the through G-protein coupled receptor involvement GrlJ 
as the receptor responsible.    
 Dictyostelium contains 55 monomeric and heterotrimeric G-protein coupled 
receptors, which includes four cAMP receptors, eight cAMP-like receptors, one 
secretin receptor, seventeen Grl-family receptors and twenty five frizzled receptors 
(Prabhu and Eichinger, 2006). Heterotrimeric G-protein signalling is crucial to the 
developmental cycle in Dictyostelium, since gβ- cells cannot aggregate upon 
starvation (Lilly et al., 1993) due to an inability to amplify external chemical gradients, 
such as in the case of cAMP (Wang et al., 2011).  This is consistent with studies of 
neutrophil chemotaxis, where subunit inhibition results in the disruption of motility 
through effects on PI3K pathway (Lehmann et al., 2008).  In addition, studies have 
shown Dictyostelium cells lacking the Gβ-subunit cannot regulate actin 
polymerisation efficiently (Peracino et al., 1998).  Since the phenylthiourea-mediated 
block in cell behaviour did not occur in cells lacking heterotrimeric G-protein 
assembly, the block in Dictyostelium behaviour is likely to be G-protein coupled 
receptor mediated.  
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Phenylthiourea detection also occurs through G-protein coupled receptor 
activation in mammalian cells (Bufe et al., 2005), resulting in dissociation of Gα-
gustducin from heterotrimeric T2R receptors (Caicedo et al., 2003; Clapp et al., 
2008).  Gα-gustducin dissociation results in phosphodiesterase-mediated reduction 
in intracellular cAMP concentration, which subsequently results in the inhibitory 
regulation of calcium signalling (Clapp et al., 2008).  In Dictyostelium, cAMP 
production is regulated by PKB/Akt and CRAC-mediated activation of adenylyl 
cyclase A (Garcia and Parent, 2008a; Kae et al., 2007; McMains et al., 2008).  
Therefore, the signalling mechanisms responsible for the regulation of intracellular 
cAMP differ between human taste cells and Dictyostelium.  However, inhibition of 
Dictyostelium cell behaviour through G-protein coupled receptor activation could 
result in decreased cAMP levels through inhibition of signalling pathways involved in 
chemotaxis such as PI3K or TORC2 (Kamimura et al., 2008; Charest et al., 2010) 
In human taste cells, regulation of cAMP and subsequent calcium signalling 
by Gα-gustducin may not be crucial to bitter tastant detection since the G-protein is 
not expressed in all taste receptor cells (Caicedo et al., 2003).  The Gα-subunit, 
Gαi2, is also expressed in most bitter taste receptor cells, although its role in bitter 
taste transduction is currently unknown (Caicedo et al., 2003; Ueda et al., 2003; 
Kusakabe et al., 2000).  Dissociation of Gαi2 from CXR4 receptors in leukocytes 
results in PI3K activity and subsequently initiates chemotactic behaviour in 
leukocytes (Ngai et al., 2009).  Therefore, dissociation of Gαi2 in taste cells upon 
bitter tastant detection may regulate PI3K activity.  Since Dictyostelium and 
leukocytes share many common signalling pathways (Jin et al., 2009), G-protein 
dissociation upon G-protein coupled receptor-mediated detection of bitter tastants 
may inhibit PI3K activity.     
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T2R receptor activation also results in the dissociation of Gβ3 and Gɣ13 
subunits in mammalian taste cells, which activate phospholipase C to degrade PIP2 
into diacylglycerol and inositol triphosphate (Rossler et al., 2000; Rossler et al., 
1998).  In Dictyostelium, PIP2 formation, regulated by PTEN, also activates 
phospholipase C to produce diacylglycerol and inositol triphosphate (Kortholt et al., 
2007).  Phospholipase C activation is shown to regulate PIP3 mediated chemotaxis 
(Kortholt et al., 2007; Suire et al., 2012), disruption of which by phenylthiourea, could 
therefore interfere with the maintenance of cell polarity and correctly orientated 
migration.   
In chemotactically-competent Dictyostelium cells, G-protein coupled receptor-
mediated migration is driven through four key signalling pathways, which include the 
PI3K (Huang et al., 2003), phospholipase A2 (although a receptor responsible is yet 
to be discovered) (Chen et al., 2007), soluble guanylyl cyclase (Veltman et al., 2008) 
and TORC2 complex (Kamimura et al., 2008).  This research has identified 
phenylthiourea-mediated GrlJ activation alone to be responsible for inhibiting at least 
one of these key signalling pathways in Dictyostelium since grlJ- cells show partial 
resistance to the bitter tastant.  
6.4.3. Involvement of the PI3K pathway 
 Phosphoinositide signalling is one of the four key signalling mechanisms 
initiated upon cAR activation (Veltman et al., 2008). Cells lacking the ability to 
activate the PI3K pathway, both pharmacologically and upon gene ablation, maintain 
their ability to migrate towards a steep but not shallow chemotactic gradients (Hoeller 
and Kay, 2007; Loovers et al., 2006).  In shallow gradients and in random cell 
movement, cells lacking the ability to generate PIP3 gradients are rounded and form 
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unstable protrusions (Loovers et al., 2006; Hoeller and Kay, 2007).  The PI3K 
pathway is therefore critical in migration during shallow chemotactic gradients, 
playing a comprehensive role in the general control of basic cell motility (King and 
Insall, 2009; van Haastert et al., 2007a).  During random cell movement, the PI3K 
pathway is thought to negatively regulate the formation of pseudopods and control 
stochastic changes in the actin cytoskeleton in a process independent of G-protein 
signalling (Sasaki et al., 2007).  PI3K activity therefore occurs both dependent and 
independent of G-protein coupled receptor activation, where inhibition during random 
cell movement or chemotaxis in a shallow gradient could have detrimental effects on 
cell behaviour.   
To determine whether the PI3K pathway was involved in phenylthiourea-
mediated inhibition of cell movement, a mutant lacking all PI3K activity, PI31-
5K/PTEN- was used in random cell movement assays.  Addition of phenylthiourea 
showed that the PI31-5K/PTEN- mutant is partially resistant to the block in 
Dictyostelium behaviour observed in wild-type cells (Figure 6.3).  Inhibition of 
signalling through the PI3K pathway results in the loss of spatial and temporal 
control in Dictyostelium chemotaxis (Huang et al., 2003).  This effect is shown 
throughout this thesis in both random cell movement and chemotaxis in a steep 
gradient of cAMP, where phenylthiourea causes cells to round up and stop moving 
(Chapters 3-5).  Since Dictyostelium behaviour was inhibited under both of these 
conditions, signalling mechanisms other than the PI3K pathway are likely also to be 
inhibited upon phenylthiourea detection. 
To examine a role for PI3K-dependent signalling through GrlJ in 
phenylthiourea detection, the transient stimulation of PIP3 was assessed.  In these 
experiments, wild-type and grlJ- cells expressing PHCRACGFP were incubated with 
192 
 
latrunculin in a control buffer or phenylthiourea (3mM) before global stimulation with 
cAMP.  Treatment of cells with latrunculin results in a loss of cell polarity and 
disruption of the actin cytoskeleton, resulting in PIP3 accumulation across the whole 
cell membrane upon global stimulation (Janetopoulos et al., 2004).  Under control 
conditions, using latrunculin-treated cells, global stimulation resulted in a surge in 
PHCRACGFP fluorescence at the cell membrane in both wild-type and grlJ
- cells, 
which is consistent with previous findings (Huang et al., 2003; Xu et al., 2007) 
(Figure 6.4).  PHCRACGFP is a marker for PIP3 synthesis since the phosphoinositide 
binds to the pleckstrin homology domain within CRAC (Dormann et al., 2002). Under 
physiological conditions (in the absence of latrunculin), PIP3 also enables the 
recruitment of myosin-I to the cell membrane, where it induces actin polymerisation 
and subsequent formation of pseudopods in the direction of the cAMP gradient 
(Chen and Iijima, 2012).    
Upon global stimulation of transformed cells (with PHCRACGFP) pre-incubated 
with phenylthiourea (3mM), only grlJ- cells showed translocation of fluorescence to 
the membrane, where polarisation in wild type cells was inhibited (Figure 6.4).  This 
evidence identified GrlJ as a receptor that blocks the translocation of CRAC to the 
cell membrane.  To test the GrlJ-mediated detection of phenylthiourea resulted in 
inhibition of PIP3 and not CRAC, quantification of the phosphoinositide by mass 
ELISA identified a block in PIP3 production in wild type and grlJ
-/+ but not grlJ- cells 
upon global stimulation (Figure 6.5).  These data together therefore indicated 
detection of phenylthiourea through GrlJ caused a block in PIP3 production.  
Synthesis of PIP3 can be blocked by a number of mechanisms, such as increased 
PTEN activity for example, which is shown to act as a negative regulator of cell 
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polarity, by converting PIP3 back into PIP2 (Iijima et al., 2004; Huang et al., 2003; 
Iijima and Devreotes, 2002).   
PTEN is previously shown to act as a global inhibitor of PIP3 production at the 
cytoplasmic face of the membrane (Gerisch et al., 2012).  Global stimulation with 
cAMP initiates negative fluctuations in PTEN resulting in a subset of the membrane 
lacking PTEN and allowing for the synthesis of PIP3 synthesis, resulting in 
specifically orientated polarisation (Gerisch et al., 2012).  These spatially orientated 
patches of PIP3 subsequently allow for the formation of pseudopods (Asano et al., 
2008; Postma et al., 2004).  Increased PTEN activity could therefore decrease 
spatially orientated patches of PIP3 in addition to enhancing PIP3 degradation at the 
membrane upon global stimulation.  
Another mechanism for a decrease in PIP3 production mediated by GrlJ could 
be a reduction in total phosphoinositides.  Previous research has shown an anti-
epileptic drug, valproic acid, blocks chemotactic migration of Dictyostelium cells 
towards cAMP by reducing the production of phosphoinositides (Xu et al., 2007; 
Chang et al., 2012).  In Dictyostelium, phosphoinositides are constantly recycled, 
where inositol triphosphate (a product of phospholipase C mediated PIP2 
degradation) is converted into inositol and subsequently into phosphatidylinositol 
(PIP), before conversion to PIP2 (Chang et al., 2012).  In addition, de novo synthesis 
of phosphoinositides is also regulated by myo-inositol-3P-synthase (INO1) mediated 
breakdown of glucose-6-phosphate (a product of respiration) into inositol 
monophosphate; as well as propyloligopeptidase, which regulates the conversion of 
higher order inositol phosphates to inositol triphosphate (Chang et al., 2012).  
Although valproic acid is taken into cells by solute carrier proteins (Terbach et al., 
2011), activation of GrlJ by phenylthiourea could provide an inhibitory effect on 
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phosphoinositide levels by inhibiting enzymes involved in recycling or de novo 
synthesis.  Alternatively, as with valproic acid, phosphoinositol levels could also be 
reduced by a mechanism, independent of inositol recycling (Chang et al., 2012). 
In addition to potential targets downstream from G-protein coupled receptor 
signalling, such as increased PTEN activity or decreased phosphoinositol levels, 
GrlJ activation by phenylthiourea may inhibit proteins upstream of PI3K activity.  For 
example, the myosin, MyoG, is required for Dictyostelium polarisation and 
chemotaxis in response to cAMP stimulation (Breshears et al., 2010).  Ablation of 
this protein in Dictyostelium results in rounded cells that are unable to polarise or 
migrate in random movement or chemotactically towards cAMP (Breshears et al., 
2010).  GrlJ activation by phenylthiourea could therefore inhibit MyoG, preventing 
Dictyostelium PI3K activity and causing subsequent inhibition of random cell 
movement and motility. 
GrlJ-mediated inhibition of PI3K signalling by phenylthiourea may also be 
inhibited by monomeric G-protein signalling.  Dictyostelium chemotactic signalling 
occurs primarily as a result of heterotrimeric G-protein dissociation from cAR in 
response to cAMP, leading to the activation of monomeric G-proteins, particularly 
RasC and RasG (Bolourani et al., 2006).  These activated GTPases then target 
activation of a number of signalling cascades, which includes the PI3K pathway 
(Kortholt et al., 2011).  In addition, another RasGTPase, Rap1, is shown to regulate 
PIP3 formation by direct interaction with the PI3K pathway (Kortholt et al., 2010).  
Finally, RasGTPase activation also has a distinct role in basal chemotactic motility, 
which is independent of signal amplification pathways (Kortholt et al., 2011).  Since 
phenylthiourea results in a complete block in Dictyostelium behaviour, GrlJ activation 
could therefore potentially block Ras signalling, which could result in both an 
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inhibition in cell movement as well as inhibition of signal amplification targets such as 
PI3K. 
In Dictyostelium, Ras signalling is regulated by both RasGEFs and RasGAPs, 
which activate and deactivate the monomeric G-protein respectively.  Disruption of 
RasGAP activity, such as Nf1, results in severe chemotactic defects, where cells are 
unable to deactivate GTPase activity (Zhang et al., 2008).  This results in prolonged 
PI3K activity and an inability for surges in PIP3 to be negatively regulated in 
directional sensing (Zhang et al., 2008).  Conversely, disruption of RasGEFs, such 
as RasGEFA and RasGEFR, results in reduced activation of RasC and RasG, 
respectively (Kae et al., 2007).  Disruption of RasC and RasG results in decreased 
PI3K activity, inhibiting adenylyl cyclase and PKB/Akt activity respectively, (Bolourani 
et al., 2006), both of which are involved in the PI3K pathway (Lilly and Devreotes, 
1994; Funamoto et al., 2001; Meili et al., 1999).  Therefore phenylthiourea-mediated 
activation of GrlJ could induce decreased RasGEF or potentially increased RasGAP 
activity, which would result in the disruption of PI3K-mediated signalling, amongst 
other chemotactic signalling pathways.    
Monomeric G-protein activation of Ras may also be inhibited by regulators 
further upstream, such as disruption of guanine exchange factors for heterotrimeric 
Gα-proteins.  For example, previous research has identified disruption of the guanine 
exchange factor, Ric8, responsible for the dissociation of Gα2 in response to 
chemotactic signalling, results in dramatic reductions of motility down shallow cAMP 
gradients (Kataria et al., 2013).  In addition, G-protein coupled receptor-mediated 
activation of Ras and subsequent PI3K signalling is also shown to be regulated by 
phospholipase Cβ2/β3 signalling in neutrophils, inhibition of which could therefore 
also result in reduced PIP3 formation (Suire et al., 2012). 
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In mammals, TAS2R38 activation by phenylthiourea produces a 
phosphodiesterase cascade, resulting in a reduction of intracellular cAMP, as well as 
phospholipase Cβ2-mediated cleavage of PIP2 into IP3 and DAG (Bufe et al., 2005; 
Kinnamon, 2011).  Therefore, whilst phospholipid signalling is central to T2R 
receptor signalling events, the PI3K pathway has not been investigated in bitter taste 
transduction.  Interestingly, previous research has shown binding of odorants, such 
as the bittersweet compound, citral, activates PI3K in mouse and rat olfactory 
receptor neurones (Ukhanov et al., 2013; Ukhanov et al., 2011; Brunert et al., 2010).  
Binding of odorants such as citral to olfactory receptors is believed to cause a 
stabilising effect, which mediates PI3K activity to inhibit downstream cell excitation 
(Ukhanov et al., 2011; Ukhanov et al., 2013).  In Dictyostelium, phenylthiourea 
causes partial inhibition of cell behaviour by inhibiting PI3K activity (Figure 6.3).  
Therefore, whilst olfactory receptor (in mammals) and GrlJ (in Dictyostelium) 
activation causes opposing PI3K activity, both mechanisms mediate an inhibitory 
cellular response.  
Activation of the PI3K pathway is also mediated by the heterotrimeric G-
protein, Gαi2, which is also found in many bitter taste receptor cells (Ngai et al., 
2009; Ueda et al., 2003; Kusakabe et al., 2000; Caicedo et al., 2003).  Since a 
mechanism for signal transduction by the G-protein response to bitter tastants 
remains unknown, compounds such as phenylthiourea may cause Gαi2 activation, 
which may result in an inhibitory regulatory role for cell excitability in taste cells.   
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6.5. Summary 
Ablation of grlJ in Dictyostelium cells resulted in partial resistance to 
phenylthiourea in motility and random cell movement assays, where the wild-type 
response was restored upon gene complementation.  Upon analysis of the molecular 
mechanisms behind GrlJ-mediated detection of phenylthiourea, inhibition in cell 
behaviour was caused by G-protein coupled receptor activation.  Further analysis 
into the signalling pathways downstream from GrlJ activation, identified inhibition of 
the PI3K pathway to be involved in the phenylthiourea mediated block in random cell 
movement and motility.   
Finally, the currently accepted mechanism of action for phenylthiourea 
detection in humans is regarded as insufficient (Hayes et al., 2008), and hence 
alternative pathways and/or receptors may exist.  GrlJ is a GABAB-like protein that 
shares sequence homology with other GABAB receptors, and it possible that this 
similarity may extend beyond structure to potential mechanisms of action for 
phenylthiourea detection.  This hypothesis will be explored in chapter 7. 
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Chapter 7 
Identification of an uncharacterised human 
protein involved in phenylthiourea detection 
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 In mammalian taste receptor cells, bitter taste transduction occurs through 
T2R receptor activation, where cleavage of PIP2 to release inositol triphosphate 
results in calcium release and cell excitation (Kinnamon, 2011).  Phenylthiourea and 
its related compound, propylthiouracil, are unique bitter tastants that activate the 
TAS2R38 receptor only (Bufe et al., 2005).  Sensitivity to TAS2R38 receptor 
agonists in human taste cells varies depending on single nucleotide polymorphisms 
in the TAS2R38 gene, resulting in five different haplotypes and three different taster 
statuses: supertaster, taster and non-taster (Bufe et al., 2005).  Previous research 
has however shown high concentrations of the TAS2R38 agonist, propylthiouracil, 
causes identical bitter sensation in both taster and non-taster status individuals  
(Hayes et al., 2008).  This research has provided convincing evidence that other, yet 
to be identified receptors, must be involved in perception of TAS2R38 agonists such 
as phenylthiourea and propylthiouracil (Hayes et al., 2008; Genick et al., 2011). 
Previous chapters in this thesis describe the inhibition of cell movement in 
Dictyostelium by phenylthiourea involves G-protein coupled receptor-mediated 
signalling, partially through GrlJ.  Phenylthiourea-mediated activation of GrlJ results 
the inhibition of transient PIP3 production upon global stimulation with cAMP in 
chemotactically-competent cells (Chapter 6).   
In this chapter, an uncharacterised human protein was identified by homology 
to GrlJ, and a role for this protein in Dictyostelium phenylthiourea perception was 
examined.   
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7.1. Identification of an uncharacterised human protein 
 To determine whether any other organisms contained a protein related to GrlJ 
and thus may detect phenylthiourea, a database search to identify proteins 
homologous at a protein level (BLAST analysis) was performed using GrlJ.  This 
identified fourteen of the seventeen members of the Grl-family of receptors in 
Dictyostelium and a number of proteins from various multicellular organisms and 
bacteria (Table 7.1).  Interestingly, the first protein belonging to a chordate was an 
uncharacterised human protein, Q8NHA5, sharing weak homology with GrlJ, 
showing 26% identity and 48% similarity, with a BLASTP probability of 2e-20.  To 
investigate the structure of Q8NHA5, the protein sequence was analysed using 
hydrophobicity analysis (Kyte and Doolittle, 1982), which confirmed the protein 
contained a seven transmembrane domain.  This was also confirmed using the Pfam 
27.0 database (Punta et al., 2012). 
 To compare the Dictyostelium GrlJ and the human Q8NHA5 proteins directly, 
protein sequences were aligned using Clustal Omega multiple sequence alignment 
tool (Sievers et al., 2011) (Figure 7.1.).  Based upon these alignments GrlJ and 
Q8NHA5 shared limited amino acid similarity in the N and C terminal regions, 
although some sequence conservation occurred within the transmembrane domains.  
Since all G-protein coupled receptors have seven transmembrane domains, GrlJ 
was also aligned with the unrelated proteins, human TAS2R38 (Appendix 7) and 
Dictyostelium cAR1 receptor (Appendix 8), where substantially less sequence 
homology was observed throughout these regions.  This suggested transmembrane 
sequence homology between Q8NHA5 and GrlJ specifically, rather than a common 
sequence found in all G-protein coupled receptors. 
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Since grlJ encodes a GABAB-like receptor (Prabhu et al., 2007b), the human 
Q8NHA5 protein sequence was compared with other human GABAB receptors, 
where Q8NHA5 shared high sequence homology with GABAB receptor subunit 1 
isoform 1B showing 93% identity and 94% similarity; 1A showing 90% identity and 
91% similarity; and 1C showing 90% identity and 91% similarity.   Subsequent 
alignment of Q8NHA5, GABABR1B, GABABR1C and GABABR1A showed most sequence 
similarity within the transmembrane regions of the protein (Figure 7.2.).  Since GrlJ 
encodes a GABAB-like receptor and Q8NHA5 shared substantial sequence 
homology with GABABR1 isoforms, it is likely that the uncharacterised Q8NHA5 
protein is a GABAB subunit 1 receptor.   
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 BLAST hit/     Amino Acid  BLASTP Identity Similarity 
Protein Name Organism Receptor Length probability (%) (%) 
GRLJ_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  783 0 100 100 
GRLF_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  770 0 60 74 
GRLB_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  755 0 58 74 
GRLA_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  798 0 55 73 
GRLO_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  819 1.00E-164 41 58 
GRLC_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  800 1.00E-102 28 51 
GRLH_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  764 5.00E-99 31 52 
GRLG_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  772 8.00E-97 30 52 
GRLM_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  749 7.00E-92 30 51 
GRLD_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  791 2.00E-90 29 49 
GRLK_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  704 3.00E-87 30 52 
GRLL_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  708 8.00E-70 27 48 
203 
 
GRLN_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  891 2.00E-58 28 47 
C3Y433_BRAFL  Branchiostoma 
floridae  
Putative uncharacterized protein  1104 2.00E-26 26 47 
C3YEC0_BRAFL  Branchiostoma 
floridae  
Putative uncharacterized protein  631 1.00E-22 28 52 
B3RUR6_TRIAD  Trichoplax 
adhaerens  
Putative uncharacterized protein  729 1.00E-21 27 47 
A7RHX2_NEMVE  Nematostella 
vectensis 
Predicted protein (Fragment)  719 2.00E-21 25 50 
Q6FFI9_ACIAD  Acinetobacter 
sp.  
Putative uncharacterized protein  393 4.00E-21 26 46 
B3RTG5_TRIAD  Trichoplax 
adhaerens  
Putative uncharacterized protein  837 7.00E-21 26 46 
GRLE_DICDI  Dictyostelium 
discoideum 
Metabotrophic glutamate receptor B like  816 2.00E-20 23 44 
Q8NHA5_HUMA
N  
Homo sapien Uncharacterized protein  866 3.00E-20 26 48 
Table 7.1. Database search (BLAST analysis) for proteins sharing homology with GrlJ.  A basic local alignment search tool analysis was performed using the 
protein sequence of GrlJ identifying fourteen of seventeen Dictyostelium Grl-family proteins (highlighted by in grey), two uncharacterised Branciostoma floridae 
(lancelet) proteins, two uncharacterised Trichoplax adhaerens (placozoa) proteins, one predicted Nematostella vectensis (sea anemone) protein, one 
uncharacterised Acinetobacter sp.(bacteria) protein and one uncharacterised Homo sapien protein (highlighted in dark grey).  In addition, Dictyostelium GrlJ also 
shared protein sequence homology with ten G-protein coupled receptors belonging to the slime mould Polysphondylium palladium.  Since Dictyostelium and 
Polysphondylium are closely related, these results have been omitted for simplicity. 
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grlJ            ------------------------------------------------MKILLYIAIILS 12 
Q8NHA5          MGPGAPFARVGWPLPLLVVMAAGVAPVWASHSPHLPRPHSRVPPHPSSERRAVYIGALFP 60 
                                                                 :  :**. ::. 
 
grlJ            FFSLITISSECKIAVLLSGSPNDLGYNYLMNEARVKAESELKLDFSIYYENLEESMEEAE 72 
Q8NHA5          MSGGWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDSKVALDMGCDPGQATKYLYE 120 
                : .  . .. *: ** :: .  :   : * :      . : *: :.:  :  : :    * 
 
grlJ            KAFQDALHKG------------ANLIVVGSFVHVGLGLKYAALTKDQDIYWIIRGNKRPN 120 
Q8NHA5          LLYNDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSAT 180 
                  ::*.::              *:   : .:: :. * . .**:: * :  ::* :  .. 
 
grlJ            PDLP------------HVVILNFNSFELHYLLGYFSGLMTKTGIVG------FVAPGPDV 162 
Q8NHA5          LHNPTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPV 240 
                 . *            ::. :: .:  :   *. :.  :.::**        *  *.  * 
 
grlJ            NTISTDNSFYLGAKYARPNITFLNVYVQSWYNPNVSYSAAKMLIKNG----ADLIGMSQD 218 
Q8NHA5          KNLKVYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDEMTEAVEGHITTEIVMLNPA 300 
                :.:.. :.  :* **.   * :      . *:*.:. :. :*         :::: :.   
 
grlJ            DMSCQKAMMDSGLIGIGATGYPTHLLFGGNVGVSYITNWTNLYVKYAQHVLNDDWPDYSS 278 
Q8NHA5          NTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAIWALALALNKTSGGGGRSGV 360 
                :  . . * .. ::   :.    *    *..  : ::  :   :  * :  ...    .  
 
grlJ            YFTNLSREDSIFIDDYSYKVPIDIQNLVNDEIQRLKNTSYIPYRSDPYLAQLGIPFDSKG 338 
Q8NHA5          RLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRMAWTLIEQLQGG----SYKK 416 
                 : ::. ::. : *:    :  .  : *...:    . * :.:     *       . *  
 
grlJ            LLVEDQFRANKKLLKGDSISKVIDFGQYSIPIEFIDYP-NSLKYGVTIVSGVCIFICLVC 397 
Q8NHA5          IGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFISVSVLSSLGIVLAVVC 476 
                :   *. : : .  * *.       .: :: *: : :  :.*  .*:::*.: *.:.:** 
 
grlJ            MTLVVVFKKARVIKSSSPAFLLLILLGCCIIFAACILFAQS-------PTNQTCSARIWL 450 
Q8NHA5          LSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHIGRNQFPFVCQARLWL 536 
                ::: :  .:.* *:.*.* :  *  :**.: :** : :. .           .*.**:** 
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grlJ            LSLGYTLFLGNLLVKNWRIWLLFDNPKLKK---RAITNWKLYPWVFAILAIDVMILAIWQ 507 
Q8NHA5          LGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATVGLLVGMDVLTLAIWQ 596 
                *.**::*  *.::.* * :  :* : : **   :::  ****. *  ::.:**: ***** 
 
grlJ            GLGNINAESRIGYDSLTQYQYKNVCSSDDQGSIALYLLLVFHGLVLLVACFISFKIKVVD 567 
Q8NHA5          IVDPLHRTIEVPLERR-CYGQENEQGSVAIRALGLCIFYGYKGLLLLLGIFLAYETKSVS 655 
                 :. ::   .:  :    *  :*  .*    ::.* ::  ::**:**:. *:::: * *. 
 
grlJ            IEEFNESKPITTSVY-IITFCLFIVIPLMVSPQSLTSQTTIICVCAIVTTLISMLLLFGS 626 
Q8NHA5          TEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAFAFASLAIVFSSYITLVVLFVP 715 
                 *::*: :.:  ::* : .:**: .   *: ...  :  :: .:. :.:: *::::** . 
 
grlJ            KFYKMATQGLAINETFATSTKSSSKSSKSSYGKDNPNPNAINFGEDDTSDETSEEKHKSP 686 
Q8NHA5          KMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKENRELEKIIAEKEERVSELRHQ 775 
                *: :: *:*   .*:  * ...**...:..  .   : :  :: :  :..*   .: :   
 
grlJ            KQKSVNFSNKSNSHLAVFTSDEETSKTSKLSIDFENSSKDISIDQLQQQKQQPINTNGDL 746 
Q8NHA5          LQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGSRVHLLYKVNPQHCPGNGSVRD 835 
                 *.  :: .: :.  .  .*.  .  ..: .  :. ... : :    : :: * * .    
 
grlJ            ENKSNDKIDDDNDNSSVLSKRISNQQNGETEIDSNNV 783 
Q8NHA5          KDEAERHNQDEDTGNSHLDLIVGGVFTGESN------ 866 
                ::::: : :*:: ..* *.  :..  .**::     
Figure 7.1. GrlJ and Q8NHA5 sequence alignment.  Amino acid sequences of GrlJ and 
Q8NHA5 were aligned using Clustal Omega low sequence homology, where most sequence 
homology was seen in the transmembrane domains (highlighted in grey).  “ * ” Amino acid 
positions containing a single fully conserved residue.  “ : “ Amino acid positions containing 
strongly similar properties scoring >0.5 in the Gonnet PAM 250 matrix. “ . “ Amino acid positions 
containing weakly similar properties scoring <0.5 in the Gonnet PAM 250 matrix.   
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Q8NHA5        ------------------------------------------------------------ 
GABAB_1B      ------------------------------------------------------------ 
GABAB_1A      MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQVKAINFLPVD 
GABAB_1C      MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQVKAINFLPVD 
                                                                           
 
Q8NHA5        ----------------------------------------------MGPGAPF------- 
GABAB_1B      ----------------------------------------------MGPGAPF------- 
GABAB_1A      YEIEYVCRGEREVVGPKVRKCLANGSWTDMDTPSRCVRICSKSYLTLENGKVFLTGGDLP 
GABAB_1C      YEIEYVCRGEREVVGPKVRKCLANGSWTDMDTPSRCV----------------------- 
                                                                           
 
Q8NHA5        ----ARVGWPLPLLVVMAAGVAPVWASHSPHLPRPHSRVPPHPSSERRAVYIGALFPMSG 
GABAB_1B      ----ARVGWPLPLLVVMAAGVAPVWASHSPHLPRPHSRVPPHPSSERRAVYIGALFPMSG 
GABAB_1A      ALDGARVDFRCDPDFHLVGSSRSICSQGQWSTPKPHCQVNRTPHSERRAVYIGALFPMSG 
GABAB_1C      ---------------------------------------NRTPHSERRAVYIGALFPMSG 
                                                        * **************** 
 
Q8NHA5        GWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDSKVALDMGCDPGQATKYLYELLY 
GABAB_1B      GWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDS------KCDPGQATKYLYELLY 
GABAB_1A      GWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDS------KCDPGQATKYLYELLY 
GABAB_1C      GWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDS------KCDPGQATKYLYELLY 
              **************************************       *************** 
 
Q8NHA5        NDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHN 
GABAB_1B      NDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHN 
GABAB_1A      NDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHN 
GABAB_1C      NDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHN 
              ************************************************************ 
 
Q8NHA5        PTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNL 
GABAB_1B      PTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNL 
GABAB_1A      PTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNL 
GABAB_1C      PTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNL 
              ************************************************************ 
 
Q8NHA5        K----------------------VYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDE 
GABAB_1B      KRQDARIIVGLFYETEARKVFCEVYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDE 
207 
 
GABAB_1A      KRQDARIIVGLFYETEARKVFCEVYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDE 
GABAB_1C      KRQDARIIVGLFYETEARKVFCEVYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDE 
              *                      ************************************* 
 
Q8NHA5        MTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAI 
GABAB_1B      MTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAI 
GABAB_1A      MTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAI 
GABAB_1C      MTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAI 
              ************************************************************ 
 
Q8NHA5        WALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRM 
GABAB_1B      WALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRM 
GABAB_1A      WALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRM 
GABAB_1C      WALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRM 
              ************************************************************ 
 
Q8NHA5        AWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFIS 
GABAB_1B      AWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFIS 
GABAB_1A      AWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFIS 
GABAB_1C      AWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFIS 
              ************************************************************ 
 
Q8NHA5        VSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHI 
GABAB_1B      VSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHI 
GABAB_1A      VSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHI 
GABAB_1C      VSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHI 
              ************************************************************ 
 
Q8NHA5        GRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATV 
GABAB_1B      GRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATV 
GABAB_1A      GRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATV 
GABAB_1C      GRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATV 
              ************************************************************ 
 
Q8NHA5        GLLVGMDVLTLAIWQIVDPLHRTIEVPLERRCYGQE-------NEQGSVAIRALGLCIFY 
GABAB_1B      GLLVGMDVLTLAIWQIVDPLHRTIETFAKEEPKEDIDVSILPQLEHCSSRKMNTWLGIFY 
GABAB_1A      GLLVGMDVLTLAIWQIVDPLHRTIETFAKEEPKEDIDVSILPQLEHCSSRKMNTWLGIFY 
GABAB_1C      GLLVGMDVLTLAIWQIVDPLHRTIETFAKEEPKEDIDVSILPQLEHCSSRKMNTWLGIFY 
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              *************************.  :..   :         *: *       * *** 
 
Q8NHA5        GYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAF 
GABAB_1B      GYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAF 
GABAB_1A      GYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAF 
GABAB_1C      GYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAF 
              ************************************************************ 
 
Q8NHA5        AFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKE 
GABAB_1B      AFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKE 
GABAB_1A      AFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKE 
GABAB_1C      AFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKE 
              ************************************************************ 
 
Q8NHA5        NRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGS 
GABAB_1B      NRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGS 
GABAB_1A      NRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGS 
GABAB_1C      NRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGS 
              ************************************************************ 
 
Q8NHA5        RVHLLYKVNPQHCPGNGSVRDKDEAERHNQDEDTGNSHLDLIVGGVFTGESN 
GABAB_1B      RVHLLYK--------------------------------------------- 
GABAB_1A      RVHLLYK--------------------------------------------- 
GABAB_1C      RVHLLYK--------------------------------------------- 
              *******                 
Figure 7.2. Q8NHA5 and GABAB receptor subunit 1 isoform sequence alignments.  Amino 
acid sequences of Q8NHA5 GABAB receptor subunit 1B, 1C and 1A were aligned using Clustal 
Omega showing high sequence homology.  “ * “ Amino acid positions containing a single fully 
conserved residue.  “ : “ Amino acid positions containing strongly similar properties scoring >0.5 
in the Gonnet PAM 250 matrix.  “ . “ Amino acid positions containing weakly similar properties 
scoring <0.5 in the Gonnet PAM 250 matrix.   
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 Maturation and localisation of GABAB receptors involves addition of N-
linked glycosylation sites to the N-terminus of the protein (White et al., 1998).  In 
addition, research has also identified the involvement of N-linked glycosylation 
sites the maturation of T2R receptors (Reichling et al., 2008).  To examine GrlJ 
and Q8NHA5 for potential glycosylation sites, the N-terminal protein sequence 
of GrlJ, Q8NHA5 and GABABR1B were analysed using NetNGlyc 1.0 Server.  
Interestingly, five putative sites were found in GrlJ, six were found in Q8NHA5 
and seven were found in the GABABR1B N-terminal regions.  Furthermore, all 
three receptors contained an N-glycosylation site at around the same regions 
between the 175-200th amino acid; between the 250-300th amino acid and 
between the 300-350th amino acid in the N-terminus of the protein (Figure 7.3). 
These common sites support a conserved role for the proteins.  
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Figure 7.3 Predicted N-glycosylation sites in GrlJ, Q8NHA5 and GABABR1B N-termini.  
Protein sequence analysis of N-terminal regions using NetNGlyc1.0 server identified five 
potential N-glycosylation sites GrlJ, six potential sites in Q8NHA5 and seven potential sites in 
GABABR1. 
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7.2. Expression of Q8NHA5 in Dictyostelium 
 Since Q8NHA5 shared structural similarity to GrlJ (Figure 7.4A) a role 
for Q8NHA5 in phenylthiourea detection was examined by expression of the 
human gene in Dictyostelium in wild type and grlJ- cell lines.  Full length cDNA 
was synthesised using a reading frame corrected for Dictyostelium codon bias 
and restriction sites for BglII and SpeI added to the 5’ and 3’ ends respectively 
(Figure 7.4B).  This was then cloned into the vector, PDM320, which contained 
an N-terminal FLAG tag under the control of an actin 15 promoter (Veltman et 
al., 2009).  Wild type and grlJ- cells were then transformed with the 
overexpression construct to create WT/Q8NHA5+ and grlJ-/Q8NHA5+ cell lines.  
Transformants were then placed under G418 selection, where RT-PCR of 
surviving colonies confirmed gene expression using primers specific to 
Q8NHA5 (Figure 7.4C).   The protein levels of Q8NHA5 could however not be 
confirmed by Western blot.  (Figure 7.4D).   
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Figure 7.4. Overexpression of Q8NHA5 in grlJ
-
 cells.  (A) Predicted tertiary structure of GrlJ 
and Q8NHA5 suggest both proteins show similar overall structure of seven transmembrane 
regions (coloured) with large N- and small C-terminal regions.  (B) Schematic of an 
overexpression construct created using pDM320; using BglII and SpeI restriction sites to insert 
Q8NHA5.  (C) RT-PCR showing expression of the human gene in grlJ
-
/Q8NHA5
+
 but not wild 
type or grlJ
-
 cell lines. Control bands represent constitutively active gene, IG7.  (D) Western blot 
showing wild type (W), grlJ
-
/Q8NHA5
+
 (Q) and a control rat brain (R) lysate.  A band for 
Q8NHA5, of approximately 97kDa could not be identified.  Control band in rat brain lysate was 
approximately 48kDa. 
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7.3. Spore shape analysis of grlJ- complemented with Q8NHA5 
 
 In order to determine whether expression of Q8NHA5 could recapitulate 
wild type phenotypic traits that were present in grlJ- cells (Chapter 5), grlJ-
/Q8NHA5+ spores were isolated and their shape was analysed as described 
previously (Chapter 5).  Wild type and grlJ- cells showed a significant (P<0.05) 
change in spore shape (mean aspect of 1.9±0.02 and 2.0±0.03 respectively).  
Surprisingly, grlJ-/Q8NHA5+ restored wild type spore shape (1.9±0.03) (Figure 
7.5).  A one-way analysis of variance identified a significant difference between 
wild type and grlJ- spore shape (P<0.05) but not wild type and grlJ-/Q8NHA5.  In 
addition, grlJ- and grlJ-/Q8NHA5 spore shape also showed no significant 
difference, suggesting a partial but not complete restoration of spore shape 
identified in wild type cells.  
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Figure 7.5. Determination of spore shape in wild type, grlJ
- 
and grlJ
-
/Q8NHA5
+
 strains.  A 
total of 214 Spores from each wild type, grlJ
-
 and grlJ
+
/Q8NHA5
+
 were isolated and imaged 
using phase contrast microscopy.  Spore aspect was determined and a 1-way ANOVA with 
post-hoc Tukey’s multiple comparison test revealed a significant difference (P<0.05) in spore 
shape between wild type and grlJ
-
 (P<0.05) cell lines.   
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7.4. Random cell movement analysis of grlJ- complemented 
with Q8NHA5 
 Since grlJ- cells showed significant resistance to phenylthiourea (3mM) in 
random cell movement when compared to wild type cells, chemotactically-
competent grlJ-/Q8NHA5+ cells were used in random cell movement assays as 
described previously (Chapters 5 and 6).  Addition of phenylthiourea (3mM) 
after 288 seconds resulted in loss in behaviour in grlJ-/Q8NHA5+ cells, where 
comparison of mean cell behaviour between the first and final 288 seconds 
identified a significant increase in circularity (P=0.0195) from 0.77±0.01 to 
0.86±0.00, a significant decrease in the number of protrusions formed 
(P=0.0084) from 2.6±0.1 to 1.0±0.03, and a significant decrease in motility 
(P=0.0065), from 4.6±0.4nm/sec to 1.3±0.2nm/sec.  Interestingly, a significant 
change in displacement was also identified (P=0.0078), where average cell 
displacement from 13.1±1.4µm at 288 seconds changed to 25.1±5.5µm at the 
end of the assay.  A one-way analysis of variance identified significant 
differences in displacement, circularity, protrusion formation and motility 
between wild type and grlJ- as well as between grlJ- and grlJ-/Q8NHA5+ cell 
lines, and no significant differences in any measurements between wild type 
and grlJ-/Q8NHA5+ cells (Figure 7.6).  These results suggest that the 
uncharacterised human protein, Q8NHA5, may be involved in the detection of 
phenylthiourea. 
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 Figure 7.6. Dictyostelium wild type, grlJ- and grlJ-/Q8NHA5+ random cell movement 
following exposure to phenylthiourea (3mM) after 288 seconds.  During random cell 
movement, 3mM phenylthiourea was added to grlJ
-
/Q8NHA5
+
 cells after 288 seconds and 
changes in cell behaviour monitored. A one-way ANOVA with subsequent post-hoc Tukey’s test 
was performed for (A) Displacement. A significant difference was observed at the final 
cumulative time point of the assay between WT and grlJ
-
 (P<0.05) as well as grlJ
-
 and grlJ
-
/Q8NHA5
+
 (P<0.01) cell lines.  (B) Circularity.  A significant difference was observed during the 
final 288 seconds of the assay between WT and grlJ
-
 (P<0.05) as well as grlJ
-
 and grlJ
-
/Q8NHA5
+
 (P<0.05) cell lines.  (C) Number of protrusions within a 10 frame window.  Significant 
differences between cell lines was shown with both WT and grlJ
-/+
 (P<0.01) cell lines producing 
significantly fewer protrusions compared to grlJ
-
 cells during the final 612-900 seconds.  (D) 
Motility.  A significant difference was observed between WT and grlJ
-/+
 cells to be significantly 
(P<0.01 and P<0.05 respectively) less active than grlJ
-
 cells during the final 612-900 seconds. 
In all measurements, no significant difference was observed between WT, grlJ
-
 and grlJ
-
/Q8NHA5
+
 cells under control conditions (0-288 seconds). Measurements were derived from 30 
cells measured from a minimum of triplicate experiments.  Vertical bars represent the standard 
error of the mean, *p < 0.05, **p < 0.01, n/s not significant. 
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7.5. Involvement of the PI3K pathway 
To investigate whether the Q8NHA5-mediated inhibition of Dictyostelium 
cell behaviour was through dysregulation of the PI3K pathway, global cAMP 
stimulation experiments were performed as described previously by extracting 
PIP3 (Chapter 6).  Chemotactically-competent grlJ
-/Q8NHA5+ cells were 
incubated in phosphate buffer or phenylthiourea (3mM) for ten minutes prior to 
cAMP global stimulation and lipids extracted at 0, 5 and 20 seconds post 
stimulation.  Under control conditions, PIP3 levels rose from 3.8±2.4pmol to 
10.6±5.8pmol after five seconds and dropped to 5.5±2.1pmol after twenty 
seconds post cAMP addition (Figure 7.7).  Ten minute incubation with 
phenylthiourea (3mM) resulted in a change in PIP3 levels from 1.3±0.9pmol to 
1.7±0.7pmol after five seconds to 1.3±0.7pmol after twenty seconds cAMP 
stimulation (Figure 7.7).  A two-way ANOVA identified a significant difference in 
in PIP3 production 5 seconds post-cAMP addition under control conditions 
(P<0.05), but not after phenylthiourea incubation.  This evidence suggests a 
role for the uncharacterized human protein, Q8NHA5, in detection 
phenylthiourea through inhibiting production of PIP3 in Dictyostelium.  
  
217 
 
C
on
tr
ol
P
TU
0
5
10
15
20
0 seconds
5 seconds
20 seconds
*
ns
P
IP
3
 (
p
m
o
l/
1
0
8
 c
e
ll
s
)
 
Figure 7.7. PIP3 production during global stimulation with cAMP in grlJ
-
/Q8NHA5
+ 
cells 
following ten minute incubation with phosphate buffer or phenylthiourea (3mM).  A mass 
ELISA was used to quantify PIP3 production 0, 5 and 20 seconds post stimulation with 1µM 
cAMP, where a significant  change in PIP3 production was identified 5 seconds following global 
stimulation in grlJ
-
/Q8NHA5
+
 cells under control conditions.  Incubation with phenylthiourea 
(3mM) (PTU), resulted in no significant changes in PIP3 production 5 seconds after global 
stimulation with cAMP.  The figure is representative of triplicate experiments using a 2-way 
ANOVA for statistical comparisons.  Error bars represent standard error of the mean (SEM). * 
P<0.05, ns= not significant. 
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7.6. Discussion 
 Previous experiments reported in this thesis identified GrlJ as a G-protein 
coupled receptor involved in phenylthiourea detection, and an acute block in 
Dictyostelium cell behaviour (Chapter 5).  Additional analysis showed detection 
of phenylthiourea through GrlJ inhibited PIP3 production following stimulation 
with cAMP (Chapter 6).  This mechanism contrasts to current molecular 
mechanisms of phenylthiourea detection in mammals (Kinnamon, 2011).  With 
regards to phenylthiourea and its structurally related analogue, propylthiouracil, 
the current understanding of TAS2R38 polymorphisms resulting in different 
taster status, is however insufficient, owing to the substantial variability in taster 
status (Hayes et al., 2008).  Previous genome wide association research has 
identified the variation in TAS2R38 single nucleotide polymorphisms accounts 
for only 49% of variability observed in propylthiouracil detection thresholds 
(Genick et al., 2011).  In this chapter, an uncharacterised human protein, 
Q8NHA5, was identified to be involved in phenylthiourea detection (Table 7.1).   
7.6.1. Identification of an uncharacterised human protein 
Dictyostelium contains a large number of G-protein coupled receptors, 
(~0.5% of the genome), the proportion of which places the amoeba between 
fungi and animals in evolutionary distance (Prabhu and Eichinger, 2006).  
Within the genome, Dictyostelium contains seventeen genes encoding GABAB-
like receptors, belonging to the family three group of G-protein coupled 
receptors (Prabhu and Eichinger, 2006).  To date, only two of these receptors, 
GrlE (Anjard and Loomis, 2006) and GrlB (Wu and Janetopoulos, 2013) 
receptors are shown to respond to GABA, where GrlJ, identified in this thesis, 
does not (Prabhu et al., 2007b).  In mammals, GABAB receptors belong to a 
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phylogenetic group that contains a receptor, CASR, previously shown to be 
involved in denatonium benzoate detection (Fredriksson et al., 2003; 
Rogachevskaja et al., 2011), identifying a possible role for bitter tastants in 
activation of non-T2R receptors.   Since the Dictyostelium genome contains no 
recognised T2R receptors, and evidence presented in this thesis indicates the 
involvement of GrlJ in bitter tastant detection, GABAB receptors may contain a 
binding site for which bitter tastants such as phenylthiourea can regulate 
receptor activity.   
A database search for proteins with sequence similarity to GrlJ identified 
an uncharacterised human protein, Q8NHA5, sharing low homology (Table 
7.1), that showed high homology with GABAB subunit 1 receptor isoforms 
(Figure 7.2 and 7.3).  GABAB receptors are G-protein coupled receptors, 
located pre- and post- synaptically throughout the human central nervous 
system (Terunuma et al., 2010), lungs (Chapman et al., 1993) and the 
gastrointestinal tract (Nakajima et al., 1996).  These receptors comprise of 
GABAB subunit 1 and 2 receptors, which form heterodimers, both of which are 
essential in producing functional GABAB receptors (White et al., 1998).  Ligand 
binding of GABA to GABAB receptors involves a venus fly trap domain, shown 
only to exist in GABAB subunit 1 receptors, where GABAB subunit 2 receptors 
are involved in receptor activation (Rondard et al., 2011).  GABAB receptors are 
targets of many diseases, where receptor agonism is used to treat skeletal 
muscle spasticity, pain and drug addiction (Bowery, 2006).  Activation of GABAB 
receptors also provides a broncho-protective effect, relaxing airway smooth 
muscle, reducing coughing and bronchospasm (Chapman et al., 1993).  
Interestingly, bitter tastants also cause bronchodilation by activation of T2R 
receptors in the lungs, making them a target for novel therapeutic drugs in 
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asthma treatment (Liggett, 2013; An et al., 2012).  This evidence provides a 
potential complementary role for T2R and GABAB receptor agonism, where 
activation of these receptors may induce similar signalling cascades. 
In the gastrointestinal tract, activation of GABAB receptors with baclofen 
results in increased gastric contractility (Symonds et al., 2003; Rotondo et al., 
2010) and decreased gastric volume (Rotondo et al., 2010).  Despite this, 
activation of GABAB receptors after injection with baclofen (2mg/kg) results in  
delayed gastric emptying of liquids (Symonds et al., 2003) and also causes 
conditioned taste aversion to saccharin in rats (Wilson et al., 2011).  This 
evidence suggests activation GABAB receptors located within the central 
nervous system may promote digestion and transport of nutrients through the 
gastrointestinal tract.  Interestingly, baclofen is also regarded as a moderately 
bitter tasting compound, which requires a masking agent if administered orally 
(Janardhan et al., 2010).  This data suggests compounds which activate GABAB 
receptors may also have aversive qualities that inhibit gastric motility upon 
activation in the gastrointestinal tract.  Alternatively, agonists such as baclofen 
could activate aversive receptors in the gastrointestinal tract, such as T2R 
receptors, which may delay gastric emptying and cause conditioned taste 
aversion. 
Agonists of GABAB receptors are used to treat a range of neurological 
disorders in humans such as schizophrenia, bipolar disorder, depression and 
epilepsy (Bowery, 2006; Fatemi et al., 2011).  Interestingly, bitter taster status, 
which is dependent on TAS2R38 polymorphisms, has also been linked to 
epilespy (Pal et al., 2004).  This evidence provides another possible link 
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between T2R receptors and GABAB receptors, particularly the TAS2R38 
receptor, which is responsible for phenylthiourea sensitivity.  
Despite sharing little homology, comparison of mammalian T2R 
receptors and GABAB receptors, identified the requirement for N-linked 
glycosylation sites, in maturation and localisation to the cell membrane 
(Reichling et al., 2008; White et al., 1998; Maehashi and Huang, 2009; Rands et 
al., 1990).  Whilst T2R receptors contain a conserved N-glycosylation site in the 
second extracellular loop (Reichling et al., 2008; Maehashi and Huang, 2009), 
GABAB receptors contain N-glycosylation sites in the N-terminus of the protein 
(White et al., 1998).  Determination of N-glycosylation sites in GrlJ, Q8NHA5 
and GABAB1B receptors identified a number of these sites throughout the N-
terminus, where some appeared at similar locations on the primary amino acid 
structure (Figure 7.3).  This suggests a possible conserved role for N-linked 
glycosylation sites in GrlJ, Q8NHA5 and GABAB1B proteins.   
7.6.2 Expression of Q8NHA5 in Dictyostelium 
 Transformation of Q8NHA5 into Dictyostelium cells was confirmed using 
G418 selection and RT-PCR (Figure 7.4).  Using primers specific to Q8NHA5, 
this method clearly identified gene transcription was occurring in Dictyostelium 
cells.   Unfortunately, western blot could identify protein levels of Q8NHA5.  This 
may be due to the protein instability resulting in degradation or tight protein 
folding resulting in reduced antibody binding.  Alternatively, a lack of protein 
levels may be due to cleavage of the FLAG tag, which could be due to 
Dictyostelium proteinases or phosphatases removing the epitope.  In human 
cells, FLAG tags have also been reported as unstable as a result of epitope 
positioning at the N-terminus of a protein (Quarello et al., 2010).  In addition, 
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triple-tagging with the FLAG epitope has shown relatively poor signals in 
comparison to other epitope tags (Moqtaderi and Struhl, 2008).  Using a more 
sensitive alternative to western blotting, such as ELISA, may have enhanced 
sensitivity towards the FLAG epitope attached to the Q8NHA5 protein.  
Alternatively, use of an antibody specific to Q8NHA5 would be of use in future 
experiments, as this would rely on detection of the actual protein rather than an 
epitope tag. 
7.6.3. Spore shape analysis of grlJ- complemented with 
Q8NHA5 
Transformation of grlJ- cells with a plasmid expressing Q8NHA5 tagged 
with a FLAG tag to form grlJ-/Q8NHA5+ cell lines resulted in a partial restoration 
of Dictyostelium spore shape (Figure 7.5).  Grl-family proteins may play roles 
during different stages in Dictyostelium development, where GrlJ and GrlA are 
involved in events post aggregation (Prabhu et al., 2007a; Prabhu et al., 
2007b), and GrlB is involved in the formation of mounds (Wu and Janetopoulos, 
2013).  Since Q8NHA5 partially restores spore shape to those seen in the wild 
type strain, this GABAB-like protein is likely to provide a similar role to GrlJ in 
Dictyostelium cells. 
To date, GABA signalling has only been identified in two proteins GrlB 
(Wu and Janetopoulos, 2013) and GrlE (Anjard and Loomis, 2006).  
Interestingly, GrlB and GrlE are involved in different stages of development, 
where GrlB (Wu and Janetopoulos, 2013) is responsive during early 
development and GrlE responds to GABA during sporulation (Anjard and 
Loomis, 2006).  Whilst GrlJ is shown not to respond to GABA signalling during 
sporulation (Prabhu et al., 2007b), GrlJ activation by GABA may occur at a 
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different stage in development.  Q8NHA5 may therefore have supported this 
role in the absence of GrlJ in grlJ-/Q8NHA5+ cells.    
7.6.4. Random cell movement analysis of grlJ- complemented 
with Q8NHA5 
 Previous experiments identified in this thesis showed GrlJ is partially 
responsible for phenylthiourea detection.  Exposure of grlJ-/Q8NHA5+ cells to 
phenylthiourea (3mM) in random cell movement resulted in a significant 
decrease in behaviour, indicating Q8NHA5 was also responsive to the tastant 
(Figure 7.6).  In Dictyostelium, regulation of GrlJ results in inhibitory effects on 
cell behaviour, which is also caused by Q8NHA5.  To date, no research has 
identified phenylthiourea as a receptor agonist to GABAB receptors in humans.  
Interestingly, other G-protein coupled receptors belonging to class C receptors, 
such as CASR (Rogachevskaja et al., 2011) taste type 1 (Kinnamon, 2011) and 
glutamate receptors (Monastyrskaia et al., 1999) have been associated with 
bitter, sweet and umami taste transduction respectively.  Whilst GABAB ligands 
have not been linked with taste transduction, GABA itself has been associated 
with masking the sensation of bitterness (Rotzoll et al., 2005).  Therefore 
regulation of GABAB receptors within the gastrointestinal tract may reduce or 
interfere with bitter taste perception, possibly by masking sensitivity to bitter 
tastants.   
The ability to perceive bitter tastants, particularly in relation to TAS2R38 
polymorphisms has been associated with diseases such hyperthyroidism 
(Kitchin et al., 1959; Kalow, 1986; Shivaprasad et al., 2012; Shepard and 
Gartler, 1960) and epilepsy (Pal et al., 2004).  This has been related to non-
tasters ingesting increased bitter goitrogenic substances found in plants, which 
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often contain phenylthiourea and derivatives (Kitchin et al., 1959; Pal et al., 
2004).  Since evidence in this thesis suggests phenylthiourea can activate a 
homologue of a GABAB subunit 1 receptor, phenylthiourea-mediated activation 
could further suppress bitter taste sensitivity in non-tasters, resulting in the 
increased ingestion of potentially damaging substances in humans.  This could 
also help to explain the variability seen within taster groups previously identified 
(Hayes et al., 2008). 
7.6.5. Involvement of the PI3K pathway 
 GrlJ-mediated detection of phenylthiourea has been shown in this thesis 
to occur via inhibition of the PI3K pathway (Chapter 6).  To assess the function 
of GrlJ using Q8NHA5 in grlJ-/Q8NHA5+ cells, incubation with phenylthiourea 
resulted in the inhibition of transient PIP3 production, restoring the wild type 
phenotype (Figure 7.7).  In human cell lines, GABAB signalling also involves 
PI3K activity and subsequently phosphorylating PKB/Akt (Lu et al., 2012; 
Malyala et al., 2008).  In Dictyostelium PI3K has previously been identified as a 
downstream target of GrlE activation in GABA signalling during sporulation 
(Anjard and Loomis, 2006).  Since the block in cell behaviour occurs through 
inhibition of PI3K, regulation of GrlJ and Q8NHA5 could therefore play an 
inhibitory rather than a stimulatory role on downstream PIP3 formation.  This 
evidence therefore indicates PI3K signalling also acts downstream to GABAB 
receptor activation in both humans and Dictyostelium, suggesting a functional 
role for Q8NHA5 signalling in Dictyostelium grlJ-/Q8NHA5+ cells. 
 In Dictyostelium, heterotrimeric G-protein coupled receptors are bound 
one of various Gα subunits in addition to the β subunit and the undiscovered ɣ 
subunit.  Different Gα subunits cause various responses in Dictyostelium 
behaviour where, for  example, Gα2 is crucial for cAR activation and 
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subsequent signal amplification events (Liao et al., 2013).  In contrast Gα9 is 
shown to cause inhibition on cAMP-directed movement, which includes 
negative regulation of the PI3K pathway (Brzostowski et al., 2004).  Grl-family 
proteins couple to different Gα subunits, where GrlE couples to Gα7 (Anjard et 
al., 2009), and GrlA couples to Gα4 (Anjard et al., 2009).  This data suggests 
different Grl-family proteins bind to different Gα-subunits, which may therefore 
interact with different molecular signalling pathways in Dictyostelium behaviour.  
Heterotrimeric G-protein dissociation from GABAB receptors such as GrlJ and 
Q8NHA5 with a subunit such as Gα9 in Dictyostelium is consistent with the 
inhibition in PIP3 formation shown.  Interestingly, Gα9 (along with Gα11) was 
identified in the REMI mutagenesis screen as resistant to phenylthiourea 
(Appendix 6).  Further research may therefore identify Gα9 to bind to GrlJ.   
In mammals, GABAB receptor activation results in dissociation of Gαi 
subunits (Chalifoux and Carter, 2011), which subsequently results in the 
reduction in adenylyl cyclase activity.  These subunits share a high homology 
with Gα-subunits in Dictyostelium (based upon BLAST analysis).  Since 
Q8NHA5-mediated detection of phenylthiourea results in a reduction in PIP3 
formation, the GABAB receptor is therefore likely to couple to one of the many 
Dictyostelium Gα subunits.  
7.7. Summary 
 A database search for proteins related to GrlJ identified an 
uncharacterised human receptor, which shares a high homology with GABAB1B.  
Expression of Q8NHA5 in GrlJ- cells in Dictyostelium was identified using RT-
PCR.  However, due to poor expression or potential cleavage of the FLAG 
epitope, no fusion protein could be detected could not be detected by western 
blotting.   
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Expression of Q8NHA5 in grlJ- cells partially restored wild type spore 
shape, a wild type response to phenylthiourea, where cell behaviour was 
blocked in random cell movement, and blocked PIP3 formation, suggesting 
inhibition of the PI3K pathway previously described (Chapter 6).  These 
experiments have therefore identified a previously uncharacterised human 
protein, likely to be a GABAB receptor component, involved in the detection of 
the bitter tastant phenylthiourea in Dictyostelium.  This research could therefore 
have implications in bitter taste and GABAB receptor research in the future. 
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Chapter 8 
Discussion 
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Nausea and vomiting are severe side effects associated with over 50% of 
currently marketed therapeutic drugs (Parkinson et al., 2011; Holmes et al., 
2009).  These contraindications can affect clinical response, hinder the progress 
of some drug treatment courses and reduce patient compliance (Parkinson et 
al., 2011).  In order to predict these unpleasant side effects as early as possible 
during drug development, animal research is required, which provides an 
important area for the development of new non-sentient models to comply with 
the 3R’s (reduction, replacement, refinement) principles in research.  In the 
present study, the utility of a biomedical model organism, Dictyostelium 
discoideum, was explored for its potential to predict emetic liability and possibly 
reduce the number of animals used in emetic and aversive research. 
8.1. Can Dictyostelium be used as a non-sentient model in 
emetic and tastant research? 
To assess the suitability of Dictyostelium as a model for predicting emetic 
liability, motility assays in a Dunn chamber were used to screen a broad range 
of emetic and taste aversive compounds for their acute effects on cell behaviour 
(Table 3.1).  Twenty nine emetic and/or taste aversive compounds were 
screened, seven of which caused significant reversible reductions in cell 
velocity and/or shape as well as a decrease in cell directionality (Chapter 3).  
These compounds could be sub-divided into four distinct groups, which were 
copper salts, T2R receptor ligands, a TRPV1 receptor agonist and a 
phosphodiesterase IV inhibitor.  
Since only seven of twenty nine compounds with known emetic effects in 
mammals affected Dictyostelium behaviour, its use as a general model for 
predicting emetic liability is limited.  Many of the compounds tested were 
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receptor agonists or inhibitors of receptors that do not exist in Dictyostelium.  In 
addition, the short incubation time used to measure acute effects on 
Dictyostelium behaviour may have been too short to allow compounds such as 
cytotoxic compounds, which cause DNA damage, to affect motility.    
Screening of compounds using Dictyostelium motility did however 
identify four different sub-groups of compounds that did block motility.  
Dictyostelium may therefore provide a useful model in the analysis of these 
compounds in structure-activity relationships or translational studies to identify 
novel active vanilloids or bitter tastants.  For example, the TAS2R receptors 4, 
7, 10, 39 and 46 are all activated by multiple bitter tastants, including 
denatonium benzoate and quinine hydrochloride (Meyerhof et al., 2010).  Using 
Dictyostelium, compounds structurally related to bitter tastants such as 
denatonium benzoate may also help to identify other bitter and non-bitter 
analogues, which may target specific bitter taste receptors.  Dictyostelium may 
also be of potential use to identify the potency of bitter tastants in translational 
studies.  Data obtained in this thesis (Chapter 3) has shown Dictyostelium 
detects bitter tastants at concentrations relevant to mammalian thresholds 
(Hayes et al., 2008; Delwiche et al., 2001; Meyerhof et al., 2010; Nelson and 
Sanregret, 1997; Peyrot des et al., 2011; Sibert and Frude, 1991).  For 
example, Dictyostelium was sensitive to phenylthiourea at concentrations 
ranging from 1-5mM, which is consistent with phenylthiourea causing calcium 
release in mouse enteroendocrine cells at 2-5mM.  Future research using 
Dictyostelium in translational and structure-activity relationship studies may 
therefore have potential for use in high throughput screens to identify the 
potency of other bitter tastants. 
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8.3. Identification of molecular mechanisms in bitter tastant 
detection 
The ease of using Dictyostelium to identify novel protein targets makes 
the amoeba useful biomedical model (Boeckeler and Williams, 2007; Williams 
et al., 2006b).  By performing a REMI mutagenesis screen, a number of genetic 
targets potentially involved in bitter tastant detection were identified (Chapter 
4).  This included a G-protein coupled receptor mutant, grlJ-, which showed 
partial resistance to phenylthiourea.  Whilst ablation of grlJ in the Ax2 
background used in this thesis resulted in the formation of previously identified 
malformed spores, an increased growth rate was not observed (Prabhu et al., 
2007b) (Chapter 5).  This may be due to strain specific differences that have 
been observed between laboratories.  For example, previous research has 
identified strain specific differences in development using different parent 
strains to ablate the gskA gene (Schilde et al., 2004; Harwood et al., 1995).  
REMI mutagenesis screening also identified two racGEFs (gxcP- and 
gxcKK-), both of which showed resistance to denatonium benzoate in motility, 
possibly through a parallel pathway.  Denatonium benzoate may therefore 
activate an unidentified receptor, a signalling pathway involving GxcP and 
GxcKK, or directly regulate a number of racGEFs to inhibit cell behaviour.  
Further research is required to identify the molecular mechanisms involved in in 
the regulation of racGEFs by denatonium benzoate. 
A final mutant identified in the REMI mutagenesis screen for further 
analysis, was Pkd2, involved in the detection of naringenin.  Ablation of pkd2 in 
Dictyostelium showed complete resistance to naringenin during random cell 
movement (Chapter 4).  This research has since identified a role for naringenin 
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in inhibiting the formation of polycystic cysts through the Pkd2 receptor in 
mammalian kidney cell lines (Mark Carew, Kingston University, personal 
communication; Waheed et al. 2013).  Identification of Pkd2 using a REMI 
mutagenesis screen has therefore supported the role for Dictyostelium as a 
suitable model in biomedical research. 
In pursuing the GrlJ-mediated response to phenylthiourea, ablation of 
grlJ in the Ax2 background confirmed the partial resistance in cell behaviour to 
phenylthiourea.  grlJ- cells also showed resistance to phenylthiourea in both 
proliferation (in shaking suspension) and growth on bacterial plates (Chapter 
5).  GrlJ-mediated cell rounding, induced by phenylthiourea in both motility and 
random cell movement, suggests an inhibitory effect on F-actin polymerisation, 
which is partially regulated by PI3K activity (Chen and Iijima, 2012).  PI3K 
activity was also suppressed by phenylthiourea-mediated regulation of GrlJ 
(Chapter 6).  Since macropinocytosis (Lee and Knecht, 2002) and phagocytosis 
(Chen and Iijima, 2012) are also reliant on PI3K activity and F-actin remodelling, 
GrlJ-mediated inhibition of cell behaviour may give rise to the observed 
inhibition of growth in shaking suspension and on bacterial plates. 
Since phenylthiourea-mediated regulation of cell behaviour was shown to 
be G-protein coupled receptor dependent, resulting in the subsequent inhibition 
of PIP3 formation, it is likely GrlJ regulates heterotrimeric G-proteins involved in 
motility (Figure 8.1).  However, since GrlJ only showed partial resistance to 
phenylthiourea, at least one other molecular mechanism must be involved.  
Previous research has identified four key signalling mechanisms required for 
efficient motility, where inhibition of one or two pathways does not inhibit motility 
(Veltman et al., 2008).  Therefore, whilst GrlJ inhibits PIP3 production and may 
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also inhibit other pathways (not identified in this thesis), the receptor is unlikely 
to be responsible for complete inhibition in cell behaviour by phenylthiourea.  
Since the inhibition of Dictyostelium behaviour by phenylthiourea is shown to 
involve heterotrimeric G-protein activity, it is likely that this other mechanism is 
also a G-protein coupled receptor (Figure 8.1).  
 
Figure 8.1. Phenylthiourea-mediated regulation of GrlJ on Dictyostelium cell behaviour.  
Under control conditions, during chemotactic and random cell movement, cAMP binds to the 
cAR receptor, resulting in G-protein dissociation, which activates Ras.  PI3K activity is 
subsequently increased, which converts PIP2 to PIP3. Heterotrimeric G-protein and Ras-
mediated activation of PI3K along with other amplification pathways results in normal cell 
behaviour.  Detection of phenylthiourea by GrlJ, results in the regulation of heterotrimeric G-
proteins, subsequently inhibiting the PI3K pathway and reducing cell behaviour.  In addition, 
heterotrimeric G-protein regulation by an unknown receptor(s) is likely also to inhibit cell 
behaviour. 
GrlJ shares homology with sixteen other Grl-family proteins, few of which 
have been characterised (Prabhu et al., 2007b).  Fourteen of the seventeen Grl-
family receptors share similarities ranging from 60% to 74%, and identities 
ranging from 23% to 44% (Chapter 7).  Other Grl-family receptors may 
therefore also regulate cell behaviour through detection of phenylthiourea.  
Since Dictyostelium is shown to respond to a number of bitter tastants and GrlJ 
has been identified as a receptor that detects phenylthiourea, further research 
may also identify bitter tastants as targets for other Grl-family receptors.   
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  A search for related proteins also identified an uncharacterized human 
protein, Q8NHA5, which shared homology with GABAB receptors.  
Transformation of Q8NHA5 into grlJ- cells restored sensitivity to phenylthiourea 
in cell movement and in PIP3 production (Chapter 7).  This suggests this 
human GABAB-like receptor may be involved in phenylthiourea detection 
(Robery et al. 2013).  In humans, activation of GABAB receptors also inhibits 
PI3K activity, resulting in decreased PIP3 production in a similar manner to that 
shown for Dictyostelium (Lu et al., 2012; Malyala et al., 2008).   
 In humans, GABAB receptors are most commonly targeted by the drug 
baclofen (Janardhan et al., 2010), a bitter tasting compound that is not shown to 
activate any T2R receptors.  Phenylthiourea and baclofen appear to share a 
degree of structural similarity (Figure 8.2), where both compounds contain an 
amine group in addition to a benzene ring.  Future research may therefore 
examine a role for baclofen in regulating Dictyostelium behavior as well as a 
role for this compound in GrlJ and/or Q8NHA5 function.   
 
Figure 8.2. Chemical structures of baclofen and phenylthiourea.  Both compounds share 
some structural similarities, such as the presence of an amine group and a benzene ring. 
 
Whilst agonists to GABAB receptors, such as baclofen, are not known to 
activate T2R receptors, both types of receptor are shown to regulate common 
functions in humans, such as causing bronchodilation (Liggett, 2013; Chapman 
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et al., 1993) suggesting they may share common downstream mechanisms of 
action.  Using compounds that regulate both GABAB and T2R receptors, such 
as phenylthiourea, identified in this thesis, could enhance current research into 
novel treatments for respiratory diseases such as asthma.   
GABAB receptors are targets for multiple disorders of the central nervous 
system, such as anxiety, depression, drug addiction and neurodegenerative 
diseases (Kumar et al., 2013).  In addition, the GABAB receptor is a target of 
anti-spasmodic treatments (Kumar et al., 2013).  Since Dictyostelium has 
identified phenylthiourea as potentially regulating a GABAB receptor, 
development of novel therapeutic treatments for a range of diseases may in 
future include compounds such as phenylthiourea or structurally related 
analogues.  Dictyostelium may have a potential use for identifying novel GABAB 
receptor targeting compounds in a similar way to the discovery of novel 
potential epilepsy treatments (Chang et al., 2012). 
 Finally, previous research has identified bitter taster status, which is 
dependent on single nucleotide polymorphisms on the TAS2R38 gene resulting 
in varying sensitivity to compounds such as phenylthiourea, is not sufficient to 
explain variability in bitter taste sensation (Hayes et al., 2008; Genick et al., 
2011).  Since GABAB receptor activation was previously identified to mask bitter 
tastants (Rotzoll et al., 2005), research in this thesis suggesting a role for 
phenylthiourea in the activation of a potential GABAB receptor, may therefore 
explain the variation in phenylthiourea sensitivity observed in different TAS2R38 
haplotypes.   
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8.4. Summary 
 In this thesis, the utility for using Dictyostelium as a model for predicting 
emetic liability was investigated.  Although the model is unlikely to provide a 
reliable predictor to a wide range of emetic compounds, it did show a response 
to multiple bitter compounds.  Pursuing the bitter taste response in 
Dictyostelium identified a G-protein coupled receptor, GrlJ, as responsible for 
partial inhibition of cell behavior by phenylthiourea and controlling the block in 
PIP3 production.  Finally an uncharacterized human protein, Q8NHA5, was then 
identified as a likely GABAB receptor that restored sensitivity of grlJ
- cells to 
phenylthiourea, suggesting this human protein may function as a target for the 
bitter tastant.   
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Compound Concentration 
(mM) 
Velocity (pre) 
(µm/sec) 
Velocity (post) 
(µm/sec) 
P-value 
(Velocity) 
Aspect  
(pre) 
Aspect 
(post) 
P-value 
(Aspect) 
5-flurouracil 0.25 0.2111±0.002 0.1680±0.003 ns 2.573±0.034 2.192±0.024 ns 
Actinomycin D 0.7 0.2211±0.003 0.1229±0.002 ns 2.575±0.023 2.106±0.015 ns 
Cisplatin 0.3 0.1474±0.002 0.1827±0.002 ns 2.682±0.018 3.119±0.031 ns 
Cycloheximide 5 0.2266±0.004 0.1903±0.002 ns 2.525±0.027 2.267±0.033 ns 
Methotrexate 0.25 2.2197±0.003 0.2165±0.003 ns 2.352±0.017 2.470±0.023 ns 
Streptozotocin 0.001 0.1891±0.002 0.1669±0.0022 ns 2.277±0.020 2.125±0.019 ns 
Vincristine 0.001 0.2564±0.003 0.2451±0.003 ns 2.582±0.014 2.355±0.018 ns 
5-hydroxytryptamine 0.1 0.1649±0.002 0.1907±0.002 ns 3.086±0.032 2.958±0.022 ns 
Apomorphine HCl 1 0.1496±0.003 0.1488±0.002 ns 3.020±0.030 2.852±0.024 ns 
Substance P 0.001 0.1843±0.003 0.1555±0.003 ns 2.914±0.015 2.973±0.028 ns 
Nicotine 0.1 0.1300±0.004 0.1178±0.003 ns 2.594±0.035 2.682±0.022 ns 
Loperamide HCl 0.1 0.1250±0.002 0.7288±0.002 ns 2.582±0.018 2.337±0.018 ns 
Veratridine HCl 0.5 0.1785±0.003 0.1899±0.003 ns 2.784±0.043 2.800±0.137 ns 
Fluoxetine 0.0065 0.1576±0.002 0.2101±0.001 ns 2.893±0.017 1.807±0.023 ns 
Digoxin 0.001 0.1334±0.003 0.0798±0.002 ns 2.595±0.025 2.019±0.014 ns 
Pyrogallol 10 0.2038±0.003 0.1787±0.004 ns 2.990±0.022 2.749±0.028 ns 
Lithium Cl 10 0.2151±0.004 0.2164±0.004 ns 2.532±0.020 2.451±0.031 ns 
Metformin 10 0.1392±0.003 0.1150±0.003 ns 2.724±0.023 2.638±0.027 ns 
PGF2α 0.1 0.1673±0.003 0.1765±0.003 ns 3.034±0.033 3.164±0.034 ns 
Appendix 1.  Summary of non-effective compounds on Dictyostelium cell behaviour (velocity and aspect). Emetic compounds showing no effect on 
Dictyostelium behaviour included cytotoxic agents (5-fluorouracil, actinomycin D, cisplatin, cycloheximide, methotrexate, streptozotocin and vincristine), receptor 
agonists (5-hydroxytryptamine, apomorphine hydrochloride, substance P, nicotine, loperamide hydrochloride,and veratridine hydrochloride), a selective serotonin 
reuptake inhibitor (fluoxetine), an extracellular enzyme inhibitor (digoxin), a free radical generator (pyrogallol), a central nervous system depressant (lithium chloride), 
an enteroendocrine cell stimulant (metformin) and a prostaglandin (PGF2α).  Mean velocity and aspect pre- and post-addition of each compound has been 
summarised, where no significant difference was observed.  Statistical analyses were performed using 2-tailed paired Student t-tests, where a minimum of 30 cells 
were measured in each of three replicates.  ns = not significant. 
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NCBI 
Number Gene Organism 
Number 
 of 
Dictyostelium  Highest  
      BLAST Hits E-value 
7442 TRPV1 H. Sapiens >10 0.001 
51393 TRPV2 H. Sapiens 5 0.0006 
162514 TRPV3 H. Sapiens 8 6.00E-05 
59341 TRPV4 H. Sapiens 4 0.002 
56302 TRPV5 H. Sapiens >10 5.00E-09 
55503 TRPV6 H. Sapiens 7 2.00E-05 
193034 TRPV1 M. musculus >10 4.00E-04 
22368 TRPV2 M. musculus 1 1.00E-04 
246788 TRPV3 M. musculus 10 2.00E-05 
63873 TRPV4 M. musculus 3 5.00E-03 
194352 TRPV5 M. musculus >10 5.00E-06 
64177 TRPV6 M. musculus >10 6.00E-09 
177117 OSM-9 C. elegans >10 5.00E-06 
188314 OCR-2 C. elegans >10 5.00E-07 
 
Appendix 2.  BLAST analysis of the Dictyostelium genome for proteins showing amino 
acid similarity to TRPV receptors from multiple species.  Potential homologues are defined 
by an E-value of less than 1.00E
-40
, thus Dictyostelium does not contain proteins showing 
significant sequence similarity to be considered as homologues. 
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NCBI 
Number 
Gene 
 
Organism 
  
Number  
of 
Dictyostelium  
BLAST Hits 
Highest  
E-value 
50834 TAS2R1 H. sapien 0 N/A 
50831 TAS2R3 H. sapien 0 N/A 
50832 TAS2R4 H. sapien 0 N/A 
54429 TAS2R5 H. sapien 0 N/A 
50837 TAS2R7 H. sapien 0 N/A 
50836 TAS2R8 H. sapien 0 N/A 
50835 TAS2R9 H. sapien 0 N/A 
50839 TAS2R10 H. sapien 0 N/A 
50838 TAS2R13 H. sapien 0 N/A 
50840 TAS2R14 H. sapien 0 N/A 
50833 TAS2R16 H. sapien 0 N/A 
259294 TAS2R19 H. sapien 0 N/A 
259295 TAS2R20 H. sapien 0 N/A 
259293 TAS2R30 H. sapien 0 N/A 
259290 TAS2R31 H. sapien 0 N/A 
5726 TAS2R38 H. sapien 0 N/A 
259285 TAS2R39 H. sapien 0 N/A 
259286 TAS2R40 H. sapien 0 N/A 
259287 TAS2R41 H. sapien 1 0.034 
353164 TAS2R42 H. sapien 0 N/A 
259289 TAS2R43 H. sapien 0 N/A 
259291 TAS2R45 H. sapien 0 N/A 
259292 TAS2R46 H. sapien 0 N/A 
259296 TAS2R50 H. sapien 0 N/A 
338398 TAS2R60 H. sapien 0 N/A 
387339 TAS2R102 M. musculus 0 N/A 
667992 TAS2R103 M. musculus 0 N/A 
387340 TAS2R104 M. musculus 0 N/A 
57252 TAS2R105 M. musculus 0 N/A 
387341 TAS2R106 M. musculus 0 N/A 
387342 TAS2R107 M. musculus 0 N/A 
387343 TAS2R109 M. musculus 0 N/A 
387344 TAS2R110 M. musculus 0 N/A 
387345 TAS2R113 M. musculus 0 N/A 
387346 TAS2R114 M. musculus 0 N/A 
112408 TAS2R116 M. musculus 0 N/A 
353166 TAS2R117 M. musculus 0 N/A 
57254 TAS2R119 M. musculus 0 N/A 
387348 TAS2R120 M. musculus 0 N/A 
353167 TAS2R123 M. musculus 0 N/A 
387351 TAS2R124 M. musculus 0 N/A 
387352 TAS2R125 M. musculus 0 N/A 
387353 TAS2R126 M. musculus 0 N/A 
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387354 TAS2R129 M. musculus 0 N/A 
387511 TAS2R134 M. musculus 0 N/A 
387512 TAS2R135 M. musculus 0 N/A 
353165 TAS2R136 M. musculus 0 N/A 
387616 TAS2R140 M. musculus 0 N/A 
387514 TAS2R143 M. musculus 0 N/A 
664690 TAS2R200.1 D.rerio 0 N/A 
553134 TAS2R200.2 D.rerio 0 N/A 
798975 TAS2R202 D.rerio 0 N/A 
36094 GR47A D. melanogastar 0 N/A 
117484 GR59B D. melanogastar 0 N/A 
38935 GR66A D. melanogastar 0 N/A 
117498 GR22E D. melanogastar 0 N/A 
117349 GR22F D. melanogastar 0 N/A 
117492 GR22B D. melanogastar 0 N/A 
178236 QUI-1 C. elegans >10 
2.00E-
19 
177117 OSM-9 C. elegans >10 
5.00E-
06 
188314 OCR-2 C. elegans >10 
5.00E-
07 
 
Appendix 3.  BLAST analysis of the Dictyostelium genome for proteins showing amino 
acid similarity to known bitter receptors from multiple species.  Potential homologues are 
defined by an E-value of less than 1.00E
-40
, thus Dictyostelium does not contain proteins 
showing significant sequence similarity to be considered as homologues. N/A = Not applicable. 
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NCBI 
Number 
  
Gene 
  
Organism 
  
Number 
of 
Dictyostelium 
BLAST Hits 
Highest  
E-value 
29850 TRPM5 H. Sapiens 0 N/A 
56843 TRPM5 M. musculus 0 N/A 
 
Appendix 4.  BLAST analysis of the Dictyostelium genome for proteins showing amino 
acid similarity to TRPM5 receptors from human and mouse.  Potential homologues are 
defined by an E-value of less than 1.00E
-40
, thus Dictyostelium does not contain proteins 
showing significant sequence similarity to be considered as homologues. N/A = Not applicable. 
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Appendix 5.  Analysis of Dictyostelium wild-type cells during random cell movement 
following exposure to curcumin (5µM) after 288 seconds.  Cell behaviour was measured 
during random cell movement, with data from 30 cells quantified every 18 seconds over a 900 
second period with the addition of curcumin (5µM) after 288 seconds.  (A)  Displacement.  No 
significant change was observed between the first 288 and final 288 seconds of the assay (B) 
Circularity.  No significant change was observed between the first 288 and final 288 seconds of 
the assay.  (C) Protrusion formation.  A significant decrease in protrusion formation was 
identified between the first and final 288 seconds of the assay (P<0.05). D: Motility.  A 
significant decrease in cell motility was identified between the first 288 and final 288 seconds of 
the assay (P<0.05) Data from A-D is presented as mean of triplicate experiments analysing a 10 
cells in each.  Statistical analyses were performed using paired two-tailed Student t-tests 
comparing average values from T=0-288 and T=612-900 seconds as indicated. ns = not 
significant. 
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Chemical Gene Name A Gene Name B Gene Product A Gene Product B 
P abcC3   ABC transporter C family protein   
V abcC8   ABC transporter C family protein   
D, V abcG12   ABC transporter G family protein   
P abcG9   ABC transporter G family protein   
V acsA   acetyl-CoA synthetase   
N adcF   arrestin domain-containing protein   
P agpB   1-acylglycerol-3-phosphate O-acyltransferase   
N, V arcC   actin related protein 2/3 complex, subunit 3   
D arfGAP   Arf GTPase activating protein   
D, N, P, V armc8 DDB_G0269732 armadillo repeat-containing protein DnaJ homolog subfamily member 1 
P, N chr3:958029       
V cinC   elongation factor 2,  vegetative specific protein H6   
N, V cprA   cysteine protease   
D cupC cupD calcium up-regulated protein calcium up-regulated protein 
D, N, P, V DDB_G0267590   GRAM domain-containing protein   
V DDB_G0267824 DDB_G0267822     
D, P DDB_G0268150 DDB_G0268148 Pseudogene   
V DDB_G0268242       
D DDB_G0268250       
V DDB_G0268902   long stretch of CAA (cationic amino acid)    
D, N, P, V DDB_G0269022 DDB_G0268874     
N DDB_G0269090       
D DDB_G0269308   Pseudogene   
P DDB_G0269478 act31   actin related protein 
D, N, V DDB_G0269760   BTB/POZ domain-containing protein.    
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V DDB_G0269998 rnf10   RING zinc finger-containing protein 
V DDB_G0270300       
N DDB_G0270796   Pseudogene   
D DDB_G0270856   RabGAP/TBC domain-containing protein   
D, N, P, V DDB_G0271296 DDB_G0271294     
P DDB_G0272160       
D DDB_G0272282   protein serine/threonine kinase   
V DDB_G0272450 G0272290_RTE     
V DDB_G0272965 DDB_G0272670     
D, N, P, V DDB_G0272999   putative Ca2+ channel.  polycystin-2-like protein   
N DDB_G0273017   isocitrate lyase   
D, P, V DDB_G0273629 DDB_G0273627     
N DDB_G0274199 DDB_G0274197 putative metallophosphoesterase methyltransferase type 12 protein 
P DDB_G0275117       
D DDB_G0275393 DDB_G0275329     
N, P, V DDB_G0276263       
P DDB_G0276327 DDB_G0276271     
N, V DDB_G0277069   Deleted   
P DDB_G0277685       
D DDB_G0277769 DDB_G0277795 putative secreted protein; contains a signal sequence   
V DDB_G0277777 DDB_G0277761   endoribonuclease L-PSP 
D, P DDB_G0277795 DDB_G0277769     
D DDB_G0278235 dhkB   histidine kinase 
D DDB_G0278245 DDB_G0284605 Deleted P-type ATPase, Calcium ATPase 
D, V DDB_G0278323 DDB_G0278663   coiled-coil domain-containing protein 
N, V DDB_G0278591       
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D, P DDB_G0278663 DDB_G0278323 coiled-coil domain-containing protein   
V DDB_G0278761   NF-X1-type zinc finger-containing protein   
D DDB_G0278953   CBS domain-containing protein   
D DDB_G0279203       
N, P DDB_G0279339 DDB_G0279341     
P DDB_G0279341 DDB_G0279339     
V DDB_G0280107       
N, V DDB_G0280135 DDB_G0280133 methionine adenosyltransferase beta subunit putative protein serine/threonine kinase 
V DDB_G0280141       
V DDB_G0280441 cpiB   cystatin A2. cysteine protease inhibitor 
D, N, P DDB_G0280593   Uncharacterised protein KIAA1370   
D DDB_G0281447       
D DDB_G0282455       
V DDB_G0282719 DDB_G0282827     
V DDB_G0282783 DDB_G0282555   similar to a D. purpureum protein 
D, P, V DDB_G0283077   putative glycoside hydrolase   
P DDB_G0283417   putative protein tyrosine phosphatase   
N DDB_G0283719   DUF1740 family, HAT helix repeat-containing protein   
P DDB_G0283753 rpl26   S60 ribosomal protein L26 
D DDB_G0283967 erkB   extracellular response kinase 
D, N, V DDB_G0284149 DDB_G0284147 peripheral membrane protein located at Vid vesicles   
D DDB_G0284279   Pseudogene   
D, N, P, V DDB_G0284561       
D, P DDB_G0284989   Deleted   
D, V DDB_G0285143 osbJ Unknown 
oxysterol binding family protein, member 
10 
D, P DDB_G0285169 DDB_G0285173     
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V DDB_G0285215   domain similarity to bacterial hypothetical proteins   
N DDB_G0285547 DDB_G0285545 TRE3-A ORF2 Ctr copper transporter family protein 
V DDB_G0285705   RING zinc finger-containing protein   
D, P DDB_G0285747 DDB_G0285483 Deleted   
D DDB_G0286053 leo1 Unknown RNA polymerase II complex component 
V DDB_G0286081       
N DDB_G0286175   Unknown   
V DDB_G0286175  DDB_G0286141     
P DDB_G0286765  DDB_G0286763 AAA ATPase/BCS1-like protein   
N DDB_G0286943 DDB_G0286941 Unknown   
V DDB_G0286973       
D DDB_G0287077 gpaC protein prenyltransferase alpha subunit G-protein subunit alpha 3 
P DDB_G0287085       
V DDB_G0287201       
D, P, V DDB_G0287491   paramecium surface antigen repeat-containing protein   
V DDB_G0287873       
D DDB_G0287933   putative caspase   
D DDB_G0288003 DDB_G0288001 EGF-like protein Putative fatty acyl-CoA synthetase 
N DDB_G0288035 DDB_G0288037     
D DDB_G0288523   
1-acyl-sn-glycerol-3-phosphate acyltransferase 
gamma    
D, V DDB_G0288865 agpC Uncharacterised N-acyltransferase yjgM 
1-acylglycerol-3-phosphate O-
acyltransferase 
V DDB_G0289409       
D DDB_G0289805 DDB_G0289777 TRE3-B Pseudogene 
N DDB_G0290305 DDB_G0290307   RNA-binding region containing protein 
D DDB_G0290307 DDB_G0290305 RNA-binding region RNP-1 protein   
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D DDB_G0290867 jcdF Deleted JmjC protein 
D DDB_G0291203   transmembrane protein   
V DDB_G0291277 DDB_G0291275   mucolipin, putative Ca2+ channel 
D DDB_G0291394   Putative lipase YJR107W   
V DDB_G0291924       
V DDB_G0291968       
D, N DDB_G0292236   contains a signal peptide   
V DDB_G0293032       
V DDB_G0293282       
V DDB_G0293440       
V DDB_G0293486 fncI TRE3-C ORF1 Fanconi anemia group I protein 
D DDB_G0293492   glycoside hydrolase family 25 protein   
D DDB_G0293548 empB   emp24/gp25L/p24 family protein B 
V DDB_G0293662       
V DDB_G0294174 DDB_G0267208   DIRS1 ORF1 fragment 
D DDB_G0295725 DDB_G0278603 Unknown   
D, P dhKE   /HisK family protein kinase   
V eif2b1 panC translation initiation factor eIF-2B alpha subunit pantoate-beta-alanine ligase 
V eif3H   translation initiation factor 3 (eIF3) subunit H   
D, V eIF4g DDB_G0275393 eukaryotic translation initiation factor 4 gamma   
D elp3   elongation protein 3   
D exdl2B exdl2A 3'-5' exonuclease protein 3'-5' exonuclease protein 
D fnKD-2 fnKD-1 FNIP repeat-containing protein FNIP repeat-containing kinase 
D fnkE   putative protein serine/threonine kinase   
D forJ DDB_G0287061 formin homology domain-containing protein Rab GTPase domain-containing protein 
D, V frmC   leucine-rich repeat-containing protein (LRR)   
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D fuk DDB_G0269680 Fucokinase FG-GAP repeat containing protein 2 
P, V gacE   RhoGAP domain-containing protein   
V gbpC DDB_G0291109 RasGEF domain-containing protein   
P gbpD   
RasGEF domain-containing/ cyclic GMP-binding 
protein   
D glnA3 DDB_G0279473 glutamate-ammonia ligase NADH oxidase domain-containing protein 
D, P gnd   6-phosphogluconate dehydrogenase (decarboxylating   
V gpaE   G-protein subunit alpha 5   
P gpaI   G-protein subunit alpha 9   
D, P gpaK   G-protein subunit alpha 11   
P grlJ DDB_G0272442 G-protein-coupled receptor (GPCR) family 3 protein 9   
P gxcH   PH domain-containing/RhoGEF protein   
N, V gxcI   RhoGEF domain-containing protein   
V gxcP   pleckstrin homology (PH) domain-containing protein   
D impA   FKBP-type peptidylprolyl cis-trans isomerase (PPIase)   
P impaI   Inositol monophosphatase (IMPase)   
D, N, P kif11   kinesin family member 11   
N lmpA   lysosomal integral membrane glycoprotein   
D lysA   WD-40 repeat-containing protein   
N lysS mrpl17 lysine-tRNA ligase ribosomal protein L17, mitochondrial 
N mcfA   
transmembrane protein, mitochondrial substrate 
carrier   
D memo1   Mediator of ErbB2-driven cell motility   
D, N, V mhkB   myosin heavy chain kinase B   
D mlh3   MutL DNA mismatch repair protein   
N, V mlh3   MutL DNA mismatch repair protein   
V nol9 parG NUC156 family protein poly (ADP-ribose) glycohydrolase 
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V noxC   NADPH oxidase flavocytochrome   
N ponB DDB_G0286245 putative actin binding protein   
P psaB   puromycin-sensitive aminopeptidase-like protein   
D, V purL   phosphoribosylformylglycinamide synthase   
P, V rabR DDB_G0271978 Rab GTPase Pseudogene 
P ranbp1   Ran binding protein 1 domain-containing protein   
P rasV   Ras GTPase   
D, N rasW   Ras GTPase   
V rpa1 DDB_G0275951 RNA polymerase I, largest subunit putative transmembrane protein 
D rpl13a   
protein component of the large (60S) ribosomal 
subunit   
D rpl26   
protein component of the large (60S) ribosomal 
subunit   
V rpl3 DDB_G0291924 60S ribosomal protein L3   
D rpl32 DDB_G0271978 S60 ribosomal protein L32   
P rpl35a nek2 S60 ribosomal protein L35a protein serine/threonine kinase 
V rpl6  psmC5 60S ribosomal protein L6 26S proteasome subunit ATPase 5 
D, V rvb2 DDB_G0280773 RuvB-like protein 2   
P samm50 limG sorting and assembly machinery like protein LIM-type zinc finger-containing protein 
P sec31   WD40 repeat-containing protein   
P sibC   von Willebrand factor domain-containing protein   
D spt6   SH2 domain-containing protein   
P syn8A   syntaxin 8/  t-SNARE family protein   
V tal DDB_G0280945 Transaldolase   
V tgrA_ps3 cpnF immunoglobulin E-set family gene phospholipid-binding protein 
V tgrH_ps1 dcp2 immunoglobulin E-set family gene mRNA-decapping enzyme 2 
P thoc1 DDB_G0275497 putative THO1 protein (nuclear matrix protein p84)   
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P 
tRNA-Ser-GCU-
1   serine transfer RNA   
V 
tRNA-Tyr-GUA-
5 DDB_G0285545 tyrosine transfer RNA Ctr copper transporter family protein 
N ube2c DDB_G0278773 ubiquitin-conjugating enzyme E2 vesicle-associated membrane protein 
D ublcp1-2 ublcp1-1 ubiquitin-like CTD phosphatase 1 ubiquitin-like CTD phosphatase 1 
D udKA   uridine kinase, uridine phosphokinase   
P, V usp39   SAP DNA-binding domain-containing protein   
D, P wrnip1   Werner helicase-interacting protein 1   
V ykt6 dus4l v-SNARE family protein tRNA-dihydrouridine synthase 4-like  
N zntB crlE zinc/iron permease G-protein-coupled receptor family protein 
 
Appendix 6.  REMI mutants showing resistance to tastants.  Insertions in 187 genes that were found to convey resistance to bitter tastants denatonium 
benzoate (D), phenylthiourea (P), naringenin (N) and/or valproic acid (V).  Gene names and a brief gene description have been indicated.  Where two genes have 
been listed, the blasticidin and barcode insertion has occurred upstream or downstream of each gene, where it is unclear exactly which gene has been affected. 
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GrlJ            MKILLYIAIILSFFSLITISSECKIAVLLSGSPNDLGYNYLMNEARVKAESELKLDFSIY 60 
TAS2R38         ------------------------------------------------------------ 
                                                                             
 
GrlJ            YENLEESMEEAEKAFQDALHKGANLIVVGSFVHVGLGLKYAALTKDQDIYWIIRGNKRPN 120 
TAS2R38         ---------------------------------------MLTLTRIRTVSYEVR------ 15 
                                                         :**: : : : :*       
 
GrlJ            PDLPHVVILNFNSFELHYLLGYFSGLMTKTGIVGFVAPGPDVNTISTDNSFYLGAKYARP 180 
TAS2R38         -----------STFLFISVLEFAVGFLTN------------------------------- 33 
                           .:* :  :* :  *::*:                                
 
GrlJ            NITFLNVYVQSWYNPNVSYSAAKMLIKNGADLIGMSQDDMSCQKAMMDSGLIGIGATGYP 240 
TAS2R38         AFVFLVNFWDVVKRQALSNSDCVLLCLS------ISRLFLHGLLFLSAIQLTHFQKLSEP 87 
                 :.**  : :   .  :* * . :*  .      :*:  :     :    *  :   . * 
 
GrlJ            THLLFGGNVGVSYITNWTNLYVKYAQHVLNDDWPDYSSYFTNLSREDSIFIDDYSYKVPI 300 
TAS2R38         LNHSYQAIIMLWMIANQANLWLAACLSLL---------YCSKLIR--------FSHTFLI 130 
                 :  : . : :  *:* :**::  .  :*         * ::* *        :*:.. * 
 
GrlJ            DIQNLVNDEIQRLKNTSYIPYRSDPYLAQLGIPFDSKGLLVEDQFRANKKLLKGDSISKV 360 
TAS2R38         CLASWVSRKIS------------------------------------------------- 141 
                 : . *. :*.                                                  
 
GrlJ            IDFGQYSIPIEFIDYPNSLKYGVTIVSGVCIFICLVCMTLVVVFKKARVIKSSSPAFLLL 420 
TAS2R38         -----------------QMLLGIILCSCICTVLCVWCFFSRPHFTVTTVLFMNN------ 178 
                                 .:  *: : * :* .:*: *:     *. : *:  ..       
 
GrlJ            ILLGCCIIFAACILFAQSPTNQTCSARIWLLSLGYTLFLGNLLVKNWRIWLLFDNPKLKK 480 
TAS2R38         --------------------NTRLNWQIKDLNLFYSFLFCYL------------------ 200 
                                    *   . :*  *.* *::::  *                   
 
GrlJ            RAITNWKLYPWVFAILAIDVMILAIWQGLGNINAESRIGYDSLTQYQYKNVCSSDDQGSI 540 
TAS2R38         -----WSVPPFLLFLVSSGMLTVSLGRHMRTMKVYTRNSRDPSLEAHIK----------- 244 
                     *.: *::: ::: .:: ::: : : .::. :* . *.  : : *            
 
GrlJ            ALYLLLVFHGLVLLVACFISFKIKVVDIEEFNESKPITTSVYIITFCLFIVIPLMVSPQS 600 
TAS2R38         ALKSLVSFFCFFVISSCAA-----------------------------FISVPLLILWRD 275 
                **  *: *. :.:: :*                               ** :**::  :. 
 
GrlJ            LTSQTTIICVCAIVTTLISMLLLFGSKFYKMATQGLAINETFATSTKSSSKSSKSSYGKD 660 
TAS2R38         KIGVMVCVGIMAACPSGHAAILISGNAKLRRAVMTILLWAQSSLKVRADHKADSRTLC-- 333 
                  .  . : : *  .:  : :*: *.   : *.  : :    : ..::. *:.. :     
 
GrlJ            NPNPNAINFGEDDTSDETSEEKHKSPKQKSVNFSNKSNSHLAVFTSDEETSKTSKLSIDF 720 
TAS2R38         ------------------------------------------------------------ 
                                                                             
 
GrlJ            ENSSKDISIDQLQQQKQQPINTNGDLENKSNDKIDDDNDNSSVLSKRISNQQNGETEIDS 780 
TAS2R38         ------------------------------------------------------------ 
                                                                             
 
GrlJ            NNV 783 
TAS2R38         --- 
 
Appendix 7. Amino acid homology between GrlJ and TAS2R38.  Dictyostelium GrlJ and 
human TAS2R38, responsible for phenylthiourea detection, were aligned using Clustal Omega.  
Low sequence homology is seen in the transmembrane regions (highlighted in grey), where 
only a small region of the transmembrane domains of the two proteins overlap. 
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GrlJ            MKILLYIAIILSFFSLITISSECKIAVLLSGSPNDLGYNYLMNEARVKAESELKLDFSIY 60 
cARA            -------------------------MGLLDGNP--------------ANETSLVLLLFAD 21 
                                           **.*.*                *:.* * :    
 
GrlJ            YENLEESMEEAEKAFQDALHKGANLIVVGSFVHVGLGLKYAALTKDQDIYWIIRGNKRPN 120 
cARA            FSSMLGCMAVLIGFWRLKLLRNHVTKVIACFCATSFCKDFPSTILTLTNTAVNGG----F 77 
                :..:  .*      ::  * :.    *:..*  ..:  .:.:         :  *      
 
GrlJ            PDLPHVVILNFNSFELHYLLGYFSGLMTKTGIVGFVAPGPDVNTISTDNSFYLGAKYARP 180 
cARA            PCYLYAIVITYGSFACWLWT----------------------LCLAISIYMLIVKREPEP 115 
                *   :.:::.:.**                              :: .  : :  : ..* 
 
GrlJ            NITFLNVYVQSWYNPNVSYSAAKMLIKNGADLIGMSQDDMSCQKAMMDSGLIGIGATGYP 240 
cARA            ERFEKYYYLLCWGLP--LISTIVMLAKNTVQFVGN-------------WCWIGVSFTGYR 160 
                :      *: .*  *    *:  ** ** .:::*                 **:. ***  
 
GrlJ            THLLFGGNVGVSYITNWTNLYVKYAQHVLNDDWPDYSSYFTNLSREDSIFIDDYSYKVPI 300 
cARA            FGLFYG--------------------------------PFLFIWAISAVLVGLTSRYTYV 188 
                  *::*                                 *  :   .::::.  *  . : 
 
GrlJ            DIQNLVNDEIQRLKNTSYIPYRSDPYLAQLGIPFDSKGLLVEDQFRANKKLLKGDSISKV 360 
cARA            VIHNGVSDNKE------------------------------------------------- 199 
                 *:* *.*: :                                                  
 
GrlJ            IDFGQYSIPIEFIDYPNSLKYGVTIVSGVCIFICLVCMTLVVVFKKARVIKSSSPAFLLL 420 
cARA            ----------------KHLTYQFKLIN--YIIVFLVCWVFAVVNRIVNGLNMFPPALNIL 241 
                                : *.* ..::.   *:: *** .:.** : .. ::  .**: :* 
 
GrlJ            ILLGCCIIFAACILFAQSPTNQTCSARIWLLSLGYTLFLGNLLVKNWRIWLLFDNPKLKK 480 
cARA            HTY---------------------------LSVSHGFWAS--------VTFIYNNP---- 262 
                                              **:.: :: .        : ::::**     
 
GrlJ            RAITNWKLYPWVFAILAIDVMILAIWQGLGNINAESRIGYDSLTQYQYKNVCSSDDQGSI 540 
cARA            -----------------------LMWRYFG------------------------------ 269 
                                        :*: :*                               
 
GrlJ            ALYLLLVFHGLVLLVACFISFKIKVVDIEEFNESKPITTSVYIITFCLFIVIPLMVSPQS 600 
cARA            ------------------------------------------------------------ 
                                                                             
 
GrlJ            LTSQTTIICVCAIVTTLISMLLLFGSKFYKMATQGLAINETFATSTKSSSKSSKSSYGKD 660 
cARA            --------------AKILTVFTFFG--YFTDVQKKLEKNKNNNNPSPYSSSRGTSGKTMG 313 
                              :.::::: :**  ::. . : *  *:.  ..:  **. ..*.   . 
 
GrlJ            NPNPNAINFGEDDTSDETSEEKHKSPKQKSVNFSNKSNSHLAVFTSDEETSKTSKLSIDF 720 
cARA            G-HPTGDDVQCSSDMEQCSLERHPNMVNNQQNLNN--NYGLQQNYNDEGSSSSSLSSSDE 370 
                . :*.. :.  ..  :: * *:* .  ::. *:.*  *  *    .** :*.:*  * *  
 
GrlJ            ENSSKDISIDQLQQQKQQPINTNGDLENKSNDKIDDDNDNSSVLSKRISNQQNGETEIDS 780 
cARA            EKQTVEMQNIQIS------TSTNGQGNN-------------------------------- 392 
                *:.: ::.  *:.       .***: :*                                 
 
GrlJ            NNV 783 
cARA            --- 
                    
 
Appendix 8. Amino acid homology between GrlJ and cARA.  Dictyostelium GrlJ and cARA, 
responsible for cAMP signal detection, were aligned using Clustal Omega.  Low sequence 
homology homology is seen in the transmembrane regions (highlighted in grey), where only a 
small region of the transmembrane domains of the two proteins overlap. 
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Investigating the effect of emetic compounds on chemotaxis in 
Dictyostelium identifies a non-sentient model for bitter and hot 
tastant research 
Steven Robery1, Janina Mukanowa1, Nathalie Percie du Sert2, Paul L. R. 
Andrews2, Robin S. B. Williams1,* 
1Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway 
University of London, Egham TW20 0EX, UK 
2Division of Biomedical Sciences, St George's University of London, London 
SW17 0RE, UK 
2011, PlosOne 
Abstract  
Novel chemical entities (NCEs) may be investigated for emetic liability in a range of 
unpleasant experiments involving retching, vomiting or conditioned taste 
aversion/food avoidance in sentient animals. We have used a range of compounds 
with known emetic /aversive properties to examine the possibility of using the social 
amoeba, Dictyostelium discoideum, for research into identifying and understanding 
emetic liability, and hence reduce adverse animal experimentation in this area.  
Twenty eight emetic or taste aversive compounds were employed to investigate the 
acute (10 min) effect of compounds on Dictyostelium cell behaviour (shape, speed 
and direction of movement) in a shallow chemotactic gradient (Dunn chamber). 
Compound concentrations were chosen based on those previously reported to be 
emetic or aversive in in vivo studies and results were recorded and quantified by 
automated image analysis. Dictyostelium cell motility was rapidly and strongly 
inhibited by four structurally distinct tastants (three bitter tasting compounds - 
denatonium benzoate, quinine hydrochloride, phenylthiourea, and the pungent 
constituent of chilli peppers - capsaicin). In addition, stomach irritants (copper 
chloride and copper sulphate), and a phosphodiesterase IV inhibitor also rapidly 
blocked movement. A concentration-dependant relationship was established for five 
of these compounds, showing potency of inhibition as capsaicin (IC50=11.9±4.0µM) 
> quinine hydrochloride (IC50=44.3±6.8µM) > denatonium benzoate (IC50=129±4µM) 
> phenylthiourea (IC50=366±5µM) > copper sulphate (IC50=1433±3µM). In contrast, 
21 compounds within the cytotoxic and receptor agonist/antagonist classes did not 
affect cell behaviour. Further analysis of bitter and pungent compounds showed that 
the effect on cell behaviour was reversible and not cytotoxic, suggesting an 
uncharacterised molecular mechanism of action for these compounds. These results 
therefore demonstrate that Dictyostelium has potential as a non-sentient model in 
the analysis of the molecular effects of tastants, although it has limited utility in 
identification of emetic agents in general.  
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A novel human receptor involved in bitter tastant detection 
identified using the model organism Dictyostelium discoideum 
Steven Robery1, Richard Tyson2, Christopher Dinh3, Adam Kuspa3, Angelika A 
Noegel4, Till Bretschneider2, Paul L R Andrews5, Robin S B Williams1 
1Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway 
University of London, Egham TW20 0EX, UK 
2Molecular Organization and Assembly in Cells, University of Warwick, 
Coventry, CV4 7AL, UK 
3Department of Biochemistry and Molecular Biology, Baylor College of 
Medicine, Houston, Texas 77030, USA 
4Institute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, 
Germany 
5Division of Biomedical Sciences, St George's University of London, London 
SW17 0RE, UK 
2013 Journal Cell Science 
Abstract 
Detection of substances tasting bitter to humans occurs in diverse organisms 
including the social amoeba, Dictyostelium discoideum. To establish a 
molecular mechanism for bitter tastant detection in Dictyostelium, we screened 
a mutant library for resistance to a commonly used bitter standard, 
phenylthiourea. This approach identified a G-protein coupled receptor mutant, 
grlJ-, showing a significantly increased tolerance to phenylthiourea in growth, 
survival and movement. This mutant was not resistant to a structurally dissimilar 
potent bitter tastant, denatonium benzoate, suggesting it is not a target for at 
least one other bitter tastant. Analysis of the cell signalling pathway involved in 
the detection of phenylthiourea showed dependence upon heterotrimeric G-
protein and phosphatidylinositol 3-kinase activity, suggesting this signalling 
pathway is responsible for phenylthiourea cellular effects. This is further 
supported by a phenylthiourea-dependent block in the transient cAMP-induced 
production of PIP3 in wild type but not grlJ
-cells. Finally, we have identified an 
uncharacterized human protein gamma-aminobutyric acid (GABA) type B 
receptor subunit 1 isoform with weak homology to GrlJ that restored grlJ-
 sensitivity to phenylthiourea in cell movement and PIP3 regulation. Our data 
thus identifies a novel pathway for the detection of the standard bitter tastant, 
phenylthiourea, in Dictyostelium and implicates a poorly characterized human 
protein in phenylthiourea dependent cell responses. 
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Naringenin inhibits the growth of Dictyostelium and MDCK-
derived cysts in a polycystin-2 (TRPP2)-dependent manner 
Abdul Waheed1, Marthe Ludtmann2, Nicholl Pakes2, Steven Robery2, Adam 
Kuspa3, Christopher Dinh3, Deborah Baines1, Robin S B Williams2, Mark 
Carew1 
1School of Pharmacy & Chemistry, Kingston University, Penrhyn Road, 
Kingston upon Thames, Surrey, KT1 2EE, UK 
2Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway 
University of London, Egham TW20 0EX, UK 
3Department of Biochemistry and Molecular Biology, Baylor College of 
Medicine, Houston, Texas 77030, USA 
2013 British Journal of Pharmacology 
Abstract 
BACKGROUND AND PURPOSE:  Identifying and characterising potential new 
therapeutic agents to target cell proliferation may provide improved treatments 
for neoplastic disorders such as cancer and polycystic diseases. 
EXPERIMENTAL APPROACH:  We used the simple, tractable biomedical 
model Dictyostelium to investigate the molecular mechanism of naringenin, a 
dietary flavonoid with antiproliferative and chemopreventive actions in vitro and 
in animal models of carcinogenesis. We then translated these results to a 
mammalian kidney model, MDCK renal tubule cells, growing in culture and as 
cysts in a collagen matrix. 
KEY RESULTS:  Naringenin inhibited Dictyostelium growth, but not 
development, with an EC50 of 50-100 μM. Screening of a library of random 
gene knockout mutants identified a mutant lacking polycystin-2 that was 
resistant to the effect of naringenin on growth and random cell movement. 
Polycystin-2 (TRPP2) is a divalent cation channel, where mutations in the 
protein give rise to type 2 autosomal dominant polycystic kidney disease. 
Naringenin inhibited MDCK cell growth with an EC50 of 28 μM, and inhibited 
cyst growth with an EC50 of 3-10 μM. Knockdown of polycystin-2 levels by 
siRNA in this model conferred partial resistance to naringenin such that cysts 
treated with 3 and 10 μM naringenin were larger following polycystin-2 
knockdown compared to controls. Naringenin did not affect chloride secretion. 
CONCLUSIONS AND IMPLICATIONS:  The action of naringenin on cell growth 
in the phylogenetically diverse systems of Dictyostelium and mammalian kidney 
cells, suggests a conserved effect mediated by polycystin-2 (TRPP2). Further 
studies will investigate naringenin as a potential new therapeutic agent in 
ADPKD. 
